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ABSTRACT 
 
EXPANDING PRESUMPTIVE MALE PARTNER MANAGEMENT OF 
SEXUALLY TRANSMITTED INFECTIONS (STIs) TO WESTERN CAPE, 
SOUTH AFRICAN COMMUNITY RETAIL PHARMACIES  
 
K.L. Ward 
 
D. Pharm thesis, School of Pharmacy, University of Western Cape 
 
The effect of industrialisation has thrust the pharmaceutical profession into a 
clinical paradigm where the approach to pharmaceutical decisions is more 
disease and patient orientated. Consequently, South African community 
pharmacies are inundated with requests from the public for advice and 
treatment on a wide range of medical conditions, including sexually 
transmitted infections (STIs).   Although community pharmacies are often the 
first port of call for undiagnosed STI, limited diagnostic skills and legally-
imposed prescribing restrictions preclude pharmacists from providing the 
necessary clinical management. The epidemiological approach to treating 
sexual partners, which is based on the diagnosis of the index case by a 
medical practitioner, presents an untapped opportunity for pharmacist-
delivered treatment and counselling.   
 
The overarching goal of this dissertation is to present objective arguments and 
evidences (new and existing) around an expanded role for pharmacists in STI 
partner management. Central to this thesis is a quantitative research 
undertaking with two primary goals, the first of which is to evaluate the effect 
of an STI distance learning course on the knowledge of pharmacists with 
respect to STI and secondly, to determine whether STI information packets 
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facilitate the provision of counselling and treatment to male sexual partners. A 
secondary goal, conceived out of noted poor participation in the main study, 
was to evaluate the resistance of pharmacists to expanded scopes of practice, 
which was operationalised in this study as resistance to change (RTC).  
 
Eighty community retail pharmacies from a previous baseline, stratified 
(urban or rural), randomly sampled cross-sectional survey (Ward et al., 2003) 
and 20 identically sampled and stratified additional pharmacies comprised the 
main study sample. Pharmacists completed a distance-learning course in STI 
syndromic management and completed pre- and post-training evaluations.  
Thereafter, six rounds of simulated partner visits were made to each pharmacy 
to assess pharmacists’ proficiency with respect to counselling and 
recommending antimicrobial therapy for urethral discharge syndrome (UDS) 
and genital ulcerative syndrome (GUS).  
  
Twenty pharmacists from the main study (participants) and an equal number 
of those declining the invitation to participate during the initial recruitment 
stage (non-participants) completed a telephonic interview to determine 
whether a lack of participation was linked to the pharmacist’s inherent RTC, 
as established by pharmacists’ responses (on scales of 1-6) to 18 statements. 
 
Pharmacists’ previous commitments to participate in the main study (Ward et 
al., 2003) were not fulfilled (41% response rate). High levels of knowledge 
were reflected in the post-training evaluations and a significant improvement 
in test scores was achieved as a result of the training intervention (73.4% to 
87.5% in urban pharmacies, p<0.05 and 75.4% to 86.3% in rural pharmacies, 
p<0.05).  The overall level of counselling was deemed inadequate (an average 
of <7/13 messages were delivered).  The actual utilisation of STI information 
packets, as opposed to mere assignment to pharmacies, which made no impact 
on outcomes, promoted more extensive counselling for urethral discharge 
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syndromes (p=0.01) only. Generally, rural pharmacists were significantly 
more likely than urban pharmacists to provide appropriate therapies for 
genital ulcer syndromes (p=0.03).  
 
In the subsidiary study, RTC was marginally higher in the group of non-
participants than participants (3.4 versus 3.1) although these differences failed 
to achieve statistical significance (p=0.08).  A deep-seated resistance to 
change was therefore not attributable to poor participation in the main study. 
 
Despite the poor levels of clinical management achieved in this study, the 
country’s shift to primary health care, the continuing demand for STI services 
in the informal sector and the willingness of pharmacists to provide these 
services warrants the future involvement of pharmacists in presumptive STI 
partner management. Modifiable external factors, as opposed to deeply rooted 
internal resistance, are more likely to impede efforts geared toward expanding 
the role of community retail pharmacists. 
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TERMS AND DEFINITIONS 
 
Community retail pharmacies  
Privately owned independent or chain pharmacies consisting of a retail storefront and 
a dispensary for the regulated sale of scheduled drugs.  
 
Head pharmacist 
A qualified pharmacist who is either the owner or full-time manager of a community 
retail pharmacy. 
 
Index patient 
An index patient, in this study, refers to the initial/primary STI case, as contrasted 
with the appearance of subsequent cases. 
 
Partners 
For the purposes of this study, the term “partners” refers to contacts of patients who 
have recently been diagnosed with an STI in a health care facility. 
 
Presumptive treatment 
Within the context of this thesis, presumptive treatment refers to the treatment of 
suspected STIs without, or prior to any confirmatory laboratory tests.  An example of 
presumptive treatment is epidemiological treatment whereby treatment is given to 
contacts of patients diagnosed with STI “after a history of exposure to disease but 
without or in advance of confirmatory pathological findings” (Carne, 1997, p.115). 
 
Primary health care 
Based on the World Health Organisation Alma Ata international conference 
definition, primary health care is:  
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“essential health care based on practical, scientifically sound and socially 
acceptable methods and technology made universally accessible to individuals 
and families in the community through their full participation and at a cost that 
the community and the country can afford to maintain at every stage of their 
development in the spirit of self-determination" (World Health Organisation, 
1978, p. 4) 
 
Public private partnerships 
According to the national treasury, PPP is defined as a: 
“contract between a government institution and private party, where: the 
private party performs an institutional function and/or uses state property 
in terms of output specifications; substantial project risk (financial, 
technical and operational) is transferred to the private party; the private 
party benefits through: unitary payments from government budgets and/or 
user fees.”  (National Treasury, 2007, p.5) 
 
Public private interactions  
PPI, as defined in the South African health charter, is when: 
“One or more persons or entities involved in health care within the public 
sector interact with one or more persons or entities involved in health care 
within the private sector or the NGO sector with the object of achieving a 
mutual benefit or goal and includes but is not limited to a PPP; PPIs 
include: public financing of health services provided by the private and/or 
NGO sectors; private financing of publicly provided health services; 
innovative healthcare delivery models and business models for health 
practices; delivery models aimed at skill retention and effective 
distribution and utilisation of skills; use of public assets for the provision 
of health services by the private sector; use of private assets for the 
provision of health services by the public sector.”  (Department of health, 
2004, p.10). 
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Urban versus rural areas 
An urban area, as defined by the Provincial Administration of the Western Cape, 
includes towns, cities and metropolitan areas.  The main urban area in the Western 
Cape is the Cape Metropolis, whereas non-urban (peri-urban and rural) areas include 
commercial farms, small settlements, rural villages and other areas further away from 
towns and cities (Department of Health Western Cape, 2001). 
 
Syndromic approach 
The syndromic approach is based on classifying the causative organisms that give rise 
to a particular clinical picture/syndrome; treatment consists of multiple antimicrobials 
with known efficacy across the spectrum of organisms. Treatment encompasses a 
package of care including provision of information and education; counselling on 
completion on course of antimicrobials; contact tracing and counselling, voluntary 
counselling and testing (VCT) referral and condom promotion, distribution and 
instructions.  This approach allows any health care worker to be trained in the use of 
algorithms to reach a diagnosis and prescribe suitable treatment (Ballard et al., 2000). 
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CHAPTER 1 
INTRODUCTION 
 
____________________________________________________________________ 
 
South Africa has one of the highest prevalences of HIV in the world (UNAIDS, 
2006). Notwithstanding the recently publicized progress in national provision of 
antiretroviral therapy, prevention through various strategies, including management 
and control of sexually transmitted infections (STI) remains the cornerstone of South 
Africa’s HIV/AIDS control strategy (Department of Health, 2007a). In a healthcare 
system fraught with human resource deficiencies (Dayi & Gray, 2006), the utilization 
of existing skills and the expansion of skills inherent to specific health professions at 
primary care level could facilitate the implementation of national HIV plans. 
 
In South Africa, community retail pharmacies are often the first port of call for clients 
with medical problems; accessibility, after hour availability and prompt client 
assistance are among the reasons cited for this preference (Gilbert, 1998).  Though 
often sought for curative services (Ward et al., 2003), legislative restrictions bar 
pharmacists from diagnosing and treating medical problems, except for “minor 
ailments” (Republic of South Africa, 1997a).  To determine the extent to which 
community pharmacists are called upon to treat patients with STI symptoms, the 
treatment practices of pharmacists, and their willingness to receive training on the 
syndromic management of STI, a survey of community pharmacists was conducted in 
the Western Cape region in 2001 (Ward et al., 2003). This survey confirmed 
anecdotal reports that pharmacists are often sought for STI treatment, corroborating 
similar findings in Mexico, Nepal and Peru (Bista et al., 2002; Garcia et al., 2003; 
Turner et al., 2003). The survey also noted that pharmacists were inadequately trained 
to provide syndromic treatment and that their level of willingness to receive training 
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and provide therapy was high.  Conversely, pharmacists expressed a general 
reluctance to encroach on some of the more exclusive practices of nurses and doctors 
such as conducting a thorough physical examination of the genitalia, for which 
pharmacists do not traditionally receive training. Clinical skills in rational 
pharmacotherapy and chronic disease management already fall within the ambit of a 
pharmacist’s professional artillery, and thus, if coupled with skill development in 
clinical diagnostic procedures, their capacity to be active role-players in HIV 
prevention strategies such as the syndromic management of STI index clients is 
strengthened. Alternatively, maximizing the existing skills of pharmacists for the 
presumptive treatment of STI contacts will certainly contribute much needed human 
resources toward the challenges presented in STI partner management and therewith 
potentially stem the continued spread of disease.  
 
Community retail pharmacists in South Africa are moving away from customary 
business practices to a more service-oriented approach due in part to the country’s 
move to limit the costs pharmacists may charge for medications (Republic of South 
Africa, 1997a). By providing direct patient care, as is done in the epidemiological 
treatment of STI contacts, pharmacists may charge for their services, thereby 
offsetting any possible loss of income from the change in pricing of medications. 
Providing specific STI syndromic training and provision of treatment packets 
combined with the changing role of community pharmacist has the potential to 
increase appropriate treatment of STIs in the private sector thereby decreasing the 
overall burden of these conditions. 
 
The primary objective of this thesis was therefore to evaluate the impact of an STI 
training intervention on the general STI knowledge of pharmacists and to assess the 
impact of an STI management intervention on the counselling and treatment practices 
of pharmacists.  Furthermore, a follow-on explorative study into the willingness of 
pharmacists to embrace the new roles defined in this thesis ensued in the wake of an 
unexpectedly poor response rate; quantification and measurement of the differences 
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in resistance to professional growth (operationalised as resistance to change) between 
a sub-sample of the study participants and pharmacists who declined the opportunity 
to enrol into the study was undertaken at the end of the data collection for the main 
study.  
 
Chapter two sets the backdrop for proposed pharmacist role change initiatives within 
the South African health care system. An overview of selected health indicators 
depicts an immensely challenged health sector further subverted by human resource 
deficiencies. Private sector involvement in public health initiatives is explored with a 
view to demonstrate the need for private community pharmacists to engage more 
actively with the public sector in the provision of primary health care services. 
 
In the third chapter, a summary and synthesis of relevant literature further 
substantiates the relevance of role expansion in human resource planning today and 
marries the proposed expanded role for pharmacists with global strategies for HIV 
prevention through STI management and control at primary care level. The literature 
review critically analyses published research study findings and reviews, borrows 
insights from treatises and examines pertinent local and international policy and 
legislative documents, with a view to develop the theoretical underpinnings for an 
advanced role pharmacist in primary care, more especially in syndromic sexually 
transmitted infection (STI) management. The review is divided into two subsections, 
the first of which seeks to elucidate obscurities surrounding the value of STI 
management in the fight against HIV and the effectiveness of various elements of the 
syndromic approach.  The second instalment explores global trends in meeting human 
resource needs in primary healthcare settings. 
 
The rationale for the main study as well as the main research objectives is outlined in 
chapter 4.  A delineation of the design and methods employed in the training and 
management intervention study, as well as statistical and ethical issues are presented 
in chapter 5, followed by a description of the main results obtained from this 
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undertaking (chapter 6).  Study findings are summarized in text, tables and figures 
according to the sequence in which the data was collected; firstly the results of the 
training interventions are described in the order of descriptive, bivariate and 
multivariate analyses and this is followed, in the same order, by STI management 
intervention findings. 
 
The discussion in chapter seven explores plausible underpinnings for the results 
obtained within this thesis. The main findings, dictated by the primary hypotheses, 
will be central to the discussion, while subsidiary findings of statistical note will 
supplement this discussion by way of brief elucidation.  
 
One of the more salient findings in chapter 6, i.e. the poor response rate, is dissected 
further through a subsidiary study in chapter 8, entitled, “Resistance to change: 
predictor of poor participation in STI training course by community pharmacists?” A 
review of literature, which culminated in the retrieval of a validated measurement 
scale for underlying resistance to change, independent of extraneous or circumstantial 
factors, will be described.  This will be followed by an outline of the study objectives, 
methods, the results and a discussion of the main findings.  
  
Finally, a distillation of the research findings, scholarly views and author opinions 
draws the thesis to a close in chapter 9.  
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CHAPTER 2 
BACKGROUND 
 
__________________________________________________________________ 
 
This chapter serves to create a backdrop for the proposed advanced role for 
pharmacists in community pharmacy.  Reflections on selected historical, political, 
legislative, social, economic and epidemiological forces impacting the current 
health system will contextualise the need for health care role innovation. More 
specifically, the overview will explore the efficiency of the South African health 
system in relation to other sub-Sahara African and developing nations, the 
progress of government in attaining the goals of health through the public health 
sector and private stewardship processes and the Department of Health’s 
efficiency in dealing with the public health crisis of HIV/AIDS through various 
strategies including the management and control of STI at primary health care 
level.  Furthermore, a synopsis of the contribution made by community pharmacy 
to primary health care in general will be given, with a view to highlight untapped 
opportunities for growth within this setting. Finally, a discussion around the 
plausible impact of recent legislative changes on a future primary health care role 
for pharmacists will conclude the background.  
 
__________________________________________________________________ 
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2.1   THE SOUTH AFRICAN HEALTH SYSTEM 
Although SA is regarded as an upper middle-income nation, wide income 
disparities and a dual economy relegates it to a developing-country status. The 
socio-economic inequalities within the population contribute towards the high 
private-public health expenditure differential, which undermines the performance 
of the national health system as a whole (World Health Organisation, 2000).  
 
2.1.1 Relative efficiency 
The South African health system is comprised of a sizeable public sector and a 
mushrooming private sector; fifteen percent of the population (~7 million) –
invariably medical aid beneficiaries –patronize the latter, while nearly 85% (~40 
million) of the population utilize the former. Funding disparities between the 
private and public sector are notably rife within the health system: the private 
sector, funded by medical aid scheme contributions and individual out-of-pocket 
expenses, is inordinately well resourced, accounting for over 60% of the total 
health expenditure, while less than 40% of expenditure, constituting taxation 
funding, caters for the health needs of the overwhelming majority (Dayi & Gray, 
2006).  The resultant poor segmentation of health funding between the private and 
public sector is a fundamental reason for the unfavourable placing of South Africa 
in a WHO ranking of world health systems.  Although a relatively high proportion 
(8%) of the nation’s gross domestic profit (GDP) is spent on health, SA ranks in 
the lower percentile of the world’s nations.  This, in stark contrast to other middle 
income-developing countries performing more favourably; Chile, Croatia and 
Argentina all rank in the top 80 while South Africa only managed a placing of 
175th.  Furthermore, failure to top the list of health systems in Sub-Saharan Africa 
countries belies the superiority of the South African economy relative to Ghana, 
Kenya, Uganda and Zimbabwe – all placed above South Africa (World Health 
Organisation, 2000).  The said WHO report has, however, come under intense 
scrutiny by other development agencies and was subsequently criticised for the 
utilisation of an unsubstantiated index for the measurement of socioeconomic 
inequalities in mortality that does not correspond with international variations 
obtained from established indices (Houweling et al., 2001). 
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In addition to the sectoral segmentation with respect to health care funding, 
selected health indicators are used in the evaluation of health systems, viz, the 
overall daily adjustment life expectancy (DALE)1; responsiveness to non-health 
needs (e.g. dignity and respect conferred by health providers and the right to client 
choice of provider etc.), and disparities in individual funding contributions 
towards health expenses as a percentage of total earnings (World Health 
Organisation, 2000). Poor outcomes with regards to these indicators have 
consequently attributed to the devaluation of the South African health system.  
This begs the question: is the South African health system, in its current state, 
poised to deal with public health crises, not least of all the colossal HIV 
pandemic? 
 
The failure of the South African health system to be competitive on an 
international or even a continental level inspires poor confidence in its ability to 
deal with the myriad of public health issues currently facing this nation. While the 
responsibility for a poorly functioning health system does not wholly rest on the 
shoulders of government, their stewardship role in healthcare confers enormous 
influence on the functioning of the health system. In this regard, the government 
is deemed responsible for: 1) assuring the effective management of the public 
sector, 2) regulating the private sector, and 3) facilitating a co-operative 
relationship between the public and private sector (Leon & Mabope, 2005).   The 
successes and failures of government with respect to these key roles will, in 
essence, determine the efficiency of the system. 
 
2.1.2 Government’s stewardship role 
2.1.2.1  Management of the public health sector  
Post-apartheid South Africa inherited a highly bureaucratic and vertically 
managed health system that was deliberately oblivious to the health needs of the 
                                                 
1  Measure of years lived minus an estimated percentage for each year lived in incomplete health. 
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masses. Under the old regime, health services were delivered in a fragmented and 
discriminatory manner, overtly favouring an elitist ethnic minority residing in 
urban areas.  Furthermore, the government of the day placed greater pre-eminence 
upon curative, as opposed to preventative health, incurring enormous expenditure 
in the up-keep of secondary healthcare facilities (Department of Health, 2000a). 
 
In a bid to enhance overall accessibility and affordability of essential health 
services, the 1994 elected government of national unity, in accordance with the 
White Paper for Transformation of Health Sector in 1997, decentralized the health 
administration to a local level of control by way of a district health system (DHS) 
(Department of Health, 1997). The unified district health system, underpinned by 
the philosophy of primary health care (PHC), was geographically aligned with 
local government jurisdictions within the nine provinces of South Africa (Eastern 
Cape (EC), Gauteng (GT), Kwazulu-Natal (KZN), Mpumalanga (MP), Northern 
Cape (NC), Limpopo Province (LP), North West (NW), Free State (FS) and 
Western Cape (WC)).  Whilst provincial control over hospitals was retained, local 
authorities adopted the responsibility for administering primary health care 
services (Department of Health, 2000b). 
 
To date, significant strides have been made in implementing the DHS in South 
Africa: 700 clinics have been upgraded or built; 2298 clinics have been supplied 
with new equipment and 125 new mobile clinics have been established. Overall, 
the public sector offers services from 3500 clinics across the country (Department 
of Health, 2000b), which translates to 10.5 PHC facilities per 100 000 population.  
The density disparities between provinces, ranging from 5.5 in GT to 19 in the NC 
per 100 000 people, correspond to the district expenditure differential between the 
2 provinces (Dayi & Gray, 2006). 
 
On a national level, the utilization of PHC facilities remains sub optimal, yielding 
annual rates of less than 3.5 (national target) visits per person2. Notwithstanding 
the national underperformance, the improvement in utilization rates in nearly 60% 
                                                 
2 Public-sector dependent population only 
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of districts since 2003 inspires optimism for further progress (Dayi & Gray, 
2006).  Moreover, financial resources have been earmarked in the Medium Term 
Expenditure Framework for the DHS, and are expected to facilitate the attainment 
of this target within the next 3 years (Baron et al., 2006). 
 
Human resource deficiencies, a key determinant of poor health service delivery 
and therefore an impediment to the attainment of positive health indicators, have 
become a point of notoriety within the revamped public health sector of South 
Africa. In recent years the national shortfall of health professionals in the public 
sector has hovered around the 30% mark, ranging from 16% in the Limpopo (LP) 
to 43% in Mpumalanga (MP) in 2006.  Only a fraction of pharmacists (<20%) and 
doctors (<30%) are employed in the public sector, yielding national ratios of 4.3 
and 23.7 to every 100 000 people respectively. A more equitable spread of 
professional nurses across the public and private sector has yielded ratios in 
excess of 100 state employed nurses per 100 000 people (Dayi & Gray, 2006).  
The unequal distribution of selected health personnel – overtly favouring the 
private sector – may be attributed to several factors, among others, more lucrative 
salaries (up to six times higher than public sector) and better working conditions 
as a result of higher staff to patient ratios (Paradath et al., 2003). The recent 
implementation of government policies to avert the human resource crisis has met 
with only marginal success: compulsory community service for graduates of 
selected health professions; obligatory tenures in public service for health 
professional students holding government bursaries; the introduction of racial 
quotas to ensure the enrolment of students representative of peripheral areas, and 
enhancement of student preparedness for public service through service training 
initiatives, have resulted in only nominal improvements in public sector staffing 
(Dayi & Gray, 2006).  The aforementioned initiatives have, furthermore, achieved 
negligible strides in promoting staff retention at the end of obligatory public 
service, which has translated to high human resource turnover in public sector 
facilities and poor continuity of care. 
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The unbalanced distribution of human resources is aggravated by a problem of   
skill scarcity. Due to aggressive health professional recruitment from Western 
first world countries, the pool of human resources has dwindled quite 
dramatically. In a bid to avert the “brain drain”, South Africa, in concert with 
other Southern African Development Community (SADC) countries, has 
successfully negotiated ethical international recruitment codes of conduct with 
countries such as the United Kingdom.  Furthermore, national policy-driven 
training initiatives to increase the number of health professional graduates, 
coupled by skill-mix initiatives to enhance the capacity of available staff, should 
augment efforts to mitigate the skills dearth (Paradath et al., 2003). 
 
In summary, the South African government faces enormous challenges in its 
plight to successfully manage the public heath sector, not least of all the human 
resource deficiencies, skills dearth and financial constraints.  The fate of the 
public health sector ultimately hinges on vital decisions taken at governmental 
level, which may or may not involve the private sector. 
 
2.1.2.2   Regulation of private sector and public-private partnerships 
Although the private sector generally meets the regulatory function of government 
with antipathy and cynicism, this stewardship role should perhaps be regarded as 
a necessary vice. Attesting to this view is the enactment of various pieces of 
legislation over the past 10 years, inter alia the Health Act No. 61 of 2003 
(Republic of South Africa, 2003) and the Medical Schemes Act No. 131 of 1998 
(Republic of South Africa, 1998) as amended, which have effectively enhanced 
general accessibility of healthcare facilities and medical schemes to previously 
marginalized segments of the population. Amendments to the Health Act have 
made provision for the equitable distribution of private health establishments in 
South Africa through the selective granting of certifications of need.  Similarly, 
modifications to the Medical Schemes Act have paved the way for greater 
accessibility to health insurance by high-risk populations, the aged and less 
affluent, through minimum benefit packages (Republic of South Africa, 1998, 
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2003).  Furthermore, the Medicines and Related Substances Control Act 2002 as 
amended – pending an appeal by pharmaceutical representative bodies – will 
enable the government to regulate the non-profit sale of medicines, thereby 
enhancing the affordability of essential drugs (Republic of South Africa, 1997a).  
 
The prevailing acrimony between the Department of Health and private enterprise 
is antithetical to sentiments expressed by the health minister in the Health Act 
preamble with respect to the desired synergism between the two sectors, i.e. to:   
 “Promote a spirit of cooperation and shared responsibility among public 
and private health professionals and providers and other relevant sectors 
within the context of national, provincial and district health plans.” 
(Republic of South Africa, 2003, p. 4).   
By contrast, strategies promoting mutually beneficial partnerships between 
government and the private sector are more likely to foster the desired 
cooperation. 
  
As strong proponents of public private interactions (PPIs), the government 
acknowledges the importance of private sector involvement in addressing public 
health priorities. The establishment of such interactions is predominantly based on 
a service delivery model (Leon & Mabope 2005), which allows the private sector 
to offer services on behalf of the public sector and/or the exchange of services or 
goods between the two sectors. Consequently, an abundance of resources in the 
private sector are tapped by the public sector without the incurrence of exorbitant 
cost and risk. 
 
Regrettably, setbacks have abounded in the implementation of healthcare PPI in 
South Africa due to fundamental planning glitches. In the absence of a policy 
framework defining PPI and outlining the objectives and procedural establishment 
thereof, the process of developing sound and sustainable partnerships has been 
hampered. Discord in vision between various stakeholders prevails in 
consequence of these conceptual gaps, which further subverts a well-intended 
innovation. A further threat to successful PPI establishment has been the growing 
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mistrust emanating from the private sector in response to government’s perceived 
regulatory encroachment on private enterprise (Leon & Mabope, 2005).   
  
The fragmented approach to establishing PPIs without a guiding policy 
framework potentially undermines continuity of interactions between the public 
and private sector and widens the gulf of mistrust between the two sectors.  In 
essence, the regulatory imperatives of government will not be adequately fulfilled 
unless the fundamental policies for PPI implementation are expressly delineated.  
With this in place, government will be well poised to exploit the leveraging effect 
of establishing partnerships with a richly resourced private sector.  
 
In summary, the incumbent government has made significant strides in 
remodelling the foundation of public health, thereby closing some of the 
healthcare gaps induced by the apartheid regime. However, health indicators in 
general reflect poorly against national targets and residual interprovincial 
disparities remain a concern. Furthermore, the sustainability of supplementary 
funding to accommodate the escalating public health budgets is questionable, 
while human resource deficiencies and skill scarcity are, at this juncture, 
tantamount to a crisis. The best way forward remains ill-defined; however, 
attempts to develop cohesive strategies involving both the public and private 
sector are certainly at a premium in the face of immense public health challenges, 
not least of all a burdensome HIV epidemic. 
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2.2   THE HIV/AIDS PANDEMIC 
 
2.2.1   A public health priority?  
South Africa is currently plagued by one of the most devastating HIV pandemics 
in the world (UNAIDS, 2006); the magnitude and pervasiveness of disease is 
clearly demonstrated in the results of the 2006 national antenatal survey reflecting 
a prevalence of 29.1% (Department of Health, 2007b).  The impact of deaths due 
to AIDS is far-reaching, adversely affecting the economic, social and welfare 
systems as well as overall population growth (Actuarial Society of South Africa, 
2003); nearly 40% of deaths among the most economically viable age group (15-
49 year olds) are attributed to HIV/AIDS (Dorrington et al., 2001), overall life 
expectancy has plunged from 57 in 1998 to 50.7 in 2006 and the number of 
orphaned children as a result of HIV has escalated to a disconcertingly high 1.2 
million (Dayi & Gray, 2006).   
 
A gross failure by the Department of Health and other governmental ministries to 
promptly address the rising HIV levels in the early 1990s has contributed toward 
the rampant spread of infection from prevalence rates of 0.7% in 1990 to an 
astounding 22.8% in 1998.  Furthermore, the dissident views held by leading 
politicians in the ruling governmental party at the turn of the 21st century, are 
thought to have further fuelled this epidemic. While the first HIV/AIDS and STI 
strategic plan for 2000-2005 (Department of Health, 2000c) was essentially 
prevention-based, vehement lobbying from advocacy groups successfully paved 
the way for the launch of an Operational Plan for Comprehensive HIV and AIDS 
Care encompassing strategies to roll out ARV therapy in selected public sector 
health facilities (Department of Health, 2003). By early 2006, national 
antiretroviral therapy (ART) coverage rates3 in the public sector were 18.3%, 
ranging from 6.8% in MP to 43.2% in WC (Dayi & Gray, 2006).   
 
                                                 
3 ART coverage is the percentage of the population estimated to be in need of ART who are 
receiving ART. 
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In recent years infection rates have plateaued, although exhibiting no signs of 
tapering off. The provinces hit hardest by the epidemic are KZN (39.1%), MP 
(32.1%) and FS (31.1%), while the WC remains the province exhibiting the 
lowest HIV prevalence. The steady increase in WC infection rates from 3.1% to 
15.2% from 1996 to 2006 is, however, a growing concern (Department of Health, 
2007b).   
  
2.2.2   Prevention through management and control of STI 
Notwithstanding the significant strides made in terms of accessing ARV therapy, 
prevention remains the cornerstone of public health strategies, inter alia, 
improving the management and control of the estimated 11 million new STI 
episodes occurring in South Africa annually (Department of Health, 2007b; Sonko 
et al., 2003). Syndromic management was adopted as a national treatment 
approach in public primary healthcare facilities in the mid-1990s and by 2002, 
50% of public sector professional nurses had received training in SM and nearly 
95% of all public PHC clinics offered STI services (Health Systems Trust, n.d.). 
The advent of syndromic management in the public sector overlapped with 
plummeting syphilis prevalence rates (from 11.2% in 1999 to 2.7% in 2005) and a 
similar decline in the incidence of treated STI4  (from 6.4% in 2000 to 4.8% in 
2005) (Department of Health, 2007b; Health Systems Trust, n.d.). However, 
recent inclines in both syphilis prevalence (from 1.6% to 2.7% between 2004 and 
2005) and new episodes of STI (from 4.8% to 5% between 2005 and 2006), 
warrants sustained efforts in the management and control of STI, with an 
emphasis on improving the dissemination of treatment guidelines, overall quality 
of care and partner management (Sonko et al., 2003). These figures are but a drop 
in the proverbial ocean of disease when considering the propensity for STI clients 
to seek treatment in the private sector (Wilkinson et al., 1998) and the unknown 
segment of the population practicing self-treatment or remaining untreated.  
 
                                                 
4 The percentage of people 15 years and older that have been treated for a new episode of a STI 
(annualised). 
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Contrastingly, syndromic STI training of private sector doctors and occupational 
nurses has been languid and riddled with problems. Research indicates that STI 
treatment protocols are seldom adhered to in the private sector, which has 
translated to relatively poor pharmacological treatment, counselling, provision of 
health education, promotion of voluntary counselling and testing and partner 
notification (Dartnall et al., 1997).  Subsequently the Department of Health has 
developed strategies to standardize STI treatment across the various sectors of 
health through, among others, the development of public health-underpinned 
curricular for the training of health professionals at undergraduate and post-
graduate level, and the development of PPI at primary levels of care (Sonko et al., 
2003). 
 
In summary, the languid governmental response to a threatening HIV epidemic in 
the early 1990s severely hampered future efforts to obliterate the disease.  
Consistent with natural disease phenomena, the prevalence of HIV has reached a 
plateau-level in South Africa.  However, the high point at which the infection 
rates have settled has dire implications for an already overburdened public health 
sector. Private sector contributions to HIV prevention strategies through STI 
management have yielded relatively unfruitful interim outcomes among private 
doctors and nurses; however, perseverance with this sector is of paramount 
importance if the goal to standardize STI care through syndromic management is 
to be achieved.    
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2.3 PRIVATE COMMUNITY RETAIL PHARMACY: A POTENTIALLY 
UNDERUTILISED PRIMARY HEALTH CARE STRATEGY? 
 
2.3.1   Primary healthcare roles for pharmacists  
In the first half of the 20th century, pharmacy as a profession evolved from the 
pre-industrial era of apothecary towards a more technical role in the age of rapid 
burgeoning of the pharmaceutical industry.  In the second half of the century the 
profession shifted paradigmatically towards a patient-oriented clinical role and at 
the close of the 20th century the philosophy of pharmaceutical care had become 
the bedrock of pharmacy (Pearson, 2007). In the various practice environments, 
pharmaceutical care refers to the provision of drug therapy for the purpose of 
achieving definite outcomes that improve a patient’s quality of life (Helper & 
Strand, 1989). Due to legislative restrictions allowing only limited diagnosing and 
prescribing by pharmacists (Republic of South Africa, 1997a)5, this translates to 
the implementation and monitoring of pharmaceutical plans invariably designed 
by authorized health care professionals.  
 
The “evolved” pharmacist at community retail level is often the first port of call 
for clients with medical problems; accessibility, after hour availability and prompt 
client assistance are among the reasons cited for this preference (Gilbert, 1998).  
Though often sought for curative services, including STI management (Ward et 
al., 2003), community pharmacists are restricted to performing the following 
primary health care functions: provision of essential clinical services including 
screening for various chronic diseases and prevention of childhood diseases via 
blood glucose, cholesterol and HIV testing, urine testing, peak-flow, blood 
pressure monitoring and immunizations respectively; referral services; provision 
of health care education and information at individual and community level and as 
alluded to earlier, the provision of pharmaceutical care.  The restriction of 
pharmacist initiated therapy to the diagnosis and treatment of minor ailments 
                                                 
5 The Medicines and Related Substances Control Amendment Act of 1997 excludes pharmacists 
under the definition of  “authorized prescriber” of medicines with a scheduling status of 3 and 
higher.   
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undermines the training of pharmacists in clinical decision-making and 
furthermore impedes the utilization of pharmacies in addressing public health 
priorities. 
 
Allowing pharmacists to expand their range of curative services through wider 
scopes of practice may offer an alternative source of care to the public sector 
dependent population, provided that comparatively higher private costs are offset 
by government subsidies of various kinds. Evidence from a WC survey reflecting 
frequent requests for pharmacist initiated therapy by low to middle income 
groups, suggests that these facilities are already a preferred source of primary 
health care to a large segment of the public sector dependent population (Ward et 
al., 2003). The utilization of these existing facilities – 6.3 retail outlets for every 
100 000 individuals6 - potentially enhances accessibility to health services by the 
public sector dependent population by at least 50%. Unfortunately, the associated 
out-of-pocket expenditures by non-medical aid beneficiaries contribute toward the 
health-funding inequalities maiming the health system. This problem could be 
circumvented through the forging of private-public-partnerships, whereby private 
community pharmacies become conduits for government services and supplies. 
The aforementioned strategy is not a novel concept: the delivery of family 
planning services and immunization of children from these outlets by nurse 
practitioners on behalf of the state attests to the application of service delivery 
models in pharmacies.  The consequent interface between pharmacists and nurses 
is in line with the concept of pharmaceutical care, which is premised on health 
professional teamwork. 
 
2.3.2  Legislative context: a potential catalyst for role change? 
The philosophy of pharmaceutical care, in congruence with the primary healthcare 
philosophy, is strongly patient centred and is supported by parallel pricing 
regulations that encourages the levying of a professional fee for services rendered 
                                                 
6  2523 community pharmacies registered with the South African Pharmacy Council as per 2006 
(South African Pharmacy Council, n.d.), divided by 40 263 557 (public sector dependent 
population as per 2006)  (Health Systems Trust, n.d.) 
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to a client as opposed to being excessively product and sales driven (Gilbert, 
1998; Republic of South Africa, 1997a).   
 
With a view to correct gross health inequalities of the past, the government of 
national unity is committed to achieving the goals embedded in a National Drug 
Policy (Department of Health, 1996), which includes, among others, improved 
access to essential drugs within the context of good pharmaceutical care. Selected 
legislative amendments informed by this policy, viz, the Medicines and Related 
Substances Control Act and the Pharmacy Act, warrant further elaboration due to 
their impact on community pharmacy practice. 
  
The Medicines and Related Substances Control amendment act No. 90 of 1997 
(Republic of South Africa, 1997a) prescribes a transparent pricing system which 
fixes the price at which manufacturers shall sell medicines and Scheduled 
substances to any person other than the state . The final mark-up charged by 
pharmacies constitutes a tier-structured dispensing/professional fee in lieu of 
indiscriminate product mark-ups, thus affording end-users of medicine the ability 
to query exorbitant medicine pricing and to challenge disparate prices between 
various pharmacies.  The consequent standardization of medicine pricing demands 
a level of service delivery that adds value to the product, thereby conferring 
competitive distinctiveness to a particular pharmacy.   
 
In a bid to standardize the cost of numerous other professional services delivered 
by pharmacies, the South African Pharmacy Council, in accordance with the 
Pharmacy amendment act No. 88 of 1997 (Republic of South Africa, 1997b), has 
developed a schedule of services for which pharmacists may levy a fee.  These 
services include, inter alia, the screening and testing of biological and physical 
parameters, the compounding of extemporaneous items and medical or 
pharmaceutical consultations, for which pharmacists may or may not require 
additional training (Republic of South Africa, 2007).  The provision of financial 
incentives to perform professional services could potentially incite greater 
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willingness among pharmacists to upgrade their skills, and to challenge the 
professional boundaries imposed by official scopes of practice. 
  
Furthermore, the enactment of pharmacy lay ownership – in accordance with the 
Pharmacy amendment Act No. 88 of 1997 (Republic of South Africa 1997b) – has 
seen major retail companies, leveraged with existing wholesale and distribution 
divisions, entering the market as strong competitors against smaller, independent 
pharmacies. Notwithstanding the institution of legislative safeguards to level the 
playing fields between independent and corporate pharmacies through the 
outlawing of perverse incentives such as discounting or rebates from 
pharmaceutical companies, the competitive edge conferred to large retailers due to 
the unregulated logistics fees (storage and distribution to retail outlets) added to 
medicines, is a threat to the continued existence of independent and small chain 
pharmacies. The viability of these smaller enterprises calls for innovative business 
models that will ensure consumer patronage. 
 
In essence, the new reimbursement structures and service oriented approach to 
community pharmacy, coupled to the threat of corporate pharmacies, demands a 
reinvention in community pharmacy. The retention of traditional pharmacy 
business models has and will continue to spell the demise of many community 
pharmacies, whereas innovative approaches that incorporate needs-driven service 
models and partnerships forged with the public sector could signal the dawn of a 
new brand of primary health care community pharmacies. 
 
2.4   CONCLUSION 
The South African socio-political, economic and healthcare landscape is evidently 
primed for the proposed advanced roles for pharmacists in primary health care, 
inter alia, STI management.  Moreover, the inauspicious state of the national 
health system demands an exploration into innovative public private interactions 
that will be mutually beneficial to all stakeholders, thereby boding well for 
improved healthcare in South Africa.  
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 CHAPTER 3 
LITERATURE REVIEW 
 
____________________________________________________________________ 
 
This literature review critically analyses published research study findings and 
reviews, borrows insights from treatise and examines pertinent local and international 
policy and legislative documents, with a view to develop the theoretical 
underpinnings for an advanced role pharmacist in primary care, more especially in 
syndromic sexually transmitted infection (STI) management. The HIV/AIDS 
strategic document developed by the health ministry of South Africa contains a 
concretised plan for dishevelling the scourge that besets this nation. Prevention is the 
cornerstone of the said plan, and key priority areas such as STI management and 
control through syndromic treatment modality interventions are aimed at reducing the 
infection rate by 50% by 2011 (Department of Health, 2007a). In a healthcare system 
fraught with human resource deficiencies, the utilization of existing skills and the 
expansion of skills inherent to specific health professions at primary care level could 
facilitate implementation of the aforementioned interventions.  
 
The opening segment of this review attempts to elucidate obscurities surrounding the 
value of STI management in the fight against HIV and the effectiveness of various 
elements of the syndromic approach and the second instalment explores global trends 
in meeting human resource needs in primary healthcare settings. The literature review 
culminates in the aims and objectives central to this thesis. 
 
____________________________________________________________________ 
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3.1 SYNDROMIC MANAGEMENT OF STI 
In recent years the response of the South African government to the HIV crisis has 
shifted from gratuitous debates around the causal relationship between HIV and 
AIDS towards the implementation of a prevention-slanted HIV and AIDS and STI 
strategic plan (Department of Health, 2000c). This plan highlighted STI management 
and control as a primary goal, notwithstanding prevailing uncertainty around the true 
value of STI interventions in HIV prevention (Grosskurth et al., 2000a; Kamali et al., 
2003; Wawer et al., 1999).  Under the new dispensation of antiretroviral (ARV) 
therapy, prevention remains the cornerstone of strategic plans and STI related 
interventions are firmly embedded in syndromic treatment modalities (Department of 
Health, 2007a). Against a backdrop of uncertainty concerning impact, the point of 
departure for this review is to affirm the fundamental premise that STI management 
and control are indispensable to any HIV/AIDS strategic plans. 
  
In an era of modern medicine where new medical interventions and technological 
innovations are rapidly burgeoning, the Spartan approach to treating STI 
syndromically has been the subject of wide debate. The effectiveness of World Health 
Organisation (WHO) syndrome algorithms has improved incrementally over the years 
through the incorporation of risk assessments, clinical examinations and diagnostic 
assays – composite algorithms are currently employed by public primary healthcare 
services in South Africa (World Health Organisation, 2003). However, in 
infrastructurally poor milieus such as community pharmacies, which are not 
conducive to performing invasive speculum examinations for microscopy and gram-
stain analyses, and phlebotomies for syphilis serology, the basic algorithms, devoid of 
these augmentations may be required if pharmacists are allowed to perform these 
techniques in the future. The controversy around syndromic management therefore 
sets the background for the second review instalment in which the validity and 
efficacy of basic algorithms, incorporating confirmed entry point client complaint and 
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risk assessment, are evaluated independently and where possible against augmented 
algorithms. 
 
One further aspect of syndromic STI management that has recently come under 
intense scrutiny is the expedient approach to treating sexual contacts presumptively, 
i.e. based on the diagnosis of the index client. In the face of poor partner treatment 
rates in South Africa and other developing countries, effective and innovative 
strategies, which enhance partner accessibility to treatment, are desperately needed.  
To this end, the simplicity of presumptive treatment certainly lends itself to a 
community pharmacy setting; however, the controversy shrouding this treatment 
modality warrants an exploration of literature into the scientific basis thereof.  
 
WHO strongly advocates the training of all healthcare workers in the recognition and 
treatment of STI using simple syndrome algorithms. Furthermore, the South African 
Minister of Health (MOH) has been mandated to regulate education and training 
efforts targeted at nurses, doctors, dentists and pharmacists with a view to increasing 
manpower for the management of various communicable diseases, inter alia, STI 
(Republic of South Africa, 2003).  In this regard, however, South Africa has taken a 
relatively conservative stance by overlooking healthcare workers outside the medical 
and nursing fraternity. This review instalment will explore the design and operational 
features of pharmacist-led STI control programmes in other countries and seek to 
demonstrate that pharmacists, undergirded with sufficient and appropriate training 
and support, exhibit the required competencies to provide quality STI care. 
 
Finally, with a view to attain congruency between service provision and service 
utilization, there is a need for responsiveness to health seeking behaviour of target 
communities; to this end the attitudes and perceptions of STI clients are reviewed in 
the literature. 
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3.1.1   STI and HIV linkage 
 
3.1.1.1   Biological and clinical studies 
There is no shortage of scientific reviews centring on the biological link between STI 
and HIV (Galvin & Cohen, 2004; Flemming & Wasserheit, 1999; Rottingen et al., 
2001; Sangani et al., 2004). A substantial body of evidence gives credence to the 
hypothesis that HIV shedding increases in the presence of a co-existing STI.  
Although risk estimates for ulcerative STI are slightly superior in relation to those for 
non-ulcerative STI, both infection types are recognized co-factors in HIV 
transmission.  Risk estimates derived from a meta-analysis of reputable studies show 
that clients presenting with ulcerative STI are 2.7 times more likely to contract HIV 
after unprotected intercourse with an infected individual than a client without an STI, 
while for non-ulcerative STI the risk estimate is 1.7. Individually, ulcerative 
chancroid, syphilis and herpes simplex virus (HSV) yielded risk ratios of 2.1, 2.5 and 
7.7 respectively while corresponding values for non-ulcerative Neisseria Gonorrhoea 
(NG), Chlamydia Trachomatis (CT), Trichomoniasis Vaginalis (TV) and Bacterial 
Vaginosis (BV) were 2.1, 2.2, 1.5 and 1.4 respectively (Dallabetta & Neilson, 2004). 
That STI are co-factors in the causal pathway of HIV transmission is therefore “no 
longer a hypothesis” (Cohen, 1998) and reinforces the empirical evidence 
underpinning the HIV prevention strategies advocated by WHO, inter alia, STI 
control. 
Presumably, the biological association between STI and HIV gives leverage to the 
argument that the treatment of STI would reduce viral shedding relative to a viral set 
point. If we assume that reduced viral shedding mitigates infectiousness and thereby 
minimizes transmissibility, then the hypothesis that improved STI treatment at 
community level will reduce HIV incidence rings plausible. Experts in the field 
explore these two issues at a clinical and epidemiological level and their findings are 
summarized below. 
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In West and East Africa, Ghys et al. (1997), Wolday et al. (2004) and McCelland et 
al. (2001) sought to determine the impact of STI treatment on the viral shedding in 
genital secretions of HIV positive women. Generally, all curable STI were included 
in the evaluations, although the latter study targeted diseases causing cervicitis only. 
In Southern Africa, Cohen et al. (1997) investigated the association between viral 
shedding in HIV positive men and improved syndromic treatment of urethritis. All 
studies adopted a cross-sectional design spanning anywhere from 3 months to 3 years 
and a similar sequence of procedures was carried out: upon entry into the study, 
participants were clinically diagnosed for STI and treated presumptively, and at 
enrolment and follow-up 1 or 2 weeks later samples for pathogen-specific STI 
diagnosis and viral load quantification were elicited. Treatments for clinically missed 
diagnoses were offered within a few days subsequent to enrolment if necessary.  
Assays for STI diagnosis were all of comparable sensitivities, and polymerase chain 
reaction (PCR) analysis was performed across the board to quantify viral shedding.  
Only patients not receiving highly active antiretroviral therapy (HAART) were 
deemed eligible for participation so as to rule out the impact of HAART on viral 
shedding. 
 
Ghys et al. (1997) enrolled 685 female sex workers (FSW) presenting with an STI to 
a local clinic in Abidgan, Cote d’Ivoire over an 8 month period and the samples 
collected for quantifying viral load were derived from cervical lavages and plasma 
sera. Among those cured of STI, detectable viral load was observed in 42% of 
participants at baseline, compared to 21% at follow-up (p<0.005). The prevalence of 
viral shedding among participants who experienced treatment failure was the same at 
baseline and follow-up. A logistic regression model fitted with ulcerative STI, non-
ulcerative STI and HIV-1 cervical viral shedding reflected significant associations 
with NG (AOR 1.9, 95% CI 1.2-3.0), C. Trachomatis (AOR 2.5, 95% CI 1.1-5.8), 
cervical and vaginal ulcer (AOR 3.9, 95% CI 2.1-7.4) and immunosuppression/less 
than 14% CD4 percentage (AOR 6.3, 95%CI 3.4-11.9). An independent association 
between HIV-1 serum viral load and HIV shedding was not found leading authors to 
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surmise that local factors, such as STI are the more likely determinants of HIV 
transmissibility than the circulating viral load.  
 
Wolday et al. (2004) enrolled women from the general population, attending a health 
centre in Addis Ababa, Ethiopia, into a study evaluating the effect of improved 
syndromic treatment on viral shedding from the cervix as well as the impact of 
unsuccessful treatment outcomes on shedding.  Of the 71 HIV positive individuals, 
60 presented with symptoms of STI and the 11 who had no symptoms served as a 
control.  As expected, cervical HIV-1 shedding was significantly higher among 
females with an STI in comparison to the controls, yielding median values of 3.15 
and 1.9 log10RNA copies/swab respectively (p=0.02).  Similarly, the prevalence of 
detectable cervical HIV-RNA was higher among STI carriers than controls (68% vs. 
27%, p=0.02). Furthermore, cervical HIV-RNA load was significantly higher in 
females with genital ulcer syndrome (GUS) than genital discharge syndrome (GDS) 
(p=0.02). While the overall effect of syndromic treatment significantly reduced viral 
shedding (p=0.02), this was not the case for treatment of individual STI syndromes; 
genital shedding after syndromic treatment of GUD and GDS, taken separately, 
showed no appreciable decline from baseline (p>0.05). Authors ascribe this lack of 
significant effect to the poor treatment outcomes yielded by the syndromic approach 
(notably for GUS) as a result of missing and over diagnosing numerous infections. 
This line of reasoning is further corroborated by findings within the successfully 
treated subgroup: the median genital HIV load declined significantly only in the 
females exhibiting clinical improvement –a mean decrease of 0.43 log10 copies from 
baseline was achieved and more than 56% demonstrated a decrease in cervical HIV-
RNA.  The failure to cure GUS, as alluded to by the authors, could be attributed to 
the presence of HSV-2, which was not quantified in this study.  
 
Between 1996 and 1999, McCelland et al. (2001) enrolled 70 HIV positive women 
with concurrent cervicitis from an STI clinic in Mombasa, Kenya, to evaluate the 
changes in cervical site specific shedding with syndromic treatment of cervicitis (due 
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to NG, CT or non-specific etiology). Among the successfully treated women, 72.2% 
demonstrated a decrease in cervical HIV-1 RNA with overall viral loads decreasing 
from a median of 4.05 at baseline to 3.24 log10copies/swab at follow-up (p=0.001), 
and median cervical HIV-1 RNA levels decreasing from 3.94 to 3.28log10 
copies/swab (p=0.02) and 4.21 to 3.19 log10 copies/swab (p=0.02) for GC and CT 
respectively. These declining viral levels, as noted by authors, were comparable to 
values achieved after instituting highly active antiretroviral therapy (HAART) in a 
study conducted by Cu-Uvin et al. (2000). 
 
In Malawi, Cohen et al. (1997) designed a prospective, sequence comparison study of 
2 cohorts, one consisting of 206 HIV-1 infected men with concomitant urethritis, 
selected from an STI clinic and the control bearing 127 HIV-1 infected men without 
urethritis, recruited from a dermatological clinic. The main hypothesis was that 
antibacterial treatment of urethritis would reduce semen viral loads in HIV positive 
patients. The sequence comparison at baseline, week 1 and week 2 allowed for 
retreatment in the event of treatment failure and subsequently higher resolution of 
urethritis was attained by week 2.  As expected, the HIV viral load (copies/ml) at 
baseline did not differ significantly from the follow-up group at week 2 in the control 
group.  At baseline the median seminal plasma HIV-RNA concentrations were eight 
times higher in the STI group than in the control group (12.4 vs. 1.51x104copies/ml; 
p=0.035), having similar CD4 counts and blood viral burdens.  Furthermore, men 
with NG yielded higher concentrations of viral RNA in semen than those with non-
gonococcal urethritis (NGU) (median 15.8 vs. 2.52 X104 copies/ml; p=0.003). After 
initiating antibiotic therapy for urethritis a significant decrease in HIV-RNA 
concentration in seminal plasma was detected. Median concentrations of seminal 
plasma HIV-1 RNA with sequential samples at baseline, week 1 and week 2, 
decreased from 12.4x104 copies/ml to 8.91 x 104 copies/ml and 4.12x104 copies/ml 
respectively (both p-values  <0.05).   The most considerable changes in viral load 
from baseline to week 1 and week 2 were observed in patients treated for NG, 
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although significant, albeit less dramatic changes were observed in patients treated 
for NGU at week 2. 
 
An analysis of the few articles evaluating the correlation between the treatment of 
curable STI and viral shedding has led to two important observations: i) STI 
diagnoses (combining clinical and assay-derived findings) and treatment, especially 
of NG, in the general population (Cohen et al., 1997; McCelland et al., 2001; Wolday 
et al., 2004) and among high risk groups (Ghys et al., 1997; Woolday et al., 2004), 
are associated with a decrease in genital HIV concentration – although only 
conjectured in the latter population –  and in some cases are comparable to the 
decrease in viral load achieved through HAART (McCelland et al., 2001), and ii) the 
impact of syndromic treatment on viral shedding is conditional upon treatment 
success rates achieved (Ghys et al., 1997), which calls for, inter alia, stringent 
validation of syndrome algorithms. The untold impact of HSV-2 on the 
aforementioned findings should however be factored into the interpretation of results, 
especially in regions burdened with high HSV-2 prevalence (Woolday et al., 2004). 
This notwithstanding, the encouraging clinical outcomes in this review beg the 
following question: could an STI treatment intervention at community level reduce 
HIV-1 incidence? 
  
3.1.1.2. Impact of STI on HIV: Community-level interventions 
Community based trials evaluating the implications of the discussed biological 
findings on HIV-1 incidence impose overwhelming financial and logistical burdens, 
which may explain the dearth of studies evaluating changes in HIV-1 trends. Three 
randomised control trials (RCTs) were conducted in rural Eastern Africa where STI 
control interventions were hypothesized to reduce incidence of HIV-1 in targeted 
populations. 
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Grosskurth et al. (1995) was a frontrunner in implementing a randomised matched 
control trial at a population level to evaluate the impact of an STI intervention on the 
HIV-1 incidence in a rural Tanzanian region between 1991 and 1994.  The 
intervention consisted of 5 components, viz the establishment of an STI reference 
clinic; a 3 week STI training course for healthcare workers; a supplementary delivery 
system ensuring improved drug supply; periodic site visits by research personnel and 
community education with an emphasis on STI treatment. Over 12 000 adults in 
twelve communities were paired according to geographical delineations –so as to 
control for regional variations in HIV prevalence –and one in each pair was randomly 
assigned to the intervention group immediately after a baseline survey.  The control 
group was not exposed to the intervention until the 2-year follow up. Surveys, 
syndromic diagnoses and laboratory tests for STI (including HIV) were conducted at 
baseline and follow-up.  This open cohort study produced comparable follow-up 
coverage rates in the intervention and control group. Surveys encompassed issues 
such as sexual behaviours, demographics, history of STI, travel out of area, and male 
circumcision status. The aforementioned variables were fitted into a logistic 
regression model to control for individual differences between subjects.  Results 
showed that the intervention proved to be protective against HIV-1 acquisition; the 
intervention group exhibited a lower seroconversion rate (1.2%) in comparison with 
the control group (1.9%), (ARR 0.58; 95%CI 0.42-0.79), translating to a 40% 
reduction in HIV-1 infections.  The reductions were consistent in all matched pairs 
and were observed in both sexes. Although the intervention group reflected a slightly 
lower STI prevalence than the control for symptomatic and etiological STI, the 
differences were not significant.  Since the intervention focused on enhancing STI 
treatment only and was devoid of any behavioural interventions, the subsequent 
absence of sexual behaviour change as reflected by reported condom use might be 
regarded as inconsequential. The authors, in consonance with Wolday et al. (2004), 
ascribe the decline in HIV-1 incidence to the successful treatment and resultant 
shortened duration of clinical STI.   
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In 1999, Wawer et al. sought to evaluate the impact of a mass STI treatment strategy 
on HIV-1 incidence in the Rakai district of Uganda, renowned for incurring high 
HIV-1 and STI rates. Fifty-six communities, selected on the basis of infrastructure, 
HIV-1 incidence and population stability were clustered into 10 groups in such a way 
that STI reintroduction into the clustered regions was precluded. A further delineation 
into three blocks ensured that cluster communities of comparable HIV prevalence 
were paired. One cluster community within each pair was randomly assigned to 
receive home-based, directly observed therapy for STI over a 30 month time frame at 
10 month intervals, while the control group received anthelminthics at corresponding 
time intervals. Serological HIV-1 testing was performed at each intervention point 
and all communities received identical education on STI prevention in community 
meetings. The results in this study reflected no difference in overall HIV incidence 
between the intervention and control group of the general population and neither was 
any differences detected in the subgroup of pregnant women.  This pattern was 
sustained across allotted time intervals as well as individual cluster blocks. The only 
noteworthy successes in STI control between intervention and reference group were 
achieved after the second follow up treatment for syphilis (Prevalence Ratio (PR) 0.8, 
95% CI 0.71-0.89) and TV (PR 0.59, 95% CI 0.38-0.91).  In the sub sample of 
pregnant women, mass treatment significantly decreased the rate of cervical and 
vaginal infections during pregnancy, however, no reduction in HIV-1 incidence was 
observed either during or after pregnancy.  
 
Masaka was the site of a three-armed randomised controlled STI intervention trial, 
which ran concurrently with the mass-treatment trial in neighbouring district, Rasaka. 
The impact of 2 distinct interventions on a sample of 18 communities spanning a 6-
year period was evaluated.  Communities were matched in triplets based on 
comparable HIV incidences. Matched communities were assigned to one of three 
study arms: A) information, education and communication activities (behavioural 
arm); B) the aforementioned activities in addition to improved management of STI 
(STI intervention arm); and C) general community development activities, inter alia, 
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home-based care for elderly and health promotion (control). Serological testing for 
HIV as well as STI assays were performed at baseline and again at 2 year intervals in 
an open cohort which by the final round of the study had amassed over 14 000 
participants.  Neither the overall incidence of HIV-1 nor the incidences at each study 
round varied significantly between either of the two intervention groups (A or B) and 
the control group (C). The incidence of all STI, bar one (CT), were significantly 
impacted by at least one intervention: the overall HSV-2 incidence/100 person years 
was lower in the behavioural (A) than control arm (Adjusted Incidence Rate Ratio 
(AIRR) 0.65; p=0.04); the higher titre active syphilis incidence/100pyar in the STI 
intervention arm (B) was well below that observed in the control arm (AIRR 0.58; 
p=0.04) and this pattern was sustained for NG (AIRR 0.28; p=0.02). The only 
noteworthy improvement in behavioural indices was observed for condom use in high 
risk encounters, as established by reported condom use at most recent sexual 
encounter with casual partner.  These findings were associated with both the STI 
intervention arm (Adjusted prevalence ratio (APR) 95% CI 1.02-1.56) and to a lesser 
extent, the behavioural arm (APR 1.12; 95% CI 0.99-1.25) (Kamali et al., 2003). 
 
The evidently disparate findings emanating from the three community randomised 
controlled trials have been the subject of numerous reviews which have generated 
several explanatory hypotheses. Tentative explanations for the lack of appreciable 
reduction in HIV-1 incidence in the two Ugandan trials are categorized under 
population, intervention and study design differences (enumerated below) 
(Grosskurth et al., 2000a; Hitchcock & Fransen, 1999; Boily et al., 2000; Hudson, 
2001; Korenromp et al., 2001, 2002; O’Farrel, 2001; Dik et al., 1995).  Korenromp et 
al., in 2004 employed the use of statistical modelling to test the validity of the 
hypotheses based on the following differences: 1) at the time of the study, the HIV 
epidemic in Tanzania and Uganda reflected uniquely different challenges by virtue of 
the diametrically opposed stages of disease; the Tanzanian epidemic was in the stage 
of infancy with low but steadily rising infection rates, while the Ugandan epidemic 
was mature and exhibiting plateauing trends; 2) sexual risk behaviours and STI 
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prevalence leading up to and including the study period were notably greater in the 
Mwanzan population; 3) the unmeasured impact of  HSV-2–overlooked in all 3 trials 
– on the treatment of concurrent bacterial STI produced potentially spurious findings; 
4) the greater degree of mobility of the Rakai population due to the open cohort 
design and the close geographical proximity of the study intervention and non-
intervention communities constituted design differences; and 5) study interventions 
varied widely from syndromic treatment in Tanzania to mass STI treatment in Rakai 
and a combination of treatment and prevention education in Masaka.  Simulation 
modelling of trial data led to the refutation of many of the proposed hypotheses, 
however three proved to render a plausible explanation for the poor impact of 
interventions on HIV-1 infection rates in Rakai and Masaka: low rates of curable co-
factor STI, the reduction in risk behaviours prior to the trials and the advanced stage 
of the epidemic (Korenromp et al., 2004). The concluding remarks of the authors are 
consonant with those of Dallabetta et al. (2004) which infer that in many African and 
Southern Asian populations where STI infection rates are high and treatment services 
are sub optimal, syndromic and mass treatment of STI are likely to stem the spread of 
HIV infection.   
 
Therefore, the seemingly incoherent findings in the three randomised controlled trials 
do not discount STI control as an effective HIV prevention strategy; on the contrary, 
these results augment our understanding of the environmental and demographical 
contexts within which specific interventions are likely to succeed. The clinical and 
epidemiological evidence presented in this review favours the continued support of 
WHO advocated HIV strategies to improve STI treatment delivery. Furthermore, the 
clinical inferences derived from biological studies have wide applicability for both 
the HIV infected and uninfected populations, viz, a reduction in the host’s 
infectiousness and transmissibility with respect to HIV (Cohen et al., 1997; 
McCelland et al., 2001; Wolday et al., 2004), and amongst the seronegative 
population, a reduced susceptibility to HIV seroconversion (Cohen et al., 1998; 
Dallabetta & Neilson, 2004). 
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In essence, syndromic treatment modalities are well suited for the South African 
milieu, where STI infection rates are high and more than 80% of the population relies 
on very basic primary healthcare services for sexual heath. STI management and 
control by way of syndromic treatment should therefore remain a key component in 
South African HIV-1 prevention programmes.  
 
3.1.2   Syndromic approach to treating STI 
3.1.2.1 Syndromic diagnosis: algorithm validity 
In view of disparities existing between countries in terms of etiological agents 
implicated, syndrome prevalence and infrastructural and resource capacities, 
adaptations to WHO syndrome algorithms are an accepted and widespread 
phenomena.  In resource-poor settings where even the simplest diagnostic assays are 
unaffordable and a deficiency of manpower to legally provide services is prevalent, 
the least invasive and technologically dependent procedures are preferred. But is the 
pursuit of a Spartan approach to STI care compromising quality and effectiveness? 
WHO support for revised algorithms to meet country-specific needs comes with the 
proviso that health ministries assume responsibility for algorithm validation against 
gold standard microbiological assays. The ensuing review of literature evaluates the 
validity – in terms of sensitivity, specificity and positive predictive values – of the 
most basic algorithms, which may lend themselves to infrastructurally poor 
environments such as community pharmacies. 
 
Djajakusumah et al. (1998) evaluated the performance of the algorithm for urethral 
discharge syndrome (UDS) in an Indonesian city, known for its high STI prevalence. 
The most basic algorithm, devoid of diagnostic assays, and based solely on a clinical 
diagnosis underpinned by thorough risk assessment, yielded a sensitivity of 100% 
with a 75% chance of correctly predicting true positives (positive predictive value-
PPV) in a population.  This translates to no under treatment and minimal over 
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treatment. Comparable results were yielded in a study conducted in Benin, Russia 
where the sensitivity of an identical algorithm for UDS was 91.5% and the PPV was 
65.2% (Alary et al. 1998).  Authors ascribe the latter findings to a relatively low 
prevalence of CT and NG in this first world country, as disease prevalence is known 
to greatly influence the PPV. Chalamilla et al. (2006), in an evaluation of the 
relationship between syndromic management and microbiological diagnosis, 
corroborates the aforementioned findings and deems syndromic treatment appropriate 
in men with GDS.  In this study concordance between GDS syndrome diagnosis and 
etiological findings of NG and CT was reported in 90% of cases (no validity indices 
supplied). 
 
Conversely, a meta-analyses review by Sloan et al. (2000) of basic algorithms relying 
primarily on risk assessment factors, signs and symptoms in the identification of NG 
and CT in females reflected poor sensitivity and PPV (54.34% and 18% respectively) 
and reasonably satisfactory specificity (74.8%). Interestingly, the algorithm relying 
on a speculum examination yielded similarly poor specificity and PPV. The 
concluding remark emanating from the review, in concurrence with many of the 
authors of studies included in the meta-analysis, was that the approaches utilizing the 
aforementioned screening tool were found to be inefficient; these algorithms were 
found to have poor PPV and sensitivity (11.5-41% and 48.9-55.0% respectively), and 
a wide range of specificity (54.2-88.2%) for the identification of NG, CT and TV 
(Desai et al., 2003).  WHO algorithms relying on sexual risk assessment and patient 
symptoms only (no signs) in diagnosing BV, candidasis, TV and cervical infection 
yielded excellent sensitivity (100%), very poor specificity (0-56%) – due to wider 
spectrum of organisms investigated – and weak PPV (2-19%) (Hawkes et al., 1999).   
 
In a sample of women, Desai et al. (2003), detected poor GUS algorithm sensitivity 
for detecting syphilis (14.8%), while high specificity was noted (96.7%). The ability 
of the algorithm to correctly predict the true number of syphilis cases in the sample 
was a modest 57.1%, which authors ascribe to the low prevalence of GUS in this 
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Indian region. Notably, the addition of a simple and relatively cheap diagnostic test, 
such as RPR (rapid plasma reagin) markedly increased the sensitivity of the 
algorithm. A clinical diagnosis for GUS in the absence of RPR also proved 
unsuccessful in Dar es Salaam, Tanzania where active syphilis was incorrectly 
diagnosed in all the patients presenting with genital ulceration – positive serology 
was more often linked to GDS than GUS (Chalamilla et al., 2006). 
 
Literature demonstrates that algorithms for UDS, which rely exclusively on the 
objective sign of discharge, hold promise for use in infrastructurally poor settings, 
such as community pharmacies, provided that periodic surveillance of local 
etiological agents is performed and the prevalence within the said region is high. On 
the other hand, the basic algorithms for vaginal discharge syndromes (VDS) are not 
recommended for use in pharmacies due to their weak discriminative ability and poor 
prediction of true positive cases.  Finally, the inconsistent clinical findings 
characteristic of syphilis warrants the reliance on phlebotomies for syphilis diagnoses 
in both GDS and GUS.  
 
3.1.2.2   Syndromic treatment: success rates 
While validated algorithms are essential requirements for optimal treatment 
outcomes, this does not guarantee efficacy. WHO regards efficacy, in terms of STI 
clinical cure rates, as the most important criterion for algorithm selection and sets the 
benchmark of success in STI treatment at 95% (World Health Organisation, 2001). 
Treatment successes for infectious diseases could be measured at 3 different levels 
viz, microbiological sterility (biological tests of cure), partial clinical cure (symptom 
amelioration) and complete clinical cure (absence of symptoms), although the articles 
reviewed below heed the latter two.   
 
It is well known that treatment outcomes hinge on factors other than algorithm 
selection and consequently the studies under review controlled for potentially 
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confounding variables by levelling provider skill through training interventions, 
ensuring that effective drugs were on code at treatment intervention sites, and 
measuring reported client compliance to treatment regimens. 
 
In the Tanzanian RCT described earlier (Grosskurth et al., 1995) health unit register 
books were collected from primary health centres and dispensaries in the intervention 
communities at the end of the 2 year study period for an assessment of the clinical 
effectiveness of syndromic STI case management, as reflected by the cure rates for 
VDS, UDS and genital ulceration syndrome (GUS). Simple algorithms relying on 
risk assessment and clinical examination were utilized in case management.  Entries 
on follow-up observations were available from 8492 (91%) of syndromes treated and 
the complete clinical cure rate for all syndromes at follow-up, one week after 
syndromic treatment, was 94%. A marginally higher percentage of males relative to 
females were symptom free at follow-up; 83% vs. 81% respectively for GUS and 
98% vs. 96% for UDS and VDS.  The overall cure rate after 1st, 2nd or 3rd follow-up 
was 98%. According to authors, female clinical cure rates may have been spuriously 
high, given the propensity towards asymptomatic cervical infection in women 
(Grosskurth et al., 2000b).   
 
In an attempt to refine the national STI control strategy, the National AIDS 
Programme in Rwanda commissioned a pilot project to assess the performance of 
basic STI algorithms in terms of clinical patient outcomes between September 1993 
and March 1994.  All algorithms relied on risk assessment and clinical assessments 
only, with the exception of VDS algorithms, which in addition to the aforementioned 
tools included a speculum examination. Twelve nurses from a primary health centre 
and a hospital outpatient’s dispensary attended a 3-day syndromic training course that 
included a half-day practical session. Detailed information pertaining to management 
was recorded by investigators at enrolment and treatment outcomes were noted at 
follow up.  Of the 184 patients (43%) reporting for follow-up, 84% met the definition 
of complete clinical cure for urethritis, which was comparable with VDS, cure rates. 
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By contrast, significantly higher rates of failure were observed among men and 
women treated sequentially (hit and miss approach) for GUS (Steen et al., 1998).   
 
In Cambodia a study was conducted to evaluate the operational performance and 
effectiveness of an STI intervention programme (not described in publication) on 2 
clinics, a few private pharmacies and private doctors frequented by the general 
population and more especially female sex workers.  Patients presenting with STI 
complaints were treated and asked to return for follow-up one week later. Clinical 
outcome measures were obtained retrospectively from patient records between 1997 
and 1999. Assessment of cure was completed for only 57% (5895) of syndromes.  
Treatment based on algorithms requiring history taking, risk assessment appraisal and 
clinical examination – including speculum examination for females – resulted in 
reported and confirmed absence of symptoms in 49 to 51% of female syndromes in 
the general population and slightly more impressive findings for male syndromes 
ranging from 52 to 74%.  Cure rates were highest among men in the general 
population with GDS (74%) and lowest among female sex workers with GUS (39%).   
When combining “cured” and “cured or improved” categories, 94% of males in the 
general population were considered to have favourable outcomes from treatment 
compared with 88% of women in the general population, and 84% of female sex 
workers (p<0.001). Notwithstanding these more respectable figures, cure rates remain 
below the WHO threshold of 95% (Cararra et al., 2005). 
 
 
The evidence presented here warrants caution against the use of basic algorithms 
(inclusive or exclusive of speculum examination) for women in the absence of more 
conclusive diagnostic assays.  On the other hand, the basic algorithms for male STI 
syndromes, especially UDS, consistently produce superior clinical outcomes relative 
to female counterparts, thereby conferring greater confidence in their use in 
infrastructurally poor settings such as community pharmacies. Moreover, the clear 
correlation between follow-up frequency (number of successive follow-up visits per 
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client) and cure rates (Grosskurth et al., 2000b), underscores the importance of 
factors facilitating periodic client visits such as service convenience, accessibility and 
patronage – characteristic community pharmacy features.  
 
  
3.1.2.3   STI recurrence and partner treatment 
The treatment of sexual contacts is essential for controlling STI morbidity and 
transmission; treatment prevents the development of serious complications and 
sequelae in infected contacts, reduces reinfection of index patients (improves cure 
rates), reduces the transmission of infection to new contacts and potentially lowers 
the risk of HIV transmission.  Both external and patient-specific factors may 
predispose to recurrent STI; lack of effective drugs, failed partner treatment or high 
sexual risk behaviour exhibited by partners are patient independent factors which may 
be implicated in patient reinfection, whereas ineffective antimicrobial therapy, patient 
age and poor drug compliance constitute patient dependent determinants. The purpose 
of this review is to assess the interplay of the aforementioned variables and to 
subsequently establish the relative importance of partner treatment in STI control.  
 
Blythe et al. (1992) and Whittington et al. (2001) investigated the patient specific 
correlates for recurrent CT in female index patients attending adolescent clinics, 
while controlling for extrinsic factors, inter alia, effective antimicrobial therapy. 
 
An investigation into the determinants of recurrent STI was conducted among 1308 
sexually active adolescents aged from 11 to 20 years in the gynaecological unit of an 
adolescent clinic in Marion County, United States of America (USA).  At baseline, 
measures for clinical presentation, laboratory findings (Chlamydial serotyping), 
demographics and gynaecological, STI and sexual behaviour histories were recorded 
and prompt and effective antimicrobial therapy ensued. Repeat baseline 
measurements, coupled with reported compliance to treatment and tests of cure 
results, were recorded at follow up visits every 3 months throughout the 5 year study 
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period.  Only patient race was slightly predictive of the overall recurrence rate in the 
bivariate analysis (p=0.024), however all significance was lost after data was 
analysed in a multiple linear regression model. The limited impact of patient-specific 
factors on the high recurrence rate (38%) observed in the study strongly suggests the 
influence of external partner factors. The stratification of recurrence rate by serovar 
type elucidated the confounding role of infection relapse on the results attained: the 
recurrence rate for same serovar (43.8%) in index patients was not attributed to poor 
compliance to therapy or irregular follow-up and is therefore not likely to be a result 
of relapse; by contrast, relapse was deemed plausible in the instances where index 
patients tested positive for the same serovar while in relationship with a new partner 
post therapy (44.8% of those with same serovar had a new partner) (Blythe et al., 
1992). 
 
A cohort of 1194 sexually active females aged 14-34 years were recruited from 5 
USA adolescent medicine and reproductive health clinics, treated for CT and 
subsequently followed up after 1 and 4 months to monitor for recurrent CT. The 
measurements accrued at baseline and follow up were concordant with Blythe et al. 
(1992). In multivariate analysis, independent predictors of CT at first return visit were 
failure to complete treatment (RR 3.4; 95% CI 1.6-7.3), resuming sexual activity 
since completing treatment (RR 2, 95% CI 1.03-4.4) and return beyond the intended 
appointment window (RR 1.8, 95% CI 1.01-3.2).  The stratification of recurrent 
infection according to first and second follow up elucidated the influence of relapse 
on the overall findings: the independent association between treatment compliance 
and recurrent infections at the first follow-up suggested an undermining of results due 
to infection relapse; recurrence at the second follow up was not however linked to 
compliance or any other patient factors and it was therefore conjectured that the more 
primary factors related to recurrence may be partner factors (Blythe et al., 1992; 
Whittington et al., 2001). 
 
 
 
 
 
 39
The absence of significant patient specific correlates reinforces the conjectural link 
between recurrent infection and STI partner factors. Although recurrent STI may be 
ascribed to patient and partner factors, literature suggests that the latter may be more 
strongly implicated (Blythe et al., 1992; Whittington et al., 2001). In the absence of 
novel, feasible and effective partner treatment strategies, STI control remains a futile 
objective. 
 
3.1.2.3.1 Epidemiological treatment of STI contacts 
WHO recommends the adoption of a simple and economically viable approach to 
treating sexual partners in developing countries viz, epidemiological/presumptive 
treatment.  The epidemiological treatment of STI contacts is based on the assumption 
that sexual partners and index patients are infected with identical pathogens and are 
therefore subject to similar treatment regimens.  Through contact card distribution to 
all sexual partners via the index client, the said approach targets an asymptomatic 
pool of STI clients who would generally have no reason to seek treatment and 
therefore remain untreated. Presumptive treatment forgoes laboratory investigations, 
which often defers treatment and increases the risk of patient abscondment. 
Furthermore, presumptive treatment, as observed in recent studies, attempts to bypass 
the need for comprehensive clinical examination in an effort to expedite partner 
management by way of the informal sector, inter alia, private pharmacies (Golden et 
al., 2001; Schillinger et al., 2003).   
 
Alternative partner treatment strategies may be considered at the discretion of the 
healthcare provider, viz, immediate epidemiological treatment in addition to 
collecting specimens for laboratory confirmation, or deferral of treatment until 
laboratory results become available.  In selected USA states, current legislation 
allows for an additional strategy, i.e. patient-delivered therapy, whereby a healthcare 
provider is allowed to prescribe and/or dispense antimicrobial therapy for the 
partner/s of clients presenting with CT via the index client, despite not having an 
opportunity perform a physical examination on the partner (Department of Health 
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California, 2001).   In the ensuing review, the rationale underpinning the 
recommendation of epidemiological treatment, in terms of concordance of etiological 
agents between index client and sexual contact, is explored.   
 
A retrospective evaluation of medical charts for microbiological findings of 8623 STI 
contacts against the recorded diagnosis of their index partners was undertaken by 
researchers in four US STI clinics over 2 years.  The evaluation was limited to 
partners diagnosed with CT, NG, NGU, mucopurulent cervicitis or TV. CT was 
diagnosed in 44.1% of partners of patients with CT and prevalence ranged from 12% 
of 32 men having sex with men (MSM) to 53% of 1077 heterosexual men.  NG was 
diagnosed in 38.8% of 1032 partners of patient with NG and prevalence ranged from 
13% of 55 heterosexual men to 57% of 248 women (Stekler et al., 2004).   
 
A similar pattern of concordance was noted in a smaller retrospective study that 
reviewed clinical management and contact tracing forms in all Western Australia 
public sector clinics over an 8-month period; of the 169 contacts treated, 30% of 
infections were concordant with index patients. The sexual partners of patients with 
NG and CT were more likely to exhibit concordance (53% and 52% respectively) 
than sexual contacts of syphilis. Data reflecting gender discrepancies was not 
included in the article (Mak et al., 2004). 
 
The above-mentioned findings are amenable to a double-edged interpretation: on the 
one hand, the concordance, ranging from 12% to 57% suggests that of those 
presenting for treatment, ideally only 43% (minimum) would suffer misdiagnosis and 
inappropriate treatment under the epidemiological approach; conversely, upon the 
misfortune of loss to follow-up while awaiting laboratory results, an opportunity to 
successfully treat at least some contacts presumptively is foregone. 
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3.1.3   Health seeking behaviour of STI clients 
Planning towards the effective delivery of health services hinges on an acute 
awareness and understanding of the target market’s health seeking behaviour; every 
individual has a predilection to a particular type of service, which is based on the 
fulfilment of specific criteria. Surveying client preferences and the accompanying 
reasons for these partialities is key to matching service delivery with needs, and could 
consequently enhance service utilization, and in the long run, potentially improve 
health indicators. The inherent social stigmas and perceptions associated with STI 
demands a higher degree of sensitivity and privacy than the norm. Therefore, several 
African and Asian countries plagued by the scourge of HIV and STI have surveyed 
the healthcare preferences, and in some instances explored the factors influencing 
choice, of high risk groups such as FSW and military recruits as well as members of 
the general population.     
 
To describe the health seeking behaviour of FSWs in Abidjan, Cote dÍvoire, 
Vuylsteke et al. (2001) selected and surveyed a clustered random sample of FSW 
(500 women in total) regarding the STI service most recently accessed by them and 
the underlying factors influencing this choice. For the most recent episode of STI, the 
majority of FSWs sought treatment in the formal sector (55.6%), some consulted the 
informal sector (36.9%), including private pharmacy treatments and the remainder 
(4.7%) refrained from consulting anywhere. The various services were deemed 
satisfactory by virtue of perceived efficacy of treatment (82%), absence of treatment 
costs (37%) and friendly health staff disposition (10%). The aforementioned factors 
did not however translate to actual utilization of services (kappa/level of agreement 
0.16). The reason cited in a focused group discussion for lack of frequenting the 
public health centres was financial barriers, while foreign FSWs, in particular, cited 
unfriendly reception by staff workers as the greatest barrier towards utilizing public 
clinics.   
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Khamboonruang et al. (1996) recruited all 869 Royal Military circle conscripts – 
notorious for frequenting FSWs – for May 1993 in northern Thailand to survey the 
risk factors for HIV acquisition by way of history taking and screening for STD and 
HIV.  Of the 282 men who had a history of STI, 184 (65.2%) had treated themselves 
with antibiotics without consulting a physician or other health professional. 
Interestingly, self-treatment for STI, particularly of bacterial origin, by way of 
pharmacy delivered treatment was significantly associated with a lower HIV 
prevalence even after controlling for other risk factors and individual STI syndromes 
in a multivariate analysis (OR 0.51, 95% CI  0.28-0.89).  Self-treatment among men 
with and without history of STI was no different in terms of age, marital status, 
history of STI, frequency of commercial sex, or most recent, lifetime or consistent 
use of condoms with commercial sex workers.   
 
Crabbé et al. (1996) set out to establish the incidence of urethritis and the health 
seeking behaviour, as recalled over the preceding 12 months, of the general male 
population (18-30 years), including a sample of factory workers (up to 40 years) in 2 
Cameroonian cities. In addition to the formal health services available to the general 
population, factory workers also had the option of attending a company clinic.  
Utilising a cluster random sampling method, 1179 men were recruited and surveyed 
regarding their socio-economic characteristics, occurrence of STI signs and 
symptoms, health seeking behaviour and cost of treatment. Educational level served 
as a proxy measurement for socio-economic status, which was thought to potentially 
influence health-seeking behaviour. Of the 189 (16%) men in the general population 
who had at least one episode of urethritis, 16% had resorted to self-medication 
without consulting either the formal or informal sector. Overall, 32% of males from 
the general population first consulted the informal sector for an STI complaint; the 
majority consulted friends and acquaintances (15%), while the remainder visited 
private pharmacies (8%), traditional healers (7%) and small stores (2%). 
Contrastingly, 53% first consulted the formal sector of public health centres (39%) 
and private practitioners (13%).  The corresponding results yielded in the sample of 
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company employees were comparable to those of the general population, although the 
preferred formal sector service consulted by employees was the company clinic 
(35%). Treatment delivery, either after consultation with the formal or informal sector 
or at first point of contact, was highest in pharmacies; sixty one percent of 
participants had obtained treatment from pharmacies, of which 39% had first 
consulted in the formal sector and 22% had not consulted anywhere.  Level of 
education was significantly associated with STI service preference in the general 
population; consultation in the formal sector was associated with a 2.7 fold increase 
in odds of having attained a higher education (at least completed secondary school). 
Costs incurred for treatment were highest when a consultation in the formal sector 
was followed by treatment acquisition in a pharmacy, which contributes in part to the 
low utilization of the formal health sector.  Participants were not asked to provide 
motivation for their choices. 
  
In Lao People’s Democratic Republic, a community-based cross-sectional survey was 
conducted among 500 household members aged 18 years or more and who had a 
history of antimicrobials use for the treatment of STI or RTI in the preceding 12 
months. Ten villages were randomly selected from each of 2 districts (one urban, one 
rural) and at least 25 participants were recruited from each village.  Participants were 
interviewed according to questionnaire eliciting information on demographics, self-
reported symptoms of STI or RTI, details of antimicrobial self-medication, and the 
understanding and use of health information. The most commonly reported symptom 
was VDS; 80% of females complained of at least one episode of VDS and lower 
abdominal pain, although this figure is probably artificially inflated due to the 
inclusion of physiologically induced vaginal discharge.  Eighty-five percent of males 
complained of UDS, almost certainly of pathogenic aetiology.  Nearly as many (73%) 
had used at least one antibiotic for the treatment of STI symptoms in the preceding 
year, which was solicited from retail pharmacies, without a prescription in 91% of 
cases. Ampicillin, a drug renowned for its poor resistance profile in Asia, was 
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prescribed most frequently, although not recommended by WHO (Sihavong et al., 
2006). 
 
Bista et al. (2002) conducted a study in Pokhara, Nepal among a random sample of 
75 chemists and druggists, some of who had been exposed to a training course in 
national STI case management guidelines.  Pharmacists were requested to keep a 
register over 1 year to establish the pattern of requests for STI syndromes.  Of note, 
seventy percent of patients made their first contact for STI management at 
pharmacies, while 14% presented with a prescription from private clinics and 16% 
from public clinics.   
 
Evidence therefore suggests that in the general population, consultation for STI 
symptoms in the formal sector is high and predicted by high socio-economic status.  
The primary factors dominating patient preference include perception of service 
quality, cost of treatment and among female sex workers, a friendly/non-judgmental 
disposition by the healthcare staff. Pharmacies are the primary source of medicines 
for STI syndromes, either commissioned by the formal sector or self-prescribed, 
although treatment practices in response to the latter do not comply with acceptable 
standards and therefore raise concerns around the quality of unregulated STI services 
provided in pharmacies. 
 
3.1.4   Standards of care in pharmacies 
Determining the gaps in pharmacist’s knowledge is essential for tailoring the content 
of STI courses to meet specific educational needs. In South America and parts of 
Africa where the formalization of STI service delivery in community pharmacies is 
being explored by independent research groups, the logical point of departure was to 
establish existing knowledge and practises of pharmacists and to subsequently 
develop interventions as informed by results. 
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3.1.4.1   STI knowledge assessment 
Five percent of Mexico City’s retail pharmacies were randomly selected to participate 
in a cross-sectional survey assessing attendant knowledge of STI diagnosis and drug 
treatment and strategies for referral, based on 3 hypothetical scenarios for UDS, HSV 
and TV/BV. A correct diagnosis, in accordance with syndromic approach for NG and 
CT was made by 9% of attendants; 12% correctly identified HSV and no attendants 
recognized the clinical presentation for TV.  Correct treatment, defined as compliance 
with specified treatment guidelines and reputable references, was recommended by 
16, 12 and 16% of attendants for NG, HSV and BV/TV respectively. While 
attendants displayed a high degree of confidence in treating VDS – 83% of them 
recommended pharmacological therapy – this was not reflective of their treatment 
proficiency since appropriate treatments were only prescribed 9 times (16% of all 
attendants).  Ampicillin, renowned for its poor resistance profile, was the most 
commonly prescribed of all antibiotics, which reflects poor quality of treatment. The 
need for a follow-up was recommended by 67%, 65% and 26% respectively for NG, 
HSV and BV (Turner et al., 2003).  Similarly, Ward et al. (2003) surveyed head 
pharmacists from 22% of Western Cape pharmacies and the findings were not 
dissimilar: of those who treat STI, more than 70% of pharmacists were inclined to 
treat VDS although the majority failed to recognize more than one implicating agent; 
adherence to recommended treatment guidelines was very poor, ranging from 0% for 
VDS to 14.6% for UDS. Furthermore, the majority of pharmacists (>60%) had never 
heard of syndromic treatment of STI or Department of Health standard treatment 
guidelines for STI.   
 
Poor STI treatment in pharmacies is not an isolated finding: private specialists, 
private doctors and occupational nurses who, by virtue of their professional training 
are deemed competent to diagnose and treat STI have also performed poorly against 
WHO benchmarks. While specialists in Pakistan were more likely than general 
practitioners to adhere to standard treatment guidelines as far as diagnosis and 
treatments were concerned, less than half of the specialists were able to correctly state 
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the dose and duration of antimicrobial treatment of the most common STI 
(Khandwalla et al., 2000).  In South Africa, surveys among private practitioners and 
occupational nurses reflect the greatest measures of success in treating UDS and 
GUS, and generally very poor adherence to treatment guidelines for pelvic 
inflammatory disease (PID) (Schneider et al., 2001, 2005; Chabikuli et al., 2002).  
Similarly, grossly inadequate treatment of PID and TV was observed among private 
practitioners in Peru, while sub-optimal treatment regimens were commonly adhered 
to in the management of VDS (Garcia & Holmes, 2003).  Public sector clinics 
outperformed private pharmacies and clinics in every aspect of STI management in 
Nairobi, Kenya where treatment was deemed unsatisfactory in all, except public STI 
clinics (Voeten et al., 2001). 
 
Pharmacists should therefore not be disqualified from delivering STI services on the 
basis of their lack of knowledge or poor existing practises, given the similar degree of 
ineptness displayed by higher skilled health professionals.  Rather, their willingness 
to provide STI treatment, coupled with the high number of treatment requests in 
pharmacies (Ward et al., 2003), should be acknowledged and exploited by health 
authorities.  At this early juncture, their relative competency in treating male STI 
syndromes presents a potential segue towards the proposed extended pharmacy role. 
 
3.1.4.2 Impact of training on STI management in pharmacies  
Although knowledge and skill attained through training courses do not guarantee 
model behaviour in practice, they remain prerequisites for behaviour change. While 
pharmacy graduates are well equipped for independent clinical decision-making, the 
lack of application of these skills in practice due to legislative restrictions provides 
clear motivation for pharmacist CPD courses in STI management. Furthermore the 
poor quality of existing STI care provided by pharmacists practising outside of their 
sanctioned professional boundaries warrants additional training.  
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In Lima, Peru, researchers designed a pre- and post-intervention trial to evaluate the 
impact of a brief one-day training course on the diagnosis, treatment and counselling 
of STI among various cadres of pharmacy staff, of which 25% constituted qualified 
pharmacists.  Trained simulated clients presented to 180 randomly selected 
pharmacies with syndromes of UDS, GUS, VDS and PID.  These pharmacies were 
then randomise to either receive or not receive the training intervention.  Although 
verbal commitment to participate in training was received from 93% of the 
intervention pharmacies, this failed to translate to actual course attendance – a  
meagre 23% response rate was achieved. Non-responders were accommodated 
through personal 1-2 hour training sessions at individual pharmacies by research 
staff. Approximately 2-3 months after the course simulated clients again visited all 
the sites to evaluate the provision of STI care. Female syndromes were least likely to 
be identified as an actual STI; at baseline the syndromes most often identified as STI 
related were genital ulcer (81%) and UDS (73%) in males, followed by VDS (43%) 
and PID (6%) in females.  Treatments rarely (5% and less) conformed to the 
recommended national or international guidelines. Although slight improvements in 
diagnosing and treating according to the recommended guidelines were observed in 
the sample, none attained statistical significance. The only noteworthy findings 
emanating from the brief training session were improvements in counselling; “by 
intent to intervene analysis, intervention pharmacies provided post-counselling more 
often than did controls (40% vs. 27%; p=0.01).” (Garcia et al., 1998). In a similar 
study conducted among various cadres of pharmacy staff in Ghana, of which less than 
one third identified themselves as pharmacists, Adu-Sarkodie et al. (2000) also 
observed significant improvements in counselling behaviour.  One hundred Ghanaian 
pharmacies were randomly assigned to either attend a one-day STI training 
programme or to receive no training.  The quality of care was assessed through 
simulated clients presenting with symptoms of urethral discharge only.  Overall, the 
clients attending the outlet sites had received better history taking and counselling on 
STI than did the controls, however few of these differences were statistically 
significant. No simulated clients attending intervention outlets were counselled to use 
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condoms (0% vs.13% p<0.05), acceptable drugs and dosages were received by 39% 
of intervention and 18% of control (p<0.05) and partner notification in the 
intervention group was significantly higher than control (40% v 21%, p<0.05).  
 
A random sample of pharmacies along a well-known transport route in a Nepali city 
was recruited by Tuladhar et al. (1998) for an STI intervention trial.  The pre-and 
post-training evaluation, with the assistance of simulate clients presenting with 
urethral discharge, was performed on 160 male pharmacists in January and November 
1996 respectively.  Nepal Chemists and Druggists Association (NCDA) used a pre-
piloted 2-day curriculum to train pharmacists in recognizing and treating STI 
syndromes as well as providing the necessary counselling on compliance, referrals, 
condom promotion and follow up visits should symptoms persist.   Precise intervals 
between training and post intervention surveys were controlled for in the analysis of 
data since evaluation could have occurred anywhere between 1 and 9 months after 
training; an analysis of a sub-sample of 38 pharmacists who had been trained 7-9 
months before the follow-up was performed. A vast improvement in selection of 
correct treatment regimens at appropriate dosages was observed from 0.8% at 
baseline to 45% (p=0.05) and 26% (p=0.05) at follow-up in the full sample and the 
earlier trained sub-sample respectively. Prior to the training intervention only 47% of 
pharmacists made attempts to counsel patients, however this value increased to 68% 
and 71% (sub sample) at follow-up (p-values <0.05). Although more modest than the 
overall improvements, treatment and counselling remained significantly better than 
the baseline values 7-9 months after training. Notwithstanding the gradient of 
improvement attained, the absolutes (≤45%) at various time points disconcertingly 
reflect a degree of incompetence among pharmacists’ treatment of UDS.  This was 
also reported by Bista et al in 2002 where post-training treatment success rates were 
achieved by only 24% of pharmacists for UDS whereas risk counselling was offered 
by 57%, partner notification by 43% and condom promotion by 35%.   
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The impact of compact (1 to 2 days) STI management courses, devoid of any other 
interventions, produced inconsistent and short-lived results among pharmacists and 
other cadres of pharmacy personnel who failed to achieve notable standards of 
treatment – notwithstanding incremental improvements post-training.  Experience 
borrowed from the aforementioned research paved the way for the development of 
more innovative and widely acceptable interventions deviating from the customary 
didactic modes of teaching.  
 
Garcia et al. (2003) set out to modify a piloted training intervention, described earlier 
(Garcia et al., 1998), in an attempt to gain broader participation from pharmacists and 
enhanced acceptability from doctors.  The outcome of a focus-group discussion with 
relevant role-players revealed that pharmacy workers preferred small interactive 
group seminars near workplaces, with incentives such as lunch, material and 
continuing supportive contact.  To increase acceptability in the medical community, 
physicians were trained concurrently to accept referrals from pharmacies.  Within the 
lower SES districts in Lima, pharmacies were matched according to location, 
population size, population density and literacy rates into 12 pairs. Six pairs were 
randomly selected for the study and one of each pair was assigned to either the 
control or intervention/experimental group.  A total of 684 pharmacies (76.2% 
response rate) participated in an intervention consisting of three 90-minute luncheon-
training seminars over a 2-month period conducted by a pharmacist and midwife 
team. In addition to the seminar, resource materials were made available for 
pharmacists and their clients; pharmacists were issued with pocket-size STI 
information cards and training manuals, health promotion posters and paraphernalia 
and referral lists for doctors and clinics, while STI/HIV prevention packets, 
pamphlets and referral slips were disseminated for client use. All physicians in the 
said districts were enrolled into a 6-hour workshop on management of STI 
syndromes. The most proficient were invited to join a referral network, which 
included 36 physicians.  The STI intervention seminars for pharmacists and 
physicians were followed up with monthly visits by the same trainers to discuss 
 
 
 
 
 50
HIV/AIDS prevention and to replenish STI/HIV materials for pharmacists and 
clients, referral lists and an STI packet. Furthermore, newsletters were distributed 
every alternate week to intervention pharmacies. One hundred of the pharmacies 
receiving the intervention were randomly selected to undergo evaluation; trained 
simulated clients evaluated proficiency in STI management at 1, 3 and 6 months post 
training. Over each evaluation time frame the intervention group consistently 
produced superior outcomes measures, including the recognition of STI from the 
presenting symptoms (p<0.05), adequate treatment for syndromes, except PID 
(p=0.06), condom promotion (p=0.06) and partner treatment recommendation 
(p<0.05).  Overall the treatment of male syndromes was consistently better than 
female syndromes; among intervention groups, success rates for adequate treatment 
of STI – defined as prescribing effective drugs for UDS and VDS and at least 
referring for GUS and PID – was better for the treatment of UDS in males (76.7%-
82.5%) than VDS (40-67.5%) and PID (50% and less) in females. Symptom 
recognition in the intervention group was consistently over 90% for UDS and GUS 
and less than 50% in the majority of other syndromes. Counselling concerning 
partner treatment in the intervention group was inconsistent and poor for all 
syndromes except for UDS, which increased from 47.5 to 84.2 over a six-month 
period.  Recommendation of condom use to females was poorer than to male clients. 
 
In Hanoi, Vietnam, Chuc et al. (2002) evaluated the effectiveness of a multi-
intervention package on pharmacy practice in a clustered randomised controlled trial 
with a time series design. Four tracer conditions of public health importance, 
including case management of UDS, were used to evaluate the impact of the 
intervention on pharmacy practice.  One in each pair of the 29-paired pharmacies was 
assigned to receive the multicomponent intervention and all cadres of pharmacy 
personnel at the selected sites were invited to participate in the study. The first 
intervention was a regulatory enforcement by an inspector who visited the pharmacy 
and drew emphasis on regulations around prescription drugs.  Secondly an 
educational intervention consisting of two 45-minute face-to-face educational 
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sessions, supplemented with written information on STI management was carried out. 
The third intervention was to elect one participant per geographical area to conduct 
peer facilitated discussions with other participants highlighting implementation 
difficulties in practice.  Four rounds of simulated client visits were conducted; one at 
baseline and at one month intervals following each intervention. An increased rate of 
referral observed in the intervention group (22-37%) was matched with a 
corresponding decrease in the control (20-18%) at significant p value (p=0.01).  
Correct syndromic treatment increased in both the intervention group (3-30%) and 
control group (4-19%), and while the extent of improvement was greater after the 
intervention (p<0.05), successful treatment rates remained low across the board.  
There was no difference between the intervention and control groups in terms of the 
number of participants who completed sexual risk assessments and promoted condom 
use.   
 
The multifaceted interventions involving more interactive learning components and 
peer as well as physician support produced more consistent improvements in almost 
every aspect of STI management which did not wane over time, notwithstanding the 
limited (4.5 hours) training duration involved (Garcia et al., 2003).   Furthermore 
treatment success rates were more respectable when interventions targeted 
pharmacists only as opposed to all cadres of pharmacy personnel.   
 
3.2  HEALTH PROFESSIONAL ROLE CONFIGURATION 
 Role configuration in the workplace may be defined as the establishment of 
innovative roles that traverse normally distinctive occupational boundaries. The 
purpose thereof is to optimise the utilization of skills in the workplace through 
vertical or lateral skill transference according to existing deficiencies and identified 
need. In modern healthcare systems, selected skill mix interventions are purposefully 
implemented in an effort to offset the skills dearth caused by shortages of essential 
personnel.  Skill mix changes are not, however, a universal panacea and interventions 
of this kind should be carefully weighed in terms of cost and effectiveness before 
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being introduced (Royal College of General Practitioners, 2007).  The object herein is 
to provide a theoretical framework for role redesign initiatives and to subsequently 
identify an existing skill mix model which has found application in the healthcare 
milieu and achieved success in effecting role expansion in areas of practice akin to 
the aspirations of pharmacists. 
 Hyde et al. (2005) asserts that transference of skills vertically within a single 
disciplinary hierarchy or laterally, across professional/discipline divides culminates in 
one or more of four role changes, viz, skill mix changes, job widening, job deepening 
and new role creation. Skill-mix changes through role substitution or delegation 
within an existing hierarchy paved the way for role extension in UK and South 
African pharmacy technicians to include greater dispensing and counselling 
responsibilities (Hyde et al., 2005; Hugo, 2005).  Job widening involves an extension 
or expansion of a role to include new functions, which had not previously been 
performed by any individuals. For example, a mental health pilot in the UK is 
currently underway to investigate the utilization of pharmacy technicians in ward 
chart assessment and in-patient counselling with a view to reducing prescribing errors 
and improving medication compliance (Hyde et al., 2005). Job deepening involves 
enriching the knowledge and skills base within a role to an extent that it confers 
substantially greater responsibility, autonomy and opportunity for development 
within the said role.  Advanced practice nursing is a prime example of maximizing 
the use of in-depth nursing knowledge and skill and thereby contributing towards the 
development and advancement of the profession (Vollman & Martin-Misener, 2005). 
Finally, new role creation combines new and/or existing roles and functions in 
innovative ways. The development of a new role “emergency care worker”, allows 
nurses and paramedics, upon additional training, to institute immediate emergency 
treatment from the moment a patient is transferred into an ambulance until 
hospitalization (Hyde et al., 2005).   
With the exception of the nurse-doctor interface, there is a dearth of randomised 
controlled trials (RCTs) evaluating the effectiveness of other skill mix interventions 
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in healthcare. RCTs evaluating the myriad of advanced roles for nurses reflect wide 
patient acceptance, in addition to comparable costs and standards of care between 
nurse and doctor-led services in primary and secondary care (Kinley et al., 2001, 
Kinnersley et al., 2000, Lattimer et al., 2000 and Venning et al., 2000 as cited in 
Buchanan et al., 2002). 
 
3.2.1   Expanded scope of practice: clinical nurse practitioner model  
The underlying skill mix principles applied to nursing practice and culminating in the 
development of extended roles at primary care level has been selected for further 
exploration, with a view to draw parallels between the evolution of nursing and the 
proposed expanded role for pharmacists.  The traditional community health nurse, 
according to Kim (1978a, 1978b) as cited in Cho & Kashka, (2004) in pursuit of 
promoting community health, fulfilled nine roles, viz caregiver, advocate, advisor, 
facilitator, educator, manager, or researcher, community observer, and community 
developer. The clinical nurse practitioner, an advanced practice nurse in primary care, 
has acquired additional knowledge through post-basic training courses or a Master’s 
degree (International Council of Nurses, 2001) and has traversed the boundaries of 
medicine by adopting roles in decision-making and leadership.  An expanded scope 
of practice enables clinical nurse practitioners to adopt a supervisory role in primary 
healthcare clinics, thereby shunning previously perceived subordination to doctors 
(Keyzer, 1997), and to practise independent clinical judgment and action in 
diagnosing acute illnesses, monitoring chronic conditions, prescribing medication and 
making referrals to other professionals (Hicks & Hennessy, 1997).   The role of the 
advanced practice nurse in relation to doctors, notwithstanding clear evidence of 
selected role substitution, is generally recognized as a complementary one since the 
enhanced level of nursing expertise in selected areas of patient care remains 
entrenched in a nursing philosophy.  
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The advancements in nursing practice in most countries are based on a 
complementary and needs-led skill mix model (Keyzer, 1997).  The complementary 
model enables nurses to practice at a level of expertise where functions/tasks overlap 
with those of doctors while the needs-led model redefines the services provided in 
accordance with identified community needs in lieu of traditional modes of service 
delivery. Lessons in the development of complementary nurse-doctor hybrid roles in 
primary care are borrowed from USA and UK experiences in this review for two 
primary reasons: i) unprecedented success has been achieved in the USA in terms of 
role establishment; and ii) the non-federated health system structure in the UK, as 
opposed to the US, shares greater commonality with South Africa. 
  
The notion of an expanded role for nurses was birthed out of an overwhelming need 
for physician skills in rural and inner city urban areas in the USA during the early 
1960s. Advanced practice nursing in the USA was originally based on a proxy 
medical and needs-led model, which ignored the unique expertise of nursing and 
focused on churning out doctor substitutes (Keyzer, 1997).  The aforementioned 
allusion to nursing evolution in terms of progression up the rungs of a medicine 
career ladder was, however, shortsighted and patronizing to a profession that is 
entrenched in a unique philosophy of care.  This prompted nursing representative 
bodies in the US to lobby for the adoption of a complementary model, which enabled 
nurses to retain their professional values and complement, rather than substitute 
doctors. Similarly, in the early 1980s, a shortfall of family doctors in primary care 
catalysed role redesign for   nursing in the UK, based on a complementary model 
(Buchan et al., 2002). The development and implementation of the clinical nurse 
practitioner in both countries was met with good success; nurse-led primary health 
services in the USA and UK proved to be comparable to services offered by doctors 
in terms of cost and standards of care (Vennin et al., 2000 and Mundunger et al., 
2000 as cited in Buchanan et al., 2002).  
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The major facilitator in the USA for an expanded nursing role came from within the 
nursing profession itself; the attitudes of nurses to role change and the ensuing 
lobbying role of representative organizations for nurses paved the way towards 
developing a nurse-doctor hybrid role firmly rooted in the primacy of care (Keyzer, 
1997).  Today, implementation of the role of the advanced practice nurse in the USA 
is unprecedented, boasting significant legislative and regulatory breakthroughs at 
state level and the establishment of a Council of Primary Care Nurse Practitioners.   
In the UK, efforts to develop a similar role was undergirded by strong governmental 
support, which was driven by nationally instituted policies for the reduction of 
working hours by junior doctors and the need for human resource support for the 
modernization agenda in the National Health Service. The absence of regulatory 
bodies to oversee the advanced level of nursing practice in the UK, as opposed to the 
USA, has resulted in the development of poorly defined roles and job titles 
(Buchanan et al., 2002). These contrasting facilitators for change initiation in the UK 
(top-down in the hierarchy) and the USA (bottom-up in hierarchy) may well be 
central to the disparate progress in role establishment across the two countries.  
 
3.2.2  Potential application of model to pharmacists 
The proposed expanded role for pharmacists, in concurrence with the clinical nurse 
practitioner role, calls for job deepening towards enhanced decision-making 
responsibility and higher levels of autonomy. This, coupled with the dire need for 
optimising existing workforce skills in South Africa in the face of disconcertingly 
high losses of healthcare professionals to the overseas market (Paradath et al., 2003), 
warrants the adoption of a complementary and needs-led skill mix model, based on a 
doctor-pharmacist hybrid role.  
The eight roles of a pharmacist, according to WHO and the International 
Pharmaceutical Federation, are as follows:  caregiver, communicator, decision-maker, 
teacher, lifelong learner, leader, manager and researcher (Wiedenmayer et al., 2006). 
In a broad sense, the aforementioned roles are convergent with the 5 roles fulfilled by 
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doctors, viz, caregiver, decision-maker, communicator, community leader and 
manager (Jha et al., 2005) and hence role substitution is an inept description of the 
proposed advanced role pharmacist in primary care.  Rather, the envisaged role 
remains entrenched in the 8 defining characteristics of pharmacists, while the level of 
autonomy sanctioned in the area of clinical and therapeutic decision-making is 
challenged.  This translates to enhanced functions at primary care level, including 
advanced clinical assessments and diagnostic decision-making on selected acute and 
chronic illnesses for which established guidelines exist and enhanced prescribing 
autonomy, allowing broader application of skills inherent to the pharmacy profession, 
inter alia, rational pharmacotherapy and overall disease management.  In order for 
pharmacists to retain their professional identity and independence from doctors, 
notwithstanding blurring task/function boundaries, their new roles must be grounded 
in the philosophy of pharmaceutical care. 
 
Unique facilitating factors proved instrumental in the development and 
implementation of the clinical nurse practitioner role in UK and USA primary 
healthcare facilities. Governmental support was vital to the development of the 
advanced nursing role in the UK and a similar level of political backing for South 
African initiatives in pharmacy may pave the way to comparable successes. Nursing 
advances in the USA, however, teach that political support should serve to augment 
strong pharmacy advocacy in order to drive the agenda of pharmacists and not vice-
versa.  
 
In South Africa, selected national policies potentially offer the same conduit for 
governmental support toward role redesign initiatives for pharmacists. Role redesign 
interventions are in consonance with the National Drug Policy (NDP) of 1996 and the 
National Health Act (Act 61 of 2003): the NDP supports the conferral of prescribing 
powers to any health professional on the basis of competency attainment (Department 
of Health, 1996); while the Health Act mandates the Minister of Health to 
accommodate new categories of healthcare personnel in human resource regulations, 
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in an effort to offset the deficit in respect of scarce skills, expertise and competencies 
(Republic of South Africa, 2003).  Further opportunities for skill mix interventions 
exist in the implementation of new quality assurance programmes at higher education 
institutions in SA (Republic of South Africa, 1997c).  The ensuing outcomes based 
competency standards instituted by various health professional councils, inter alia, 
the South African Pharmacy Council (Summers et al., 2001) may encourage multiple 
entry and exit points for various non-pharmaceutical healthcare professionals in the 
future.  The nursing profession, by way of section 38A of the Nursing Act, has 
already made significant strides in this regard; registered nurses, upon completion of 
supplementary courses may receive permission from the Director General to 
prescribe and dispense drugs in areas devoid of the skills of doctors and pharmacists 
(Republic of South Africa, 1978). The resultant job deepening for selected nurses is 
purportedly patterned on a complementary and needs-led skill mix model, which 
demonstrates current legislative support towards role redesign initiatives. 
Amendments to the Pharmacy and Nursing Acts further corroborate the 
aforementioned interventions; skill mix changes for post-basic pharmacist assistants 
and nursing assistants by way of uni-disciplinary role substitution and delegation 
have recently been effected in South Africa (Republic of South Africa 1978, 1997b). 
 
Notwithstanding inherent differences between the national and state level of 
healthcare and legislative control in the UK and USA respectively, the successful 
driver for nursing change initiation in the latter underscores the importance of 
mobilizing pharmacists toward professional change in South Africa.   
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3.3 LESSONS LEARNT FROM LITERATURE  
The prioritisation of STI management and control through syndromic treatment 
modalities with respect to the treatment of male clients is supported by literature and 
the inclusion thereof in HIV/AIDS strategic plans of developing countries remains 
justifiable.  The increasing demand for STI services in community pharmacies 
coupled with the availability of selected simple, yet valid and effective diagnostic  
tools underline the importance of targeting private community pharmacies for 
specific interventions and education programmes focused on syndromic STI 
management. Furthermore, the global evidence of increasing political support for role 
redesign in the healthcare workforce, the evidence of existing overlaps between the 
proposed role for pharmacists and existing skill mix models, and the varied 
experiences gained from pharmacist training interventions in STI management, 
provide motivation for further exploration into an expanded pharmacist role in 
syndromic treatment.  
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CHAPTER 4 
STUDY RATIONALE 
 
______________________________________________________________________ 
 
A myriad of interconnected problems have emerged from the literature scan and these 
have been set against a unique geographical backdrop. An enumeration of the 
dominating issues discussed in preceding chapters will provide the required 
underpinnings to the primary research question for this study.  Furthermore, an outline 
of the specific research objectives set out to answer the research question will bring 
lucidity to all ensuing study undertakings. 
 
______________________________________________________________________ 
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4.1  DEVELOPMENT OF RESEARCH QUESTION 
Several issues pertinent to conceiving the generalised and more specific research 
question were discussed in preceding chapters (background and literature review); 
these are collated and summarized in bullet-point form below and the sequential 
refinement of the research question is provided in shaded and bordered text.  
 
 
• The private health sector, servicing a minority of the South African population, 
is inordinately well resourced (in human resources and other) in comparison to 
a scantily resourced public health sector (Dayi & Gray, 2006). 
 
•  Under-allocation of healthcare budgets have translated to measly financial 
compensation of public sector employed health professionals and therewith, 
poor incentive for long-term state employment (Paradath et al., 2003).   
 
• Notwithstanding the implementation of key interventions to offset migration of 
human resources into the private sector and to engender a sense of public 
servitude within the healthcare workforce, the South African public health 
sector remains beset with enormous human resource challenges (Paradath et al., 
2003). 
 
• Government’s role in selected private health regulation is likened to a double-
edged sword; benefits to the public at large have been indisputable, however the 
perceived encroachment by government on free enterprise has engendered much 
animosity between the private and public sector and has undermined the 
requisite sectoral synergism (Republic of South Africa, 2002). 
 
• Public-private interactions are strongly advocated by the Department of Health, 
notwithstanding the anomalies encountered during implementation, which are 
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thought to stem from an absence of clear policy around the issue (Leon & 
Mabope, 2005). 
 
Future attempts to develop cohesive strategies involving both the public and 
private sector are certainly at a premium in the face of immense public health 
challenges, not least of all a burdensome HIV epidemic. Private sector human 
resources (doctors, nurses and pharmacists) are potentially under-utilised in 
public health initiatives and should be targeted more effectively, possibly 
through the establishment of public-private interactions. 
 
Could private sector community retail pharmacists plausibly fill some of the 
current public health gaps created by human resource deficiencies within the 
public sector?  
 
 
• Notwithstanding the mature stage of the epidemic in South Africa, the incidence 
of HIV remains high and reaffirms the need for continued prevention 
interventions, inter alia, STI management and control (Department of Health, 
2007b). 
 
• Clinical and epidemiological evidence presented in the review favours the 
continued support of WHO advocated HIV strategies to improve STI treatment 
delivery (Ghys et al., 1997; Grosskurth et al., 1995; McCelland et al., 2001; 
Wolday et al., 2004). 
 
• Despite the objections from certain quarters as to the effectiveness of syndromic 
management approaches, the literature has reaffirmed the value of employing 
simple syndrome algorithms, particularly in the management of male clients 
presenting with STI in infrastructurally poor settings (Alary et al., 1998; 
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Chalamilla et al., 2006; Desai et al., 2003; Djajakusumah et al., 1998; Hawkes 
et al., 1999; Sloan et al., 2000) 
 
• In a bid to effect standardised management approaches in South Africa, national 
STI management and control strategies have extended into the private sector. 
Poor quality of STI treatment by private doctors and nurses, however, remains 
substandard (Sonko et al., 2003).  
 
• Community retail pharmacies are a regular port of call for clients presenting 
with STI (Gilbert, 1998), however, a deficiency of skills in conducting invasive 
clinical examinations, coupled with legislative barriers against prescribing 
antimicrobials (Republic of South Africa, 1997a) have limited their role to one 
of referring for clinical management. 
 
The prioritisation of STI management and control through STI syndromic 
treatment modalities with respect to the treatment of male clients is supported 
by literature and the inclusion thereof in HIV/AIDS strategic plans of 
developing countries, including South Africa remains justifiable. In a healthcare 
system fraught with human resource deficiencies, the utilization of private 
community retail pharmacists could facilitate the implementation of national 
HIV plans. The increasing demand for STI services in community pharmacies 
coupled with the availability of selected simple, yet valid and effective 
diagnostic and treatment tools underline the importance of targeting private 
community pharmacies for specific interventions and education programmes 
focused on syndromic STI management of index clients. 
 
Would South African community retail pharmacists be willing to receive 
training for and subsequently offer clinical syndromic STI management services 
to male clients in their pharmacies? 
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• A WC survey of community retail pharmacists revealed that although 
pharmacists were inadequately trained to provide syndromic management of 
STI, their level of willingness to receive training and provide most aspects 
of management was high.  There was, however, a general reluctance to 
encroach on an   exclusive practice of nurses and doctors, i.e. conducting a 
thorough physical examination of the genitalia (Ward et al., 2003). 
 
• Since the presumptive treatment of STI partners, based on the diagnosis of 
the index client, often forgoes invasive clinical examinations and laboratory 
investigations, some countries, inter alia, the USA rely on patient-delivered 
therapies for partners who are unlikely to present to the formal health sector 
for treatment (Department of Health California, 2001).   
 
• “Presumptive” partner treatment is no misnomer; concordance in etiological 
agents between the index client and their partner/s ranges from as low as 
12% up to 57%.  However, this concessional approach is used when all 
other methods are deemed ineffective in targeting partners for treatment 
(Mak et al., 2004; Stekler et al., 2004) 
 
• Community retail pharmacies are the primary source of medicines for STI 
syndromes, either commissioned by the formal sector or self-prescribed, 
although treatment practices with respect to the latter are of notoriously poor 
quality (Bista et al., 2002; Crabbé et al., 1996; Khamboonruang et al., 1996; 
Sihavong et al., 2006; Vuylsteke et al., 2001). 
 
• The inception of pharmaceutical care, coupled with changing pricing 
regulations, has engendered a patient-centred approach to pharmacy that is 
service- and not product-driven (Gilbert, 1998; Republic of South Africa, 
1997a). 
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• Research in selected developing countries have shown that multifaceted 
training interventions in community retail pharmacies that included, inter 
alia, STI packets for utilisation during clinical management produce 
consistent long-term improvements in almost every aspect of STI 
management (Garcia et al., 2003; Chuc et al., 2002) 
 
No studies have evaluated the impact of training interventions on the syndromic 
management of STI in South African community retail pharmacies. Maximising 
the existing skills of pharmacists in rational pharmacotherapy and chronic 
disease management for the presumptive treatment of STI partners will 
certainly strengthen human resource deficient STI partner management 
programmes in South Africa and therewith potentially stem the continued 
spread of disease.  
 
By providing direct patient care, as is done in the epidemiological treatment of 
STI contacts, pharmacists may charge for their services, thereby offsetting the 
loss of income from the change in pricing of medications. Providing specific 
STI syndromic training and provision of treatment packets combined with the 
changing role of community pharmacist has the potential to increase appropriate 
treatment of STIs in the private sector thereby decreasing the overall burden of 
these conditions. 
 
What lessons can be learnt from other health professions as regarding expanded 
scopes of practice? 
 
 
• In the face of disconcertingly high losses of healthcare professionals to the 
overseas market, a dire need for optimising existing workforce skills 
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through role redesign initiatives in South Africa exists (Paradath et al., 
2003). 
 
• Job deepening involves enriching the knowledge and skills base within a 
role to an extent that it confers substantially greater responsibility, 
autonomy and opportunity for development within the said role (Hyde et al., 
2005). 
 
• Advanced practice nursing is a prime example of maximising the use of in-
depth nursing knowledge and skill through job deepening (Vollman & 
Martin-Misener, 2005). 
 
• Randomised controlled trials evaluating the myriad of advanced roles for 
nurses reflect wide patient acceptance, in addition to comparable costs and 
standards of care between nurse and doctor-led services in primary and 
secondary care  (Kinley et al., 2001; Kinnersley et al., 2000; Lattimer et al., 
2000; Venning et al., 2000 as cited in Buchanan et al., 2002.) 
 
• The major facilitator in the USA for an expanded nursing role came from 
within the profession itself: the attitudes of nurses to role change and the 
ensuing lobbying role of representative organisations for nurses paved the 
way toward developing a nurse-doctor hybrid role firmly rooted in the 
primacy of care (Keyzer, 1997). 
 
• Governmental support proved instrumental in the development and 
implementation of the clinical nurse practitioner in the UK  (Buchanan et 
al., 2002).  
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The proposed expanded role for pharmacists, in concurrence with the 
clinical nurse practitioner role, calls for job deepening towards enhanced 
decision-making responsibility and higher levels of autonomy. Global 
evidence of increasing political support for role redesign in the healthcare 
workforce and the evidence of existing overlaps between the proposed role 
for pharmacists and existing skill mix models, provide motivation for 
further exploration into an expanded pharmacist role in primary healthcare 
initiatives. 
 
The overarching purpose of this study was therefore to contribute to the 
small but growing body of evidence underpinning a proposed expansion in 
the scope of practice of pharmacists with a view towards enhancing their 
utilization in public health strategies, inter alia, syndromic STI management.   
 
 
Thus an extensive survey of literature and an unearthing of gaps within the current 
South African health system culminated in the following general research question: 
 
“Are community retail pharmacists capable of providing an acceptable quality 
of STI management to the male partners of index clients?” 
 
  
Further refined into sequential measurable research questions, it reads: 
 
“Will a training intervention close the expected knowledge gaps around STI 
among community retail pharmacists?” and “Could trained community retail 
pharmacists, with the aid of STI information packets, provide appropriate 
syndromic counselling and treatment to male STI partners?” 
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4.2  AIMS AND OBJECTIVES 
In an attempt to answer the aforementioned questions, the following aims and 
objectives were set out:  
a) To quantitatively evaluate the effect of an STI training intervention on the 
knowledge of pharmacists around STI, and 
b) To quantitatively determine whether the allocation of STI information packets 
augments the skills of community retail pharmacists with respect to the 
counselling and treatment of the male sexual partners of recently diagnosed and 
treated females.  
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CHAPTER 5 
METHODOLOGY 
 
__________________________________________________________________ 
 
In selecting the most appropriate methods and design procedures for this study, 
consideration was given to budgetary constraints, socio-political and geographic 
factors unique to the study location, desired representivity of study sample and the 
accuracy and reproducibility of measurements. 
 
Several extraneous factors, unique to the current South African milieu, were taken 
into consideration in the design, sampling and recruitment phases of the methods. 
Firstly, the differences in accessibility to primary health care facilities within the 
South African health regions necessitated stratification within the sampling frame 
so as to ensure representation from urbanised and rural areas. Secondly, the 
prevailing acrimony and negativity between community retail pharmacists and the 
Department of Health as a result of recent legislative impositions affecting 
pharmacy profit margins necessitated unique recruitment strategies that 
highlighted the potential benefits of this research in terms of professional growth 
and economic viability.  Thirdly, the preponderance of recent DOH research 
surveys concerning the single exit price and associated dispensing fees has 
generated generalized aversion towards research participation by pharmacists 
which warranted an approach which was least demanding upon business practice 
in terms of time, money and interference with normal routine.  
 
__________________________________________________________________ 
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5.1  DESCRIPTION OF THE TARGET POPULATION 
The target for this study was the 437 community retail pharmacies situated in the 
Western Cape province of South Africa.  Approximately ten percent of South 
Africa’s population resides in this province, of which nearly 80% find domicile in 
the urbanized Cape Metropole. Similarly, approximately 75% of community retail 
pharmacies are established in the Cape Metropole (population density: 1267/km2), 
while the remaining practices are distributed across the Cape Winelands 
(population density: 29/km2), West-Coast (population density: 9/km2), Overberg 
(18/km2), Central Karoo (population density: 2/km2) and Garden Route (19/km2) 
(Baron et al., 2006). 
 
5.2   DESIGN AND SAMPLING 
Eighty community pharmacists from the Western Cape province of South Africa 
who had participated in a previous survey regarding STI knowledge practices and 
attitudes towards providing treatment, and had further indicated an interest in 
receiving training in the future (Ward et al, 2003) were recruited telephonically in 
June 2006 to enrol in an 8-week STI distance-learning course between July and 
August of 2006. The effect of the training course on pharmacists’ knowledge of 
STI, including syndromic management, was determined in identical pre and post-
training evaluations. In order to attain the desired sample size (refer to “statistical 
issues”) an additional twenty pharmacies were randomly selected from two South 
African Pharmacy Council lists, viz the Cape Metopole pharmacies and 
pharmacies situated in the regions outside of the Metropole (hereafter referred to 
as urban and rural regions respectively). The final study sample reflected the 
proportion of pharmacies located in each region; 75 pharmacies were selected 
from the urban WC and 25 from rural WC.  These additional pharmacists were 
recruited telephonically and detailed about the study. At the end of the training all 
participants who completed the pre and post-training tests were then randomly 
assigned to either receive an STI management intervention (information packets) 
or no intervention and within a period of 6 months (October 2006 through 
February 2006) all pharmacists were visited by three trained males presenting as 
partners of patients with diagnosed GUS and three trained males presenting as 
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partners of patients with diagnosed UDS. Simulated patients then reported back to 
the study investigators regarding the actions (counselling and treatment) taken by 
the pharmacists.  
 
5.2.1   Design and sampling rationale 
5.2.1.1   Training intervention 
Traditionally, the pre and post intervention testing is used when the researcher 
wishes to remove the between-subject part of the variability of the outcome 
variable (Hulley et al., 2001). In this study, a pre-post design was employed due 
to the advantage of being able to track the same participant. Ideally, the inclusion 
of a control group would account for further explanatory factors for the outcomes 
obtained in the study (Hulley et al., 2001), however the difficulty in recruiting 
pharmacists who would not stand to benefit from a free training intervention 
weighed against the decision of employing a pre-post control group design.  
 
The gold standard of sampling techniques, randomised sampling, was employed 
since it offers a scientific basis for making inferences about the results to the 
general population (Hulley et al., 2001). 
  
As previously alluded to, a decision was taken to stratify the target sample by 
region, thereby ensuring representivity from urban and rural pharmacies. Attitudes 
toward advanced roles for pharmacists may vary between urban and rural 
pharmacists depending on the healthcare needs within the communities they serve 
and the extent to which other primary health care facilities are able to meet those 
needs.  
5.2.1.2   STI management intervention 
In a previous WC baseline survey, Ward et al., (2003) found that pharmacists 
failed to manage STI adequately and that a great need and willingness to receive 
training existed.  Since STI management (and partner management) currently falls 
outside the pharmacist’s scope of practice, there was speculation that untrained 
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pharmacists would possess neither the knowledge of epidemiological partner 
treatment approaches nor experience with accepting partner notification slips (a 
means of conveying medical diagnoses of the index patient between health care 
workers in the public sector). Therefore, untrained pharmacists were not assessed 
against their trained counterparts in the evaluation of the distance-learning course 
on actual management of STI partners; instead, an experimental-control design 
was employed to evaluate the differences in STI management between trained 
pharmacists who had either received additional assistance through information 
patient packets or those who had not.    
 
5.3   SUBJECTS AND RECRUITMENT STRATEGIES 
5.3.1   Study population 
The study population consisted of owners or full-time managers with a minimum 
qualification of a Bachelor of Pharmacy degree or Pharmacy Diploma.  Less 
senior pharmacists who lacked the authority to implement changes in the 
pharmacy were excluded.  
 
Eligible participants were recruited telephonically and study aims and procedures 
were described to them. Assenting individuals received a consent form via 
facsimile and were requested to return the signed documentation to the researcher 
within 2 days of receipt.  
 
5.3.1.1  Recruitment strategies implemented to maximise 
participation  
Experience in recruiting community pharmacists for research has taught that the 
role of the recruiter is pivotal in determining the eventual response rate. As such 
the responsible researcher was sensitised to the professional struggles and 
frustrations facing community pharmacists and trained to diffuse emotional 
verbosity tactfully and empathetically. Additionally, in view of professional 
services, as opposed to medicines being the primary profitable commodity in 
pharmacies, the researcher emphasized the economic benefits of offering services 
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for STI management from retail pharmacies in the future.  Finally the distance-
learning course was provided at no charge as this was envisaged to incentivise 
participation. 
5.3.1.2    Strategies implemented to minimise loss to follow-up 
The characteristically high staff turnover in private retail pharmacies was 
recognised as a potential threat to securing follow-up visits with enrolled 
pharmacists.  This factor supported the decision to involve only head pharmacists 
(owners and managers) who were presumed to be more likely to retain their 
positions until the end of the study period. Although this approach compromised 
the generalisability of study findings, the trade off was deemed vital in this 
relatively mobile study population. 
 
5.4   STI TRAINING AND MANAGEMENT TOOLS 
Preliminary studies on pharmacists revealed a generalized reluctance toward 
engaging in a training programme imposing high time demands. Participants had, 
however, reflected partiality toward distance learning courses, as is customary 
with the instructional methods employed in many continuous professional 
development (CPD) courses.  
 
A pre-existing WHO training package (World Health Organisation, 1997), 
adopted by the South African Department of Health for the training of physicians 
and nurses in STI syndromic management, lent itself to a distance learning 
approach and was therefore employed in this study (Appendix III). The training 
materials included six modules that used a workbook format and included 
assignments that were mailed to the study investigators at the completion of each 
module. The topics covered in the training included the following: STI glossary, 
public health significance of STI, using flow-charts for syndromic management, 
history-taking and examination, diagnosis and treatment, educating the patient and 
partner referral and care. The training materials included an electronic atlas of STI 
visuals as well as a pocket-sized copy of WC treatment guidelines (Appendix XI) 
which included 13 key elements of STI counselling (methods of STI transmission, 
STI signs and symptoms, need for prompt treatment, potential sequelae, risk of 
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HIV transmission associated with STIs, recommendation for HIV testing, 
methods of and promotion of risk reduction, condom promotion, provision/sale 
and demonstration, abstinence during treatment, treatment compliance and 
promotion of partner treatment). 
 
Throughout the duration of the course a clinical nurse practitioner was available 
by phone or electronic mail to offer learner support. Submissions of set modular 
assignments, while not formally assessed, were mandatory for all participants so 
as to assure that the participant had read the course materials. Participants 
completed the training at their own pace over an 8 week period.  
 
At the completion of their course, the principal investigator visited each 
participant over a one month period to reinforce the procedures for the impending 
evaluation of STI management and to deliver the STI management toolkit, 
consisting of blank prescriptions designed for the purposes of the study which 
could not be legally filled at any dispensary and samples of partner notification 
slips (Appendix VI) for all participants.  In addition to the aforementioned 
package, pharmacists in the experimental group received STI information packets 
containing information leaflets for patient education and counselling, a condom, 
an HIV testing referral note and contact details of neighbouring Voluntary 
Counselling and Testing sites which were designed to facilitate STI management7.  
 
 
5.5   EVALUATIONS 
5.5.1   Pre and post tests/examination  
The first evaluation consisted of pre- and post-training examinations that were 
administered by telephone at prearranged times. The questions covered each of 
the key topic areas of the training modules and the same examination was used 
before and after the training. No control measures were instituted to prevent 
pharmacists from consulting information from books or colleagues since this was 
                                                 
7 The original plan to include antimicrobials in the packets was thwarted after the request for a 
research waiver allowing pharmacists to prescribe and dispense antimicrobials for the purposes of 
the study was denied by the Medicine’s Control Council. 
 
 
 
 
 74
highly unlikely to occur during a telephonic testing with imposed time limits.  
Treatments were considered appropriate when they matched any of the 
recommended regimens in WC syndromic guidelines for the management of STI 
(Appendix XI). 
 
5.5.2 Simulated client method   
The simulated client method, an internationally applicable tool for measuring 
outcomes in pharmacy practice research, particularly the effects of behaviour 
change or training strategies (Watson et al., 2006), was used in the evaluation of 
the impact of STI information packets on STI management up to 6 months after 
the completion of the training course. Research has proven that the majority of 
individuals seeking STI management in pharmacies are in fact males, and for this 
reason, only male simulated partners were included in this study. In this 
evaluation three trained male research staff presented to the study pharmacies with 
notification slips indicating that they had sexual contact with someone who was 
diagnosed with genital ulcer syndrome (GUS) and a similar scenario was depicted 
by three males presenting as partners of individuals diagnosed with vaginal 
discharge syndrome (VDS) treatment. All simulated partners were to deny any 
symptoms of STI. The simulated partners then reported back to the study 
investigators regarding the actions taken by the pharmacists (Appendix VII). The 
main outcome required was to provide correct STI counselling and prescribing 
appropriate antimicrobials. 
  
5.5.2.1   Strategies employed to enhance accuracy and reproducibility 
Six simulated client visits paid to each pharmacy ensured adequate replication of 
the outcome measurement and would therefore provide a good summary measure 
for each clinic. Simulated clients were blinded to the assignment of experimental 
and control pharmacies and were therefore unbiased during their exchange with 
participants. Although pharmacists were aware of the evaluation by means of 
simulated clients, the actual timing of the visit was not disclosed to them. 
Anonymous calls were placed to pharmacies prior to each visit to ensure that the 
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enrolled pharmacist was on duty at the time of the visit.  Pharmacists were 
instructed to manage sexual contacts only, i.e. clients presenting with a partner 
notification slip (sample provided in their STI management toolkit) describing the 
diagnosis of the index patient.  Since partner notification slips are generally filled 
in public clinics and not in community retail pharmacies, the management of 
actual partners was not a concern; as such, there was no ethical concern of 
potentially mismanaging actual clients from the general population. 
 
Pharmacists were instructed to manage STI partners in the following sequential 
way:  
1) diagnose the simulated client based on partner’s diagnoses; 
2) write out a prescription for recommended treatment, and 
3) educate, counsel and provide STI information packet to patient (if in 
experimental group) 
5.5.2.2   Simulated client training 
Six final year pharmacy students from the University of Western Cape, School of 
Pharmacy, were recruited as simulated patients, since their prior knowledge of 
STI syndromic management was expected to be adequate due to the courses 
completed in undergraduate training. 
  
Simulated clients were trained to present with a script and were provided with 
clear guidelines for improvisation if required. 
 
 “Good afternoon…I’m not really sure whether I have a problem or not. My 
girlfriend has recently been diagnosed with an infection [hand over partner 
notification slip for either genital ulceration or vaginal discharge] and the health 
care workers suggested that I present for treatment at a pharmacy as soon as 
possible.  I feel absolutely fine and have not noticed anything suspicious-looking 
in the genital area. I just came to find out whether I should still be concerned or 
not.” 
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The mock patients were trained to respond to additional questions when probed by 
the pharmacist. 
 
“My partner was diagnosed one week ago and has subsequently completed her 
course of medication.  We did not engage in sex during this time.  This is a 
relatively new relationship, which to my knowledge is mutually monogamous. I 
have no history of STI. In our sexual relationship, condom use is irregular and 
depends entirely on the insistence of my partner. I have no fear of contracting 
HIV/AIDS since my girlfriend comes from a good home. I have no allergies to 
medication and have no other conditions or medication history.”  
 
5.6   HYPOTHESES AND STATISTICAL ISSUES  
5.6.1   Hypotheses 
5.6.1.1   Null hypotheses  
I. Test scores achieved before and after participation in an STI 
correspondence course, coupled with learner support, will be equal. 
II. An STI information packet will not influence the treatment 
recommendations made by pharmacists trained in STI management. 
III. An STI information packet will not influence the appropriateness of 
counselling delivered by pharmacists trained in STI management. 
 
5.6.1.2   Alternative Hypotheses I (two-tailed) 
I. Test scores achieved before and after participation in an STI 
correspondence course, coupled with learner support will be different.  
II. An STI information packet will influence the treatment recommendations 
made by trained pharmacists.  
III. An STI information packet will influence the appropriateness of 
counselling delivered by trained pharmacists. 
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5.6.2   Measurements 
5.6.2.1   Predictor and outcome variables in STI training intervention 
study 
Pharmacist gender (male or female), regional pharmacy location (urban or rural), 
age (>40 years or ≤40 years) and year of graduation (<1990 and ≥1990) were 
selected as binary predictors of change in STI knowledge. The outcome, mean 
difference in score (%) obtained by pharmacists, was a continuous measurement. 
The knowledge of STI was graded in terms of scores (%) achieved in pre- and 
post-tests. 
 
5.6.2.1.1   Anticipated effect of predictors  
In a baseline survey, Ward et al. (2003) discovered an independent association 
between pharmacist gender and willingness to treat STI in retail pharmacies; male 
pharmacists were more amenable to treating STI than their female counterparts 
after potential confounding variables were controlled. These findings prompted 
the inclusion of a gender variable as a possible explanatory factor for differences 
in STI test scores.   Younger pharmacists (<40 years) may be construed as having 
greater mental agility than older pharmacists and are thus expected to complete 
the comprehensive distance-learning programme with greater ease and fluidity. 
Pharmacists who graduated before 1990, the year marking the global shift in the 
profession towards pharmaceutical care and a patient-centred philosophy 
(Pearson, 2007), were expected to have a more marked improvement in 
knowledge than those who had graduated from a more clinically oriented 
curriculum post 1990. 
 
5.6.2.2  Predictor and outcome variables in STI management 
intervention study 
The assignment of STI information packets was expected to be the main predictor 
of competent STI management; the dichotomous outcome was simply “yes” or 
“no”. Additional predictors of counselling and treatment were anticipated and 
measured dichotomously, i.e. pharmacist gender, age, year of graduation, regional 
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location of pharmacy, dispensed information packets and differences in STI pre 
and post test scores. Variables overlapping with the training intervention were not 
remeasured, although the age variable was recoded into binary measurements 
(<40 and ≥40 years) for analysis. Furthermore, the difference in test scores in the 
training phase was rank ordered according to the range of knowledge differentials; 
a score of less than 20% was categorized as “1” and greater than or equal to 20% 
was categorized as “2”.  
 
The main outcomes of interest were the counselling and treatment of partners 
presenting with GUS and UDS.  Each of the 13 counselling elements was 
measured dichotomously (“yes” if mentioned and “no” if omitted), and 
summation of affirmative responses constituted the aggregate counselling score.  
Binary measurements for treatment recommendations were either “correct 
combination of antimicrobials” or “incorrect combination of antimicrobials”. 
Secondary outcomes measured in this study were referral patterns, i.e. referrals to 
a doctor without counselling or treatment or no referrals.  
 
5.6.2.2.1 Anticipated effect of predictors 
Gender was included as a variable on the same basis as before. The rationale for 
the age categorization (<40 and ≥40) was that older pharmacists were expected to 
offer more resistance to changes in scope of practice than younger pharmacists, 
thereby possibly exhibiting poorer confidence in managing STI and making more 
referrals elsewhere for clinical management.  Additionally, the anticipated 
conservatism among older pharmacists was identified as a possible barrier to 
treating STI. The year of graduation, as alluded to before, was expected to 
influence the degree of ease or difficulty in transitioning towards STI management 
based on the undergraduate training orientation of pharmacists. Since the 
allocation of STI information packets to the intervention group does not 
necessarily translate into utilization by pharmacists during partner management, a 
binary measurement was included to ascertain whether or not the information 
packet was dispensed to the simulated partner. 
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5.6.3   Statistical issues 
5.6.3.1   Sample size and power 
The sample size estimation was based on the Hypothesis C, i.e. whether or not 
STI information packets are able to improve the counselling of STI by community 
pharmacists. Due to the anticipated non-normal distribution of data for appropriate 
counselling and treatment, an adjustment to the sample size estimate derived from 
the t-test was made (Motulsky, 1996).  According to Lehman et al. (2006), when 
using a non-parametric test to determine score differences between two 
independent groups, it is acceptable to still compute the sample size required for a 
t-test, provided that the final figure is adjusted by adding 15%.  
 
Therefore, the t-test was used to estimate the sample size for the intervention and 
control group according to the following procedure (Hulley et al, 2001): 
a) The null hypothesis was stated and it was decided that the alternative 
hypothesis was two-sided. 
b) The effect size (E) was estimated as the difference in the mean value of 
the outcome variable between the study groups. 
c) The variability of the outcome (S), as its standard deviation (SD), was 
estimated. 
d) The standardised effect size was calculated, i.e. the effect size divided by 
the standard deviation of the outcome variable. 
e) Alpha (α) was set at 0.05, and beta (β8) at 0.2  
f) Used mathematically computed sample size table for the comparisons of 
means of continuous variables when using the t-test (Hulley et al., 2001, 
p.85) to determine estimated sample size based on the values of E, S, α 
and β  
 
The estimated effect size was derived from two studies found in literature as well 
as factors unique to the proposed study. The value of STI information packets has 
not previously been assessed in any studies, except when this intervention was 
coupled to STI training; Harrison et al. (2000) showed that after nurses and 
                                                 
8 β=1-Power 
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doctors received this intervention in rural Hlabisa clinics, their counselling (at 
least 3 of 5 messages) of STI clients improved by 18%.  After an STI intervention 
consisting of training only, a greater proportion of pharmacists (21% more) in a 
sample of private community retail pharmacies provided any type (at least one) of 
counselling (Tuladhar, 1998). It is therefore assumed that the impact of the STI 
information packets is very small, potentially less than 5%. In this study, however, 
given the anticipation of greater variation in responses between the possible zero 
and 13 counselling elements assessed, it is hypothesised that the information 
packet will achieve a difference of 10% in the counselling of STI clients with an 
estimated standard deviation of 15%.  A calculation of the standardised effect 
size, i.e. the effect size divided by the standard deviation, equals 0.7.  
Therefore, with alpha set at 0.05 and beta at 0.2 it is estimated that a sample size 
of 34 per group (Hulley et al., 2001, p.85) will afford 80% power to detect an 
association between the intervention and control group. Since the intention is to 
apply non-parametric statistical tests to the data, the final figure was scaled up by 
15% to 79 (Lehman & Erich, 2006).  A further scale up to 100 was considered 
sufficient to account for poor response rates and a high number of dropouts. 
 
5.6.3.2.  Analysis of data 
All data was entered onto an Excel spreadsheet and analysed using SPSS (SPSS 
Inc). To ensure ease of reading, the description of statistical analyses will be 
distinct for the two phases of the study. 
 
5.6.3.2.1 STI training intervention 
 
5.6.3.2.1.1 Univariate analyses 
Continuous variables will be described in terms of means and standard deviations 
(SDs) while categorical variables will be expressed as frequencies. 
 
5.6.3.2.1.2 Bivariate analyses 
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The effect of the training on the general STI knowledge was assessed statistically 
through the Wilcoxon signed-rank test (Wilcoxon, 1945).  This non-parametric 
analogue of the paired t-test was selected since all the assumptions for paired t-
tests were unlikely to be met, given the expected variances between the pre- and 
post-test scores.  The Wilcoxon signed-rank test statistically determines whether 
or not the median difference between pairs of observations (in this case pre-and 
post-test scores) is zero. Stratification of these pairs of observations by region, 
age, year of graduation, and gender accounted for the influence of these variables 
on the final outcome. A p-value of less than 0.05 would suggest a statistically 
significant difference between the underlying distribution of the pre- and post-test 
scores and on this basis the null hypothesis would be rejected in favour of the 
alternative hypothesis. 
 
The differences in observed and expected frequencies of correctly answered test 
questions before and after the intervention (stratified by region) were evaluated 
statistically using the Chi-squared test, a statistical test that accommodates 
categorical data and assumes that the expected values for each cell in a 
contingency table is 5 or higher.  When this assumption was not met, an 
alternative to the Chi-squared test i.e. the Fisher’s exact test was used (Hicks, 
1999). A significant difference (p<0.05) suggested that the frequency distribution 
of the pre- and post-test scores were not equal and this was interpreted as a 
significant effect of the training programme.   
  
5.6.3.2.2 STI management intervention 
 
5.6.3.2.2.1 Univariate analyses 
Mean and SD descriptive statistics will be employed in order to summarise the 
findings obtained through continuous measurements, while all categorical data 
will be summarised in terms of frequencies.  
 
5.6.3.2.2.2 Bivariate analyses 
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To measure the effect of the STI management intervention on training, each 
pharmacist received a sum score for correct treatment of patients presenting with 
GUS and a sum score for correct treatment of patients presenting with UDS (i.e. a 
pharmacist may receive a score of 66% for correctly treating 2 of the 3 urethral 
discharge patient and a score of 0% for not correctly treating any of the three 
genital ulcer patients).  In the instances when pharmacists were lost to follow-up, 
the scores assigned were averages of the number of clients actually managed (i.e. 
if pharmacists correctly managed 1 of 2 partners they received a score of 50%).  
The differences in scores between the experimental and control group in urban 
and rural arms were compared using the Wilcoxon (unpaired) rank-sum test 
(Wilcoxon, 1945). This measurement was done separately for management of 
GUS and UDS. The same procedures were followed to ascertain the differences in 
counselling and referral between the experimental and control group in urban and 
rural pharmacies for both GUS and UDS; sum scores for counselling of patients 
presenting with GUS disease and a sum score (maximum of 13) for counselling of 
patients with UDS (i.e. if three simulated partners received counselling on 3, 4 
and 6 counselling points respectively, then pharmacists were given an average 
score of 3). A significant difference (p<0.05) suggested that the median scores for 
the experimental and control group were unlikely to be equal and this was 
interpreted as a significant effect of the intervention package. 
 
5.6.3.2.2.3 Multivariate analyses 
 Multivariate analysis was employed to control for potential confounders of 
outcome variables.  A multiple ordinal regression model was fitted to establish 
independent associations between the predictors and the ordinal outcome variables 
and the direction in which the predictor is related to the ordinal outcome 
(O’Connell, 2006).  Normal binary logistic regression accepts categorical data, 
provided that only 2 possible categories of responses exist for a particular 
outcome variable.  However, collapsing scores into binary outcomes limits the 
interpretability of the findings.  A decision was taken to ordinalise the data into  
rank-ordered categories, and to fit an ordinal logistic regression model instead.  
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The basic assumption of ordinal logistic regression (an extension of binary 
logistic regression) is that the response variable behaves in an ordinal fashion with 
respect to each predictor.  The proportional odds model is the most commonly 
used and assumes that the odds ratio of the event is independent of the category of 
outcome (Bender & Grouven, 1998). The odds ratio is assumed to be constant for 
all categories, i.e., if the ordinal outcome has 4 levels, then the odds ratio is 
assumed to be equal for group 1 vs. 2,3,4; 1,2 vs. 3,4 and 1,2,3 vs. 4.   
 
The proportional odds ratios, calculated manually from the logits (log odds) 
generated in the data output in SPSS (SPSS Inc.), relates the predictor to the 
outcome in an ordinal way, i.e. if the proportional odds for one category of a 
predictor variable equals 10, then the odds of being in the higher (4) outcome 
category versus lower outcome categories (1,2,3) will be 10 times greater for that 
category of the predictor variable compared to the reference category. If the odds 
ratio is less than one, then the odds of achieving lower versus higher outcome 
categories are greater, and if the odds ration equals one, then this implies that a 
particular category of predictor variable is independent of the outcome variable. 
 
For the purposes of the multivariate analysis all continuous outcomes were rank 
ordered:  counselling was ordinalised into 4 categories: (1) poor scores of 23% (3 
out of 13) and less; (2) average scores ranging from above 23% through 46% (6 
out of 13); (3) good scores ranging from above 46% through 69% (9 out of 13), 
and (4) excellent scores of above 69%; and treatment of GUS and UDS was 
ordinalised into 4 categories: (1) poor scores of less than 33%(1 out of 3); good 
scores ranging from 33% through 50% (1 out of 2); (3) very good scores ranging 
from above 50 through 67% (2 out of 3), and (4) excellent scores above 67%.  
Gender, year of graduation, age, allocation of STI information packets to 
pharmacists, usage of STI information packets and differences in pre- and post-
test score variables were initially incorporated into the 4 separate ordinal 
regression models to test associations with counselling and treatment of the 2 
conditions. The models accounting for the most variation in outcome, i.e. the 
combination of predictors yielding the highest R-squared values, were selected as 
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the best models and only these were included in the final results. P-values of less 
than 0.05 were considered to reflect independence in the associations between 
predictor and outcome variables. 
 
Preliminary ordinal regression models and the measurements for all outcomes and 
risk factors are summarized in Table 1. 
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Table 1: Ordinal regression models for counselling and treatment 
recommendation of GUS and UDS  
 
MODEL MEASUREMENTS 
Outcome variables  
Counselling for GUS Ordinal 
Counselling for UDS Ordinal 
Treatment recommendations for GUS Ordinal 
Treatment recommendations for UDS Ordinal 
Predictor variables for each of the above outcomes  
Age Binary 
Gender Binary 
Region Binary 
Pharmacist year of graduation Binary 
Allocation of STI information packets to pharmacists Binary 
Dispensed information packets  Binary 
Difference in pre and post-training test score Binary 
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5.7   ETHICAL CONSIDERATION 
Ethical clearance was obtained from the institutional review boards of the 
University of Western Cape and the Committee on Human Research (CHR) in 
San Francisco. The primary ethical issue taken into consideration was that of 
confidentiality.   
5.7.1   Potential risks 
Participants were assigned a unique study number that was used on the pre- and 
post-tests and the form documenting the management of the simulated clients. 
Personally identifying information was retained separately from other study data. 
The personally identifying data included the contact information, the link between 
study number and name, and the signed consent forms. All information was 
retained in locked file cabinets in a locked room of one of the investigators. Data 
was entered into a research database and was identified only using the study 
number. Dissemination of findings will not contain any personally identifying 
information 
 
To minimize this risk, only those pharmacists who scored at least 70% on case 
management questions were included in the portion of the study that involves 
patient care. For those pharmacists who did not demonstrate this level of 
proficiency a recommendation not to provide syndromic treatment for STI was 
provided at the completion of the training. 
 
Currently health regulations do not permit pharmacists to dispense antimicrobial 
agents without a prescription from a doctor. Since no medication was dispensed to 
the patients, the risks of erroneously prescribed medication were negated. 
 
While private pharmacies are often called upon for treatment of symptomatic STI 
clients, they are seldom, if ever, presented with written partner notification slips 
from sexual contacts, which are invariably presented to public primary healthcare 
facilities. This notwithstanding, safeguards were instituted to prevent actual sexual 
contacts from missed pharmacological treatment opportunities; study participants 
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(pharmacists) were primed to accept “valid” partner notification slips and to refer 
all other cases immediately. A valid slip bore a reference to the study. 
 
5.7.2   Potential benefits 
The subjects were the pharmacists who, if interested in moving towards patient 
service, as is anticipated given restrictions on pricing medications, will most 
likely acquire the skills for syndromic management of STI. 
 
The purpose of this study was to address a serious public health problem. 
Untreated or inadequately treated STI contribute to ongoing transmissions of 
infections, to maternal and child morbidity and mortality, and have been shown to 
increase both the acquisition and transmission of HIV infection which is 
responsible for substantial number of deaths and years of potential life lost in 
South Africa. If this study is successful, expanded opportunities for treating STI 
and possibly reducing HIV transmission will results. The risk to subjects is 
limited while the potential benefit to society is great. 
 
5.7.3   Informed consent process 
Pharmacists were contacted telephonically and a consent form, signed by the 
investigator was faxed to these participants explaining the study objectives and 
procedures. Willing pharmacists returned the consent form to the study 
investigators and interested pharmacists were scheduled for training. 
  
All participating pharmacists were provided with verbal explanation of the study 
at the start of the training. 
  
At each point of contact with the pharmacists, information about the study and its 
procedures, risks, and benefits were explained. Potential participants were also 
informed of the voluntary nature of the study. Much of the contact was by phone 
or in person, which facilitated clarifying any confusing aspects of the study. 
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CHAPTER 6 
RESULTS 
 
 
____________________________________________________________________ 
 
The study findings are summarized in text, tables and figures according to the 
sequence in which the data was collected; the results of the STI training and 
management interventions are described in the order of descriptive, bivariate and 
multivariate analyses. A summary of the most salient results concludes this chapter. 
 
All univariate and bivariate results are tabulated according to stratification by region. 
In the multivariate analysis, the ordinal regression models reflect only those predictor 
variables, which collectively accounted for maximal variation for the outcome 
variable, as determined by the highest R-squared value (not reported in results). 
Furthermore, for the purpose of multivariate analysis, confounding variables were 
omitted from the regression model. 
 
P-values below 0.05 demonstrated statistical significance. 
____________________________________________________________________ 
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6.1   STI TRAINING INTERVENTION 
 
6.1.1  Univariate descriptive statistics 
Forty-one out of a possible 100 (41%) pharmacists initially consented to participate in  
both phases of the study; however, participation had diminished to 39% at the post-
training evaluation. This translated to 31 urban and 8 rural pharmacies, representing 
10% of urban and 7% of rural WC community retail pharmacies respectively.  The 
relatively poor response rate achieved in this study relative to similar interventions in 
other countries (Chuc et al., 2002; Garcia et al., 1998; Garcia et al., 2003; Harrison et 
al., 2000) is investigated further in Chapter 8.  Only 8 pharmacists represented rural 
WC although the stratification of pharmacies by urban and rural WC reflected 
favourably against the regional proportion of  pharmacies; 80% of consenting 
pharmacists were from urban WC and 20% were from rural WC (Figure 1).  Of those 
participants who provided a reason for declining to participate, the majority cited time 
constraints and disinterest. Figures 2 to 4 show that participants were predominantly 
middle-aged to old (83% were between the ages of 40 and 69 years), of male gender 
(80%) and had graduated before the implementation of a more clinically oriented 
pharmacy curriculum (88%).  
 
Figure1: Regional distribution of pharmacists in the original study sample (N=41) 
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Figure 2: Age distribution (in years) of pharmacists in the original study sample 
(N=41) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure3: Gender distribution of pharmacists in the original study sample (N=41) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2%
7%
22%
15%
54%
<30
30-39
40-49
50-59
60-69
80%
20%
Female
Male
 
 
 
 
 91
Figure 4: Year of graduation of pharmacists in the original study sample (N=41) 
 
 
 
 
 
 
 
 
 
 
 
 
The level of general STI knowledge prior to the training was fairly good. Figure 5 
shows that the average score attained by pharmacists at baseline was 73.8% (with SD 
of 10.1) and that the scores were of normal distribution.  The bar graph in figure 6, 
however, shows a preponderance of scores to the right of the curve, hence the higher 
average of 87.1% and smaller SD of 7.3%. 
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Figure 5: Frequency distribution of pre-training scores of pharmacists in urban and 
rural Western Cape 
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Figure 6: Frequency distribution of post-training scores of pharmacists in urban and 
rural Western Cape 
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Table 2 summarizes the frequencies of correctly answered questions.  Rural 
pharmacists were decidedly more knowledgeable about STI in the lead up to the 
training; all 8 pharmacists knew that, syphilis, gonorrhoea, chlamydia, trichomoniasis 
and candidiasis can be cured and that HIV is incurable, that GUS treatment is based 
on a syndromic rationale and that condoms offer 95% protection against HIV.  By 
contrast, only gonorrhoea and candidiasis were correctly identified as curable STI by 
all urban pharmacists.  Pharmacists displayed poor knowledge of treatment for GUS 
(0%) and UDS (<30%) before training was instituted.  Subsequent to the training 
100% of rural pharmacists additionally (compared to baseline observations) identified 
high-risk STI behaviours.  Interestingly, this group of pharmacists experienced a 
lapse in knowledge regarding the curability of syphilis. By the end of the training all 
urban pharmacists additionally (compared to baseline observations) knew that 
chlamydia and trichomoniasis are curable and that HIV is incurable.  Twice as many 
pharmacists could recall the appropriate treatment regimen for UDS, whereas none 
were able to list the correct GUS antimicrobials after training.                                .
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 Table 2: STI knowledge levels before and after an STI training intervention expressed in terms of frequencies (number of 
correct responses) and overall mean scores achieved by pharmacists in urban and rural WC pharmacies. 
 Urban Rural
Test topics  Pre-training  
(N=31) 
Post-training 
(N=31) P-value 
† Pre-training (N=8) 
Post-training 
(N=8) P -value
†
 n(%)  n(%)  n(%) n(%)  
Knows if the STI can be cured       
   HIV 30(96.8) 31(100) - 8(100) 8(100) - 
   Syphilis 27(87.1) 29(93.5) 0.01 8(100) 7(87.5) - 
   Chlamydia 30(96.8) 31(100) - 8(100) 8(100) - 
   Gonorrhoea 31(100) 31(100) - 8(100) 8(100) - 
   Herpes 16(51.6) 24(77.4) 0.04 4(50) 5(62.5) 1 
   Trichomoniasis 30(96.8) 31(100) - 8(100) 8(100) - 
   Candidiasis 31(100) 31(100) - 8(100) 8(100) - 
   Chancroid 25(80.6) 29(93.5) 0.03 3(37.5) 6(75) 0.46 
Knows the link between STI and HIV 14(45.2) 26(83.9) 0.08 5(62.5) 7(87.5) 0.71 
Identifies STI risk behaviours 29(93.5) 30(96.8) 1 6(75) 8(100) - 
Understands rational for partner treatment 19(63.1) 27(80.6) <<0.05 3(37.5) 7(87.5) 0.05 
Understands rational for syndromic 
treatment of UDS 17(54.8) 25(80.6) 0.003 6(75) 6(75) - 
Understands rational for syndromic 
treatment of GUS 19(61.3) 26(83.9) 0.005 8(100) 8(100) - 
Knows condom effectiveness 26(83.9) 31(100) - 8(100) 8(100) - 
Knows UDS treatment  9(29) 18(58.1) 0.61 2(25) 5(62.5) 0.63 
Knows GUS treatment 0 0 - 0(0) 0(0) - 
Overall score (mean %) 73.4 87.5 <<0.001* 75.4 86.3 0.02* 
†Fisher’s Exact Test  *Wilcoxon Signed-Rank Test
 
 
 
 
 96
6.1.2  Bivariate statistics 
 
6.1.2.1   Testing of hypothesis  
 
Null hypothesis: Test scores achieved before and after participation in an STI 
correspondence course, coupled with learner support, will be equal, i.e. the median 
differences in test scores will equal zero. 
 
Alternative hypothesis: Test scores achieved before and after participation in an STI 
correspondence course, coupled with learner support will be different, i.e. the median 
differences in test scores will not be equal to zero. 
 
 
Table 3: Wilcoxon Signed-Ranks Test for pre- and post-test score difference (urban 
arm) 
 Difference in pre- and post-test score 
Z -4.5 
Two-tailed significance <<0.001 
The results suggest that the median differences in pre- and post-test scores among 
urban pharmacists are not equal to zero (z = -4.5, p=<<0.005), and the null 
hypothesis is therefore rejected in favour of the alternative hypothesis. 
 
Table 4: Wilcoxon Signed-Ranks Test for pre- and post-test score difference (rural 
arm) 
 Difference in pre- and post-test score 
Z -2.4 
Two-tailed significance 0.02 
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The results suggest that the median differences in pre- and post-test scores among 
rural pharmacists are not equal to zero (z = -2.4, p=0.02), and the null hypothesis is 
therefore rejected in favour of the alternative hypothesis.   
Therefore, the observed differences in mean test scores in urban (from 73.4% to 
87.5%) and rural WC pharmacies (from 75.4% to 86.3%) were unlikely to have 
occurred due to chance alone and is probably reflective of the true impact of the 
training on STI knowledge (table 2). The transition in general STI knowledge was 
highest in urban WC, while rural pharmacists reflected smaller, yet equally 
significant improvements (Figure 7).   
 
Figure 7: Mean differences in test scores  
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6.1.2.2   Additional bivariate statistics 
Questions assessing knowledge about the curability of STI were answered correctly 
by more pharmacists after training, although the only significant improvements were 
noted for questions around the curability of GUS, viz, chancroid (p=0.03), syphilis 
(p=0.01) and herpes (p=0.04) in urban WC pharmacies (table 2). The knowledge of 
STI transmission, risk behaviours and what constitutes safe sexual practices improved 
p<<0.001 
p=0.02 p<<0.001 
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in urban and rural pharmacies, although the significance was inconsequential. 
Furthermore, the rationale for using a syndromic treatment approach and treating 
partners presumptively was poorly understood in urban WC before treatment and 
increased significantly after the training intervention in both regions. Knowledge of 
treatment for UDS was marginally better after the training in urban and rural WC, 
although of no significance statistically (p=0.61 and p=0.63 respectively). 
 
Table 5 shows that older and younger pharmacists improved their knowledge on STI 
after the training intervention, although the significance associated with the latter 
group was narrowly insignificant (p=0.05). Similarly, the improvements in 
knowledge were evident among long-standing and recent graduates (table 6), 
although the significance associated with the latter groups was narrowly insignificant 
(p=0.05). Male and female pharmacists received comparable (significant) gains in 
knowledge as shown in table 7.                                                .        
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Table 5: STI knowledge levels before and after an STI training intervention, expressed in terms of overall mean scores achieved 
by younger (<40 years) and older (≥40 years) pharmacists. 
 <40 years ≥40 years
 Pre-training  
(N=7) 
Post-training 
(N=6) P-value 
† Pre-training (N=34) 
Post-training 
(N=33) P -value
†
 n (%)  n (%)  n (%) n (%)  
Overall score (mean) 75 90.1 0.05 73.5 86.8 <<0.001 
†Wilcoxon Signed-Rank Test 
 
Table 6: STI knowledge levels before and after an STI training intervention, expressed in terms of overall mean scores achieved 
by pharmacists of recent (≥ 1990) and long-standing (<1990) graduation. 
 <1990 ≥ 1990
 Pre-training  
(N=34) 
Post-training 
(N=33) P-value 
† Pre-training (N=7) 
Post-training 
(N=6) P -value
†
 n (%)  n (%)  n (%) n (%)  
Overall score (mean) 73.5 86.8 <<0.001 75 90.1 0.05 
†Wilcoxon Signed-Rank Test 
 
Table 7: STI knowledge levels before and after an STI training intervention, expressed in terms of overall mean scores achieved 
by male and female pharmacists. 
 Male Female
 Pre-training  
(N=33) 
Post-training 
(N=32) P-value 
† Pre-training (N=8) 
Post-training 
(N=7) P -value
†
 n (%)  n (%)  n (%) n (%)  
Overall score (mean) 73.6 87.5 <<0.001 74.8 86.2 0.03 
†Wilcoxon Signed-Rank Test
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6.2 STI MANAGEMENT INTERVENTION 
6.2.1  Univariate statistics 
The second phase of the study, aimed at evaluating the differences in quality of STI 
management as determined by the influence of STI information packets on correct 
counselling and treatment of STI male partners yielded response rates of 31%.  
  
The data in table 8 suggests that the general characteristics of pharmacists in the 
experimental and control arm were a close match in terms of gender, age, year of 
graduation and region.     
 
Table 8: Community pharmacist demographics stratified by intervention and control 
group 
 
Characteristics Experimental group 
n (%)  
N=15 
Control group  
n (%) 
N=16 
Age 
<30 
30-39 
40-49 
50-59 
60-69 
 
1(6.7) 
2(13.3) 
8(53.3) 
2(13.3) 
2(13.3) 
 
0(0) 
1(6.3) 
9(56.2) 
5(31.2) 
1(6.3) 
Gender 
Female 
Male 
 
3(20) 
12(80) 
 
3(18.7) 
13(81.3) 
Year of 
graduation 
<1990 
≥1990 
 
 
12 (80) 
3 (20) 
 
 
15 (93.7) 
1 (6.3) 
Region 
Urban  
Rural 
 
12(80) 
3(20) 
 
12(75) 
4(25) 
 
 
 
 
 
 
 101
A treatment score of 33% and higher in table 9 is indicative of “good” treatment; by 
implication at least one third of simulated partners received the correct medication.  
GUS treatment was therefore deemed to be adequate, with an exception of the 
experimental arm in urban WC where a mean score of only 24% was attained. A 
score above 46% demonstrates adequate partner counselling; the implication is that 
an average of 7 out of a possible 13 messages were covered. The counselling of 
partners receiving treatment for GUS was therefore considered to be mostly 
inadequate, with an exception of the rural, experimental arm, where average scores of 
7 out of 13 were achieved. A similar pattern of results emerged for the treatment and 
counselling of partners with suspected UDS (table 10); all pharmacists with an 
exception of those in the rural, experimental arm (average scores of 70%), counselled 
inadequately and all pharmacists with an exception of those in the rural, control arm 
(average scores of 25%) treated UDS adequately.  A referral score of 33% and higher 
is indicative of having referred at least one of the simulated partners without 
attempting to prescribe antimicrobial drugs.  High referral rates are possibly a 
reflection of the pharmacist’s poor confidence in treating partners. In this study, 
scores were generally higher than 33%, with 2 notable exceptions, viz, partners 
presenting with suspected GUS and UDS in rural, control and urban, control 
pharmacies respectively. 
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Table 9: Quality of GUS management in experimental and control WC community retail pharmacies expressed as mean scores 
for aggregate counselling (fractions), elements of counselling (%), referral without treatment (%) and recommended treatment 
(%). 
 Urban Rural 
  
Experimental 
Mean score as 
fraction or %  
 
N=12 
Control 
Mean score 
as fraction or  
% 
N=12 
P-value*
Experimental
Mean score as 
fraction or % 
 
N=3 
Control 
Mean score 
as fraction or 
% 
N=4 
P-value* 
Aggregate counselling 5/13 4/13 0.56 7/13 4/13 0.16 
STI transmission 42 5 0.57 89 5 0.43 
STI signs &symptoms 58 5 0.59 44 25 0.43 
Prompt treatment 51 33 0.24 89 25 0.13 
Possible complications 17 31 0.2 89 33 0.06 
Risk HIV transmission 28 33 0.9 33 25 0.82 
 Promote VCT 38 44 0.57 89 38 0.14 
Risk reduction 56 53 0.83 78 50 0.43 
Promote condom use 49 61 0.4 78 75 1 
Condom provision 25 6 0.08 33 28 0.44 
Condom demonstration 8 11 0.71 33 0 0.25 
Promote abstinence  5 31 0.2 67 25 0.31 
Complete treatment 47 39 0.55 56 25 0.43 
Promote partner treatment 53 44 0.57 44 42 0.85 
Refer 43 36 0.61 33 0 0.25 
Correct treatment combination (GUS) 24 36 0.4 33 100 0.07 
*Wilcoxon rank-sum test
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Table 10: Quality of UDS management in WC retail pharmacies expressed as mean scores for aggregate counselling (fractions), 
elements of counselling (%), referral without treatment (%) and recommended treatment (%). 
 Urban Rural 
 Experimental 
Mean score as 
fraction or %  
 
N=12 
Control 
Mean score 
as fraction 
or  % 
N=12 
P-value* 
Experimental 
Mean score as 
fraction or % 
 
N=3 
Control 
Mean score 
as fraction 
or % 
N=4 
P-value* 
 
 
Aggregate counselling 4/13 5/13 0.58 8/13 3/13 0.06 
STI transmission  46 56 0.51 100 33 0.03 
STI signs &symptoms 28 29 0.98 78 33 0.19 
Prompt treatment 42 42 0.91 83 42 0.27 
Possible complications 17 31 0.2 89 33 0.06 
Risk HIV transmission 15 28 0.63 5 17 0.2 
Promote HIV testing 38 25 0.58 67 83 0.04 
Risk reduction 49 64 0.34 89 33 0.14 
Promote condom use 63 58 0.85 100 50 0.18 
Condom provision 49 3 0.003 22 0 0.25 
Condom demonstration 0 8 0.32 22 0 0.25 
Promote abstinence  26 56 0.07 33 25 0.71 
Complete treatment 25 53 0.03 61 25 0.21 
Promote partner treatment 47 58 0.57 78 42 0.27 
Refer 39 28 0.57 33 42 0.84 
Correct treatment combination (UDS) 54 56 0.92 67 25 0.27 
*Wilcoxon rank-sum test
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6.2.2  Bivariate statistics 
 
6.2.2.1 Testing of hypotheses 
 
6.2.2.1.1 Hypothesis Ia 
 
Null hypothesis: An STI information packet will not influence the treatment 
recommendations made by pharmacists trained in GUS management, i.e. the median 
scores for treatment in the experimental and control group will be equal. 
 
Alternative hypothesis: An STI information packet will influence the treatment 
recommendations made by pharmacists trained in GUS management, i.e. the median 
scores for treatment in the experimental and control group will not be equal.  
 
 
Table 11: Wilcoxon Rank-Sum Test for differences in correct GUS treatment 
recommendations between the intervention and control groups (urban arm) 
 Correct treatment recommendations for GUS 
Z -0.8 
Two-tailed significance 0.4 
 
The results suggest that there is no statistically significant difference between the 
underlying score distributions (and therefore medians) of the intervention and control 
groups (z =-0.8, p=0.4). The null hypothesis is therefore accepted. 
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Table 12: Wilcoxon Rank-Sum Test for differences in correct GUS treatment 
recommendations between the intervention and control groups (rural arm) 
 Correct treatment recommendations for GUS 
Z -1.8 
Two-tailed significance 0.07 
 
The results suggest that there is no statistically significant difference between the 
underlying score distributions (and therefore medians) of the intervention and control 
groups (z =-1.8, p=0.07). The null hypothesis is therefore accepted. 
 
6.2.2.1.2 Hypothesis Ib 
 
Null hypothesis: An STI information packet will not influence the treatment 
recommendations made by pharmacists trained in UDS management, i.e. the median 
scores for treatment in the experimental and control group will be equal. 
 
Alternative hypothesis: An STI information packet will influence the treatment 
recommendations made by pharmacists trained in UDS management, i.e. the median 
scores for treatment in the experimental and control group will not be equal.  
 
 
Table 13: Wilcoxon Rank-Sum Test for differences in correct UDS treatment 
recommendations between the intervention and control groups (urban arm) 
 Correct treatment recommendations for UDS 
Z 0.1 
Two-tailed significance 0.93 
 
The results suggest that there is no statistically significant difference between the 
underlying score distributions (and therefore medians) of the intervention and control 
groups (z =0.1, p=0.93). The null hypothesis is therefore accepted. 
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Table 14: Wilcoxon Rank-Sum Test for differences in correct UDS treatment 
recommendations between the intervention and control groups (rural arm) 
 Correct treatment recommendations for UDS 
Z -1.1 
Two-tailed significance 0.27 
 
The results suggest that there is no statistically significant difference between the 
underlying score distributions (and therefore medians) of the intervention and control 
groups (z =-1.1, p=0.27). The null hypothesis is therefore accepted. 
 
 
6.2.2.1.3 Hypothesis IIa 
 
Null hypothesis: An STI information packet will not influence the appropriateness of 
counselling delivered by pharmacists trained in GUS management, i.e. the median 
scores for counselling in the experimental and control group will be equal. 
 
Alternative hypothesis: An STI information packet will influence the 
appropriateness of counselling delivered by pharmacists trained in GUS management, 
i.e. the median scores for counselling in the experimental and control group will not 
be equal. 
 
Table 15: Wilcoxon Rank-Sum Test for differences in GUS counselling scores  
between the intervention and control groups (urban arm) 
 Level of counselling for GUS partners 
Z -0.6 
Two-tailed significance 0.56 
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The results suggest that there is no statistically significant difference between the 
underlying score distributions (and therefore medians) of the intervention and control 
groups (z =-0.6, p=0.56). The null hypothesis is therefore accepted. 
 
 
Table 16: Wilcoxon Rank-Sum Test for differences in GUS counselling scores  
between the intervention and control groups (rural arm) 
 Level of counselling for GUS partners 
Z -1.4 
Two-tailed significance 0.16 
 
The results suggest that there is no statistically significant difference between the 
underlying score distributions (and therefore medians) of the intervention and control 
groups (z =-1.4, p=0.16). The null hypothesis is therefore accepted. 
 
 
6.2.2.1.4 Hypothesis IIb 
 
Null hypothesis: An STI information packet will not influence the appropriateness of 
counselling delivered by pharmacists trained in UDS management, i.e. the median 
scores for counselling in the experimental and control group will be equal. 
 
Alternative hypothesis: An STI information packet will influence the 
appropriateness of counselling delivered by pharmacists trained in UDS management, 
i.e. the median scores for counselling in the experimental and control group will not 
be equal. 
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Table 17: Wilcoxon Rank-Sum Test for differences in UDS counselling scores  
between the intervention and control groups (urban arm) 
 Level of counselling for UDS partners 
Z 0.6 
Two-tailed significance 0.54 
 
The results suggest that there is no statistically significant difference between the 
underlying score distributions (and therefore medians) of the experimental and 
control groups (z =0.6, p =0.54). The null hypothesis is therefore accepted. 
 
 
Table 18: Wilcoxon Rank-Sum Test for differences in UDS counselling scores  
between the intervention and control groups (rural arm) 
 Level of counselling for UDS partners 
Z -1.8 
Two-tailed significance 0.07 
 
The results suggest that there is no statistically significant difference between the 
underlying score distributions (and therefore medians) of the experimental and 
control groups (z =-1.8, p =0.07). The null hypothesis is therefore accepted. 
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6.2.2.2   Additional bivariate statistics 
In a bivariate analysis (table 9) to determine the extent to which STI information 
packets improved the breadth of counselling for partners with suspected GUS, it is 
noted that, in the absence of information packets (control groups), pharmacists 
conveyed minimal information to partners  (4/13 messages in both urban and rural 
pharmacies) in comparison with the slightly more extensive counselling provided  
when information packets were readily available as was the case in the intervention 
groups (5/13 and 7/13 in urban and rural pharmacies respectively).  These 
differences, however, failed to achieve any statistical significance (p=0.56 and p=0.16 
in urban and rural strata respectively). As regarding the correctness of suggested 
antimicrobial therapy, these were more often recommended by pharmacists in the 
control group (no information packets), although the differences in treatment scores 
between intervention and control arms again revealed no statistical significance 
(p=0.4 and p=0.07 in urban and rural strata respectively).   
 
With respect to UDS, bivariate analyses (table 10) revealed no significant differences 
in aggregate counselling between the experimental (4/13 and 8/13 in urban and rural 
pharmacies respectively) and control (5/13 and 3/13 in urban and rural pharmacies 
respectively) groups (p=0.58 and p=0.06 in urban and rural strata respectively), 
although selected elements of counselling varied significantly; the provision of 
condoms (p=0.003) during counselling and promoting compliance to a full course of 
antimicrobial therapy (p=0.03) was mentioned in more counselling sessions delivered  
by urban pharmacists to whom information packets were assigned, while education 
on STI transmission (p=0.03) and promotion of HIV testing (0.04) were  raised more 
frequently in rural intervention pharmacies. Suggested antimicrobial drugs for the 
treatment of UDS were correct in a similar percentage of urban, control pharmacies 
(56%) and experimental pharmacies (54%), although without statistical significance 
(p=0.92). Although correct UDS treatments were recommended more often by rural 
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pharmacists in the intervention (67%) than the control arm (25%), the proposed 
treatment differentials did not approach statistical significance (p=0.27). 
 
 6.2.3  Multivariate statistics 
Ordinal regression (tables 19-22) identified very few factors independently associated 
with counselling and treatment.  Pharmacists who never utilized or dispensed the 
information packets during the counselling of partners presenting with UDS had 0.01 
times the odds of delivering good to excellent counselling than poor to average 
counselling (p=0.01) than pharmacists who always utilised the information packets 
(referent); essentially, these pharmacists counselled poorly in comparison to those 
who gave the information packets to clients (table 20).  Additionally, compared to 
rural pharmacies (referent), urban pharmacies were more likely to attain poor scores 
than good to excellent scores (adjusted odds ratio 0.1; p=0.03) for the treatment of 
GUS (table 21).   
  
 
Table 19: Ordinal regression model (with odds ratios and their 95% confidence 
intervals) for predictors of effective counselling for genital ulcer syndrome  
 
 GUS Counselling 
RISK FACTORS Odds 
ratios  
95% CI p-value 
Region    
Urban pharmacists 5.24 0.23-117.6 0.69 
Rural pharmacists Referent   
Received information 
packets    
Assigned to pharmacists 0.91 0.15-5.55 0.92 
Not assigned to 
pharmacists Referent   
Used information packets     
Never (0/3) 0.32 0.01-20 0.59 
Rarely (1/3) 0.6 0-73.7 0.83 
Often (2/3) 2.57 0.01-605.7 0.74 
Always (3/3) Referent   
Difference in STI training    
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scores 
<20% 0.39 0.06-2.6 0.33 
20 through 40% Referent   
 
 
 
Table 20: Ordinal regression model (with odds ratios and their 95% confidence 
intervals) for predictors of effective counselling for urethral discharge syndrome 
 
 
 UDS Counselling 
RISK FACTORS Odds 
ratios  
95% CI p-value 
Gender     
Female 0.25 0.02-4.12 0.33 
Male Referent   
Region    
Urban pharmacists 0.19 0.02-1.74 0.14 
Rural pharmacists Referent   
Received information 
packets    
Assigned to pharmacists 0.09 0.01-1.12 0.06 
Not assigned to 
pharmacists Referent   
Used information packets     
Never (0/3) 0.01 0-0.35 0.01 
Rarely (1/3) 0.17 0-6.28 0.34 
Often (2/3) - - - 
Always (3/3) Referent   
Difference in STI training 
scores    
<20% 0.74 0.12-4.7 0.75 
20 through 40% Referent   
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Table 21: Ordinal regression model (with odds ratios and their 95% confidence 
intervals) for predictors of effective treatment for genital ulcer syndrome  
 
 
 GUS treatment 
RISK FACTORS Odds 
ratios  
95% CI p-value 
Gender     
Female 0.75 0.09-6.58 0.8 
Male Referent   
Region    
Urban pharmacists 0.1 0.01-0.81 0.03 
Rural pharmacists Referent   
Difference in STI training 
scores    
<20% 3.65 0.55-24.38 0.18 
20 through 40% Referent   
 
 
Table 22: Ordinal regression model (with odds ratios and their 95% confidence 
intervals) for predictors of effective treatment for urethral discharge syndrome  
 
 
 UDS Treatment 
RISK FACTORS Odds 
ratios  
95% CI p-value 
Gender     
Female 0.53 0.07-3.85 0.53 
Male Referent   
Region    
Urban pharmacists 1.49 0.24-9.01 0.67 
Rural pharmacists Referent   
Difference in STI training 
scores    
<20% 1.71 0.36-8.01 0.5 
20 through 40% Referent   
 
 
No independent predictors of UDS treatment and GUS counselling were identified in 
similar ordinal regression analyses. 
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6.3   SUMMARY OF MAIN FINDINGS  
 
The findings of note in this study are summarised in bullet-point form below. 
 
• A relatively poor response rate was achieved despite numerous verbal 
commitments (Ward et al., 2003) from pharmacists to participate in the 
training and management phases of the study. 
  
• Prior to the intervention, pharmacists were reasonably knowledgeable about  
STI issues (mean score of 73.8%) and this was further (significantly) 
enhanced after training (score difference of 13.3%, p<<0.001).  The 
performance of urban pharmacists in the lead up to the training (pre-test) was 
slightly inferior to that of their rural counterparts and the improvements in 
scores post-training were subsequently higher among urban pharmacists 
(score differences of 14.1 and 10.9 were achieved in urban and rural 
pharmacists respectively, p<0.05). 
 
• Younger and more recent graduates derived no benefit from the training as 
evidenced by statistically insignificant (p=0.05) differences between pre- and 
post-test scores. 
 
• Pharmacists had no knowledge of the recommended treatments for GUS 
before (0%) and after training (0%).  
 
• At baseline, the rationale for treating partners presumptively for UDS and 
GUS was poorly understood by urban pharmacists (54.8% and 61.3% for 
UDS and GUS respectively), however, their understanding of this concept 
improved significantly after the intervention (p=0.003 and p=0.005 for UDS 
and GUS respectively). 
 
 
 
 
 
 114
• With an exception of the  rural intervention group which couns, the level of 
counselling provided by pharmacists subsequent to the training ranged from 
poor to average (in most cases, less than half of the counselling messages 
were mentioned). 
   
• Acceptable treatment recommendations were offered to at least one out of 
three simulated partners in the experimental and control groups. 
  
• Pharmacists were generally confident in prescribing antimicrobial therapies as 
evidenced by their preference to treat rather than refer without treating (a 
maximum of one out of every three simulated client visits ended with a 
referral sans treatment). 
  
• Simulated partners treated in rural pharmacies generally received more 
extensive counselling, more appropriate therapies and fewer referrals without 
prescriptions than those who visited urban pharmacists. 
 
• The allocation of STI information packets was not a significant predictor of 
overall higher counselling aggregates. 
 
• When STI information packets were assigned to urban pharmacists, their 
counselling on condom provision and treatment compliance was superior to 
relative to the (urban) control pharmacists. 
 
• When STI information packets were assigned to rural pharmacists, they 
provided better education on STI transmission and recommended HIV testing 
more frequently than the (rural) control pharmacists.  
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• Compared to their urban counterparts, rural pharmacists were more likely to 
offer correct antimicrobial therapies (good to excellent, as opposed to poor 
treatment scores) for GUS.  
 
• When 100% of assigned STI information packets were utilised by 
pharmacists, they delivered superior counselling to those who used the 
packets infrequently. 
 
 
 
 
 113
CHAPTER 7 
DISCUSSION 
 
 
____________________________________________________________________ 
 
The proceeding discussion explores plausible underpinnings for the results obtained 
within this thesis. The main findings, dictated by the primary hypotheses, will be 
central to the discussion, while subsidiary findings of statistical note will supplement 
this discussion by way of brief elucidation. The impact of the STI training 
intervention on academic performance will be explored along the lines of the actual 
content and method of course delivery, while the overall lack of profound impact of 
information packets on STI management in general will be traced back to the strength 
of a comprehensive STI correspondence course. Literature has shown that the quality 
of STI management in the private sector is often undesirable and one of the goals of 
this discussion will be to draw comparisons between the quality of STI management 
provided by pharmacists in this study and more clinically adept practitioners.  The 
chapter ends with an identification of the strengths and limitations of the study as 
well as the ramifications thereof with respect to the results obtained. 
 
_____________________________________________________________
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7.1 STI MANAGEMENT: THE CONCEPT OF DISTANCE LEARNING 
Several developing countries have evaluated the impact of various STI management 
interventions on knowledge and practice, although an intervention consisting of 
comprehensive distance learning course has not previously been tested (Chuc et al., 
2002; Garcia et al., 1998; Garcia et al., 2003; Garcia & Holmes 2003; Green et al., 
1998; Schneider et al., 2005; Tuladhar, 1998).  In this study, the favourable effect of 
an STI correspondence course on the knowledge of slightly older pharmacists with 
relatively long-standing qualification in pharmacy points to its immense value in the 
training of “experienced” pharmacists.  It could therefore be postulated that distance-
learning courses successfully breach the gap of STI knowledge amongst these 
pharmacists and therefore have a definite place in the expansion of STI partner 
management to community retail pharmacies.  The enhancement of clinical skills 
through distance-learning programmes is not a foreign concept: in the United States 
of America, distance learning courses in clinically-oriented programmes such as 
clinical laboratory science and Doctor of Pharmacy programmes have consistently 
reflected an equivalent learning experience when compared to traditional classroom-
based methods; in fact distance learners (of slightly higher mean age) consistently 
outwitted their on-campus counterparts in course examinations (Russel et al., 2007; 
Lenz et al., 2006).   
 
In addition to the unique method of instruction, further attributes that set this study 
apart from others are the comprehensiveness of course content and the variable pace 
at which learning was allowed to transpire; while clinical management predominated 
in past STI training interventions targeting pharmacists and various other health 
practitioners, this 8-week self-study course covered a broader spectrum of topics that 
was entrenched in public health principles. The contributing factors toward the 
observed increments in general STI knowledge are therefore assumed to be multiple. 
 
Learner support offered by a clinical nurse practitioner was an important facet of the 
training intervention. As such, the bivariate analysis (Fisher’s exact test), revealing 
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significantly higher aptitudes in answering case-study-type questions (employed to 
test the pharmacists understanding of the rationale for using the syndromic approach 
and for treating partners presumptively) after the correspondence training, was not 
entirely surprising. These findings are in line with the views of Jonassen (as cited in 
Huang 2002) who asserts that when interactive learning is encouraged through 
instructor’s guidance in distance learning courses, students are in fact able to develop 
critical thinking skills. The telephonic and on-line learner support provided for the 
duration of the STI correspondence course plausibly produced the evident leveraging 
effect on critical thinking skills.  Therefore, the assistance afforded to pharmacists 
during training also numbered among the multiplicity of contributory factors 
influencing the knowledge gain. 
 
 
7.2    IMPROVING PRIVATE SECTOR QUALITY OF CARE  
Despite improved scores on the post-training test and in particular, the relatively high 
proportion of pharmacists who indicated an understanding of the need for STI 
partners to receive management, the general counselling provided to the simulated 
male STI partners was poor.  Only the rural pharmacists who had been equipped with 
STI information packets provided an acceptable level of counselling, i.e. at least 7 out 
of a possible 13 messages.  Community retail pharmacists often work under severe 
time constraints and this often leads to very brief interaction with clients.  Perhaps 
rural pharmacists, in view of the greater inaccessibility of clients to healthcare 
facilities, are more willing to spend appreciable time counselling clients.  The 
suggestion that the more conscientious approach to counselling was linked to the 
higher proportion of female pharmacists in the rural intervention arm was rejected 
after multivariate ordinal regression models proved that gender accounted for 
negligible variation in the ordinal counselling outcome.  However, the small sample 
size of 6 female pharmacists provides poor confidence in the derived statistical 
conclusions.  The general counselling competencies of private doctors and nurses at 
 
 
 
 
 116
the end of a similar intervention study9 (Harrison et al, 2000) was greater than what 
was reported in this study, although the comparison may be unfair due to differences 
in the standards of what constitutes appropriate counselling; while Harrison 
considered “three out of five counselling messages” to be appropriate, this study 
raised the total number of messages to remember to 7 out of a possible 13.  In this 
study the frequencies of condom promotion, provision, and often demonstration were 
higher in pharmacies utilising information packets, pointing to the value of including 
condoms in information packets.  The high percentage (≥33%) of condom promotion 
indicates that pharmacists counselled at least one of the three clients on risk 
reduction. These findings are atypical to previous studies that failed to improve 
counselling on condom promotion, regardless of the STI management intervention 
(Adu-Sarkodie et al., 2000; Chuc, 2002; Garcia et al., 1998).   
 
Garcia et al. (2003) measured the impact of a multifaceted STI management 
intervention, comprised of STI seminars, STI manuals, STI/HIV prevention packets 
and other project resource materials. The independent impact of the information 
packets on counselling and treatment could not be disaggregated from the 
intervention mesh, however the failure of the entire intervention to boost the 
counselling proficiency of pharmacists was telling. Similarly, the counselling 
competencies of nurses and doctors in rural Hlabisa (South Africa) who received 
training and STI packets were not significantly greater than a control, although 
treatments were more often correctly aligned with local guidelines (Harrison et al., 
2000).  In this study, information packets contained STI information, referral notes 
for HIV testing and a list of neighbouring HIV testing sites, condoms and a 
diagrammatic aid for demonstrating condom use.  In contrast to the aforementioned 
studies, our findings suggest that the utilization of information packets, aimed at 
facilitating STI counselling, promoted more comprehensive information exchange to 
clients in rural pharmacies only, whereas comparable treatment patterns were 
observed in the experimental and control groups of urban and rural arms (given the 
                                                 
9 STI training and STI packets containing drugs, information pamphlets, condoms and partner cards 
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absence of drugs in packets). Indisparate counselling levels in the intervention and 
control arms of urban pharmacies could possibly be attributed to the time pressures 
that urban pharmacists face on a daily basis; time constraints may have lead to poor 
utilization of information packets, which in turn minimised the effect of the 
intervention.  The independent predicting influence of packet utilization in the 
multivariate analysis of the counselling outcome for UDS further corroborates this 
rationalization. It is plausible to suggest that community pharmacists practicing in 
rural areas feel more compelled to adopt an advanced primary healthcare role due to 
the relative inaccessibility to primary care clinics in these areas. Rural pharmacists 
may have been more proactive in implementing new tools (information packets) that 
could potentially bolster healthcare services in the community. The edge that rural 
pharmacists had over their urban counterparts in the treatment of GUS is perhaps also 
ascribed to the hypothesized needs-driven role of pharmacists in the towns of WC and 
subsequent independent upgrading of skills. Furthermore, rural pharmacies have a 
greater tendency to employ nurses on their premises (Ward et al., 2003) with the 
effect that an environment more conducive to the exchange of clinical knowledge and 
skill becomes prolific.  Notwithstanding the reasons furnished for the differences 
noted between urban and rural pharmacists, these should be considered in light of the 
very small sample size. 
  
Although few of the comparative counselling scores in this study reached statistical 
significance, these findings could possibly be spurious due to the weak statistical 
power generated from a very poor response rate. On the other hand, unmeasured 
predictors may also have come into play: as alluded to earlier, the training materials 
utilized in the first phase of this study included pocketsize STI guidelines for the WC, 
containing the 13 elements of counselling, all STI algorithms and recommendations 
for partner treatment.  These booklets were promoted as a tool to be used during 
practice and could have been more predictive of the counselling outcomes in the 
experimental and control group than the information packet itself.  Since this variable 
was however not measured during the simulated client interview, this link remains 
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conjectural.  A further reason for the lack of significant differences in counselling 
depth could be attributed to variances in the inherent counselling skills of 
pharmacists.  Although pharmacists in South Africa and worldwide are extensively 
trained during their undergraduate years in general interpersonal communication and 
counselling (Hargie et al., 1987), the actual counselling skill levels attained by 
individual pharmacists are subject to differences.  Since an experimental-control 
design, as opposed to a pre-post design, is unable to remove the between-subject part 
of the variability of the outcome variable, the influence of this factor too remains 
unknown. 
 
With regards to the therapies prescribed, a noteworthy finding was the apparent 
incongruence between behaviour and knowledge with respect to GUS treatment. 
Despite their inability to list even a solitary correct treatment regimen for GUS in the 
pre- and post-testing stage, pharmacists displayed a reasonable level of competence in 
treating simulated partners with suspected GUS. A plausible explanation for these 
seemingly contradictory findings is that pharmacists, for the purpose of the pre-post 
tests, studied from copious notes and were not provided with any leads as to the post-
test content, while summarised clinical management guidelines were accessed during 
the treatment of simulated partners.  The inclusion of these treatment algorithms in all 
training packages probably accounts for the reasonable level of success attained in the 
treatment of STI partners in control pharmacies as well.  Therefore, the combination 
of an in-depth distance learning course coupled with pocket-sized STI management 
guidelines is recommended for enhancing actual practice. 
 
Notwithstanding DOH efforts to improve access to STI management services in the 
South African public sector, the positive attributes of private sector care such as 
shorter waiting times, perceived guarantee of privacy and confidentiality, and after-
hour access seem more appealing to clients (Aljunid, 1995; Swan & Zwi, 1997). In 
fact, it is speculated that the majority of clients (particularly males) seek STI care in 
the private sector (Schneider et al., 2001; Wilkonson et al., 1998). Regrettably, the 
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lack of regulated quality assurance in the private sector presents a major deterrent to 
achieving standardization of STI management (according to the syndromic approach) 
and this undermines public sector efforts to reduce the annual incidence of new 
infections. This problem is not unique to the South African milieu: surveys of private 
general practitioners and nurses in Karachi (Pakistan) found that only 33% of general 
practitioners were able to correctly treat UDS (Khandwalla et al., 2000); 32% of 
Jamaican private practitioners issued appropriate therapies for mucopurulent 
cervicitis after a training intervention (Green et al., 1998); in Gauteng, South Africa, 
only 20% of general practitioners could treat GUS while the appropriateness of UDS 
therapies depended on the medical insurance status of patients –46% of uninsured and 
54% of insured patients received an effective drug combination – (Chabikuli et al., 
2002) and effective UDS baseline treatments (prior to an intervention) were provided 
by less than 30% of  general practitioners in the same province (Schneider et al., 
2005).  In this study absolute treatment scores of 33% and above implied that 
pharmacists generally treated at least one of the three simulated clients with the 
correct combination of antimicrobials.  As such, the overall results obtained in the 
intervention and control group reflect predominantly “good” therapeutic 
interventions, proving that pharmacists are able to (at the very least) provide 
equivalent standards of STI treatment to health care practitioners in private practice.  
One could argue that these results fall short of reflecting actual practice, given the 
directive from researchers to prescribe antimicrobials and ignore the incentives of 
selling the most profitable medicine. It is well known, for example that choices of 
medication prescribed and dispensed by private doctors are influenced by factors such 
as the medical aid/insurance status of the client, and marketing ploys of 
pharmaceutical companies (Chabikuli et al., 2002). Therefore, the absence in this 
study of conflicting business and health care provider interests may have confounded 
the outcome of good adherence to recommended treatment guidelines, and may be a 
misrepresentation of actual practice in the future.  In South Africa, however, this 
conflict has being mitigated by three legislative changes: firstly, the recent 
introduction of a new medicine pricing structure in South Africa does not allow for 
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hugely discriminating profit mark-ups between low and high costing medicines; 
secondly, the promotion of more affordable generic equivalents has become a 
mandatory element in the sale of medicine, and thirdly, the provision of perverse 
incentives during the marketing of medicines by pharmaceutical companies is now 
legally prohibited (Republic of South Africa, 1997a).  Since profits now emanate 
from the provision of professional services – for which fees are levied – as opposed to 
gratuitous mark-ups on medicines, any future involvement in the management of STI 
bodes well for pharmacists economically and for DOH efforts to promote adherence 
to treatment guidelines in private practice.   
 
 
7.3 STI PARTNER MANAGEMENT IN COMMUNITY RETAIL 
PHARMACIES 
Evidence suggests that recurrent chlamydial infections in females – a risk factor for 
developing sequelae, including infertility – are predominantly a result of untreated or 
inadequately treated male sex partners (Blythe, et al., 1992).  Notwithstanding the 
relatively poor treatment and counselling levels achieved in this study, support for 
utilization of pharmacists in the management of male partners of previously 
diagnosed and treated STI index patients remains warranted. If patient-delivered 
therapy to partners places the responsibility for safe and efficacious use of 
antimicrobials with lay people, as is fast becoming acceptable practice in 
industrialized countries (Department of Health California, 2001), then surely 
pharmacists (medicine custodians) are prime candidates for delivering partner therapy 
from one of the most frequented settings for STI management, viz, community retail 
pharmacies.  
 
 
7.4  STRENGTHS AND LIMITATIONS OF THIS STUDY 
A strength in the design was the application of stratification and randomisation 
techniques to ensure representation from urban and rural WC in the correct 
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proportions; subsequently, this study was able to detect an independent correlation 
between regional and counselling variables.  Additionally, the accuracy of study 
findings was enhanced through the repeated measurements of the same outcome 
variables by way of 6 – as opposed to a single – visits from simulated clients.  
Because simulated clients were instructed to request therapy from the head 
pharmacist only, this study provides accurate impressions and observations of how 
qualified pharmacists treat STI. Standardisation of assessments was further 
augmented by blinding simulated clients to the intervention and control assignment of 
pharmacies. 
 
There are several limitations to this study.  Perhaps the greatest weakness concerns 
the low participation rate.  Although 80 pharmacists who participated in the first 
study (Ward et al., 2003) had expressed interest in participating in a STI training 
course, few of them actually volunteered once the opportunity presented itself. This 
was particularly problematic for pharmacists from the rural Western Cape where only 
eight pharmacists began the study and seven completed it. In some of the analyses 
conducted it may be that this small number did not provide sufficient power to detect 
statistically significant differences that were being measured.  The discord between 
expressed willingness to engage in STI training and actual participation was 
investigated in a subsidiary study reported in Chapter 8.   In addition, to measure the 
pharmacist’s ability to provide correct treatment to the partners, the study pharmacists 
were told that they could prescribe medication to clients who show up with the 
Department of Health partner notification slips. Since this is not a current practice in 
South Africa, the pharmacists were likely to assume that the men who presented to 
the pharmacy with this notification slips were, in fact, research assistants. Given the 
fact that these simulated STI partners were actually not in need of treatment may have 
left the study pharmacists less interested in spending their limited work time with 
those who were not truly in need of services. 
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Another possible limitation stems from the eligibility criteria in which only head 
pharmacists were permitted to participate, which inadvertently excluded younger 
pharmacists.  This was done to ensure that participants were in decision-making roles 
and thus could freely adopt expanded clinical services. However, a consequence of 
this selection criterion is that the younger, newer graduates from pharmacy schools 
were not included. The concept of expanding clinical responsibilities of pharmacists 
is relatively new. It is quite possible that the younger, more recently trained 
pharmacists would have been more likely to participate in the study and to correctly 
apply the acquired skills and knowledge to the simulated partners than the older 
pharmacists whose training and work experience are directed towards dispensing 
prescribed therapies with a minimum of independent patient care. 
 
Finally, the unique contextual factors within the South African milieu (described in 
the opening chapters of this thesis), which are difficult to control with rigorously 
designed and implemented research alone, may have influenced the outcomes of this 
study to some degree. As such, the evidence produced in thesis may have limited 
extrapolative power for other global contexts. 
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CHAPTER 8 
RESISTANCE TO CHANGE:  PREDICTOR OF POOR PARTICIPATION IN 
STI TRAINING COURSE BY COMMUNITY PHARMACISTS? 
 
In a previous baseline survey, a group of randomly selected pharmacists in the Western 
Cape (WC) was surveyed to ascertain their knowledge, perceptions, attitudes and practices 
about the treatment of STIs (Ward et al., 2003). Study findings suggested a great need for 
pharmacist training in STI management: when provided with a hypothetical clinical 
situation, it was found that for various STI, a maximum of only 17% of pharmacists (urban 
and rural) identified the correct medication. With a view to designing a future training 
intervention study, the interest of pharmacists in participating in this project was surveyed 
at the end of the evaluation.  A large portion of both urban and rural pharmacists indicated 
a willingness to participate in the syndromic management of STIs and to receive the 
necessary training.  
 
In the follow-up training intervention study (central to this thesis), several pharmacists 
who had previously indicated willingness to be trained subsequently declined on the basis 
of time constraints and/or disinterest; only 41% of a possible 100 were agreeable to the 
STI training. Given the established need and acknowledgment by pharmacists to being 
under-utilised in HIV prevention efforts, the question that arose was why the indication of 
willingness to participate in the training was not correlated with actual participation. In the 
face of a fundamental shift in the practicing scope of pharmacists, could resistance to 
professional growth be linked to the lack of participation in the STI training intervention 
study?  In a bid to answer this question, an explorative study into resistance to professional 
growth ensued. 
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8.1   BACKGROUND 
While the resistance to change is usually construed as a negative disposition, Marris 
(1984) explains how this “conservative impulse” and characteristic ambivalence to change 
is a vital precursor to adapting to a new situation. This applies provided that a “thread of 
continuity” with past ideas, representations and principles remains in the order that the 
link with the past system is preserved. As Robinson (1991, p.823) explained, “Where 
resistance occurs it should not necessarily be perceived as a negative force within the 
process of change. It should, rather, be examined for its function in terms of coping with 
and finding meaning in a rapidly changing (nursing) world”.  
 
8.1.1   Organisational resistance to change  
Patrick (2001) described meaningful improvement in any organisation as involving three 
major questions: 1) what to change, ii) what to change to, and iii) how to make the 
changes happen.  The first two issues are usually appropriately identified, but it is the third 
question that involves the dreaded “resistance to change”. He detailed two of what he calls 
“layers of resistance” which correspond to this third question: i) the lack of a perceived 
clear path around the obstacles to the proposed change, and ii) a lack of follow-through 
even if agreement was reached to proceed with the solution.  TOC (thinking and 
communication) processes involve sufficiency logic and necessity logic. The former 
involves ideas about “if…then…because” and the latter “in order to…we must”. The 
human mind appears to have an innate ability to know whether these two constructs are 
congruent and logically consistent. This ability facilitates ease of communication and 
renders our world understandable and predictable. 
 
Mauer (1996) identified three levels of intensity of resistance, namely: i) the questioning 
or opposition of an idea; ii) underlying forces contributing to resistance; and iii) deeply 
embedded generalised resistance. The first two levels imply that certain extrinsic factors 
determine the level of resistance and that if these factors are addressed and resolved, 
change can still occur. The third level, however, involves a resistance that is acontextual. 
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It is rooted in the psychologies of both the individual and the organisation. Because it 
reflects a general characteristic, and not opposition to specific change, it is therefore more 
difficult to address.  
 
In her study, Trader-Leigh (2002) found the second level of resistance to be the most 
relevant. Based on the nature of this level, the underlying factor(s) can be addressed and 
change can thus be facilitated.  In the follow up to a baseline survey by Ward et al. (2003), 
a lack of participation was exhibited by a large number of pharmacists who had expressed 
minimal concern about perceived obstacles to future management of STI, provided that 
legislation allowed for it. In Patrick’s conceptualisation alluded to earlier, (Patrick, 2001), 
a clear path around any identified obstacles was perceived, yet a lack of follow through of 
an agreed-upon solution was perceived – that of training. Therefore, the poor response rate 
by community retail pharmacists in the main intervention outlined in this thesis could 
indicate a deeper level of resistance, which expresses itself as reticence to following 
through on the agreed-upon plan of action.  
 
Studies on change and resistance to professional growth in the health care context are 
minimal compared to those done in non-health care organisational settings. Project 2000 
was a UK project, which aimed to fundamentally change the manner in which nurses were 
educated and the manner in which they practiced. This was to meet the needs of a 
changing society and to provide a more holistic treatment programme which optimised the 
use of resources and which embraced a community–health-normalcy orientation as 
opposed to a hospital-ill-health one. Resistance was operationalised as increased stress, 
anxiety and ambivalence towards the project and was assessed by qualitative and 
exploratory methods by the use of interviews. The piloting phase of the evaluation of the 
project found that nurses in training were resistant to the increased focus on academic 
skills because they felt it was at the expense of “real” nursing skills (Robinson, 1991). 
This resistance could thus be due to the fact that the traditional concept of “the nurse” was 
being challenged. STI management is a proposed extended scope of practice for 
pharmacists, which could also challenge the traditional concept of a pharmacist. 
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Rosemann and Szecsenyi (2004) conducted a study amongst general practitioners (GPs) in 
Germany. These practitioners were asked whether they were willing to participate in a 
study aiming at improving the quality of care of patients with osteoarthritis, a condition 
considered to be relevant to the German context (as is STI management in the South 
African context). The time requirement was indicated as being approximately 30 minutes. 
Of the 76 general practitioners who were approached, only 27 agreed to participate in the 
proposed research. For the 49 GPs who did not want to participate (64%), the two most 
common reasons given for non-participation were lack of time and state-imposed 
administrative workload. The time factor was also cited as problematic by some 
community retail pharmacists who declined to participate in the main intervention study, 
however, addressing and removing these obstacles could positively favour the future 
provision of presumptive partner management, as an aspect of professional growth. 
 
No studies regarding resistance to professional growth in the field of pharmacy have been 
conducted, certainly indicating a context that needs to be explored.  
 
8.1.2   Formularising resistance to change  
If individual resistance to change was to be measured, it would be necessary to find some 
form of quantitative measure. In the 1960’s, David Gleicher of Arthur D. Little devised a 
formula for successful change. The formula, although derived from experience and 
untested in any systematic way, was popularised by Beckhard (of Beckhard & Harris) in 
the 1980’s and by Dannemiller (of Dannemiller Tyson Associates) in the late 1990’s 
(Adams, 2003). The formula, now come to be known as the Dannemiller-Tyson change 
formula, elegantly attempts to quantify the natural human tendency to resist change. The 
formula expresses change in terms of certain variables in a descriptive, non-mathematical 
way although the multiplication operator indicates that a synergy, as opposed to a mere 
summation, between the variables exists:  
C = V x D x F > R,  
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where: 
C refers to change that is a function of   
V, a positive vision for the future, 
D, dissatisfaction with the status quo, and  
F, the first steps that have been identified and/or already done to accomplish 
change 
 
Collectively, these variables must be greater than the natural human resistance to change 
(R). Dissatisfaction with the status quo in a business setting or scope of practice is not 
necessarily realised by the individual. Communicating the impact of not changing by 
management may sometimes be required before an individual becomes dissatisfied with 
the current situation. Only after the realisation that change is vital is it possible to envision 
a new and viable system to replace the current one. For this new vision to be a positive 
one, it must be attractive, attainable and credible. The first steps include the work that has 
already been done to make the change a reality, the identification of work processes and 
systems which will be impacted, how the change will impact both the internal structure 
(employees) and the external relationships (customers, suppliers, etc), and the resources 
required for the change to become a reality (Silverman, 2001). In Ward et al. (2003, 
p.610), “pharmacists regarded their role in the management of STI as under-utilised, and 
the majority strongly agreed or slightly agreed that there is a need for STI treatment 
services in community pharmacies”. This sentiment could be regarded as both a positive 
vision for the future and dissatisfaction with the status quo. More than 90% of pharmacists 
indicated willingness to conduct a history-taking, counsel on prevention of STI and HIV, 
conduct partner-notification and provide follow-up. The majority of pharmacists were 
willing to conduct visual genital inspections, and a few indicated that they would perform 
a physical examination. Although “willingness” does not necessarily always translate into 
reality, this could tentatively be regarded as “first steps” because they indicate an altered 
mind set vis-à-vis traditional pharmacy practice. 
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As in Trader-Leigh’s (2002) study, the concept of “natural human resistance to change” 
was not defined in the formula, but could be seen as a composite of Maurer’s (1996) three 
levels of resistance above. In Marris’ (1984) conceptualisation of change, it could be 
viewed as the “conservative impulse” which optimises human adaptation to a complex 
society. 
 
In the context of community pharmacy practice in South Africa, these variables are 
applicable. The dramatic reaction to the pricing regulations implemented in 2004 indicated 
a great deal of dissatisfaction with the “new” status quo. As a result, morale is low. The 
fact that pharmacists are part of the general South African “brain drain” could be viewed 
as an expression of the lack of positive vision for the future. 
 
Although the Dannemiller-Tyson model was formulated for an organisational context and 
refers to groups of people, it can also be individualised. Two pharmacists can have more 
or less the same dissatisfaction with the existing system and the same degree of vision of a 
new system, yet change occurs in the one case and not in the other because of innate 
differences in the degree to which the individual opposes change or develops personal 
vision and first steps for their pharmacy business.  
 
8.1.3   Quantifying individual resistance to change 
At this point, it is relevant to highlight two important issues. Firstly, although any kind of 
organisation, institution or society exhibits a synergy whereby its character is greater than 
the sum of the individuals comprising that group, individual factors definitely also play a 
role. As Oreg (2003, p.680) wondered, “some individuals seem to resist even changes that 
are consonant with their interests”.  Although addressing individual factors in any 
resistance to transformation is not sufficient in itself, it certainly will contribute to problem 
resolution.  
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Secondly, it appears as if the phrase “resistance to change” has become a concept in its 
own right. This state of affairs, however, has received some criticism. Dent and Goldberg 
(1999a) pointed out that Lewin first used the term as a systems concept to describe a force 
affecting both managers and employees, but the term has been perpetuated in an 
acontextual manner and increasingly interpreted in terms of individual psychological 
factors. In another article (Dent & Goldberg, 1999b, p.46), they pointed out that “Change 
is too broad a term for people (individuals) to resist”. This is revealed by the fact that 
some people actively seek out and embrace change. They pointed out that perhaps the term 
“resistance to loss” may be more appropriate: fearing the loss of the known, the loss of 
status and the loss of comfortable routines. While this idea adds another dimension to the 
understanding of the conservatism and lack of transformation found in a multitude of 
aspects of our society, the concept of resistance to change cannot be completely discarded. 
In addition, because any organisation is by definition composed of people, both individual 
factors and dynamic context-based factors will play a role in any resistance to change.   
 
The Dannemiller-Tyson formula represents simple quantification of the idea of change, 
but does not involve assessment of the actual resistance factor. This lead to the search for 
some kind of assessment and quantification of the resistance to change dimension of the 
formula. Because of the lack of congruence between willingness to participate in STI 
training and actual participation over a diverse group of pharmacists and contexts, it was 
postulated that individual and psychological factors could explain this apparent resistance 
to professional growth. 
 
In their work on a work-orientated concept of coping with change, Judge et al. (1999) 
found that factor analysis combined various personality traits and characteristics into two 
factors that were linked to change behaviour. The Positive Self-Concept factor is 
composed of locus of control, generalised self-efficacy, self-esteem and positive 
affectivity. The Risk Tolerance factor consists of openness to experience, tolerance for 
ambiguity and risk aversion. These findings were based on assessment of managers at 
different levels in large corporations, which had recently undergone major changes such as 
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reorganisation, downsizing, alteration in top management, mergers and acquisitions. 
Wanberg and Banas (2000) obtained measures of self-esteem, optimism and perceived 
control from employees. By interpreting these measures as indicative of psychological 
resilience, they found that the greater subjects rated in their resilience scores, the greater 
their willingness to accept changes at work. This data was obtained from United States 
state organisations during, and not after, changes had occurred. Both these studies were 
beneficial in showing that resistance and change behaviours can be explained in part by 
individual psychological factors.  
 
In both of these studies, the authors focused on measuring resistance to change as arising 
out of individual personality traits or tendencies. No attention was paid to whether the 
subjects exhibited a resistance based on Mauer’s first two levels, namely whether they 
questioned the value of the new ideas, or whether there were certain factors within the 
organisation which contributed towards reticence to embrace the changes. Some subjects, 
for example, may have had legitimate reasons for not viewing the changes as beneficial. 
Organisational factors such as poor motivation by management structures, unfair practices, 
etc could have given the proposed changes less credibility. It is thus certainly a 
shortcoming of these two studies that such variables were not controlled for. The primary 
reason could be attributed to the particular professional discipline of the authors - 
psychology - where the emphasis is placed on the individual and where other broader 
factors are considered beyond their scope of investigation. 
 
8.1.4   Resistance to change scale 
In response to such and other studies, which used assessment instruments that had 
originally been designed for other purposes, Oreg (2003) developed the Resistance to 
Change Scale in an attempt to assess this disposition directly. This scale was “designed to 
tap an individual’s tendency to resist or avoid making changes, to devaluate changes 
generally and to find change aversive across contexts and types of change” (Oreg, 2003, 
p.680). The development of the scale involved the assumption that resistance to change is 
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a multidimensional disposition with behavioural, cognitive and affective components. 
Based on a literature search, Oreg identified 6 sources of resistance that appeared to derive 
from an individual’s personality, namely: 
1) reluctance to lose control 
2) cognitive rigidity 
3) lack of psychological resistance 
4) intolerance to the adjustment period involved in change 
5) preference for low levels of stimulation and novelty 
6) reluctance to give up old habits 
For each of these sources, 4 – 10 questionnaire items were generated. In addition, four 
items were written to tap a general attitude towards change. Examination of the items for 
ambiguity and redundancy lead to elimination, addition or rephrasing of items. The final 
pool of items was administered in the form of a 6-point Likert scale to over 200 
volunteers. Only 57% of these volunteers identified themselves as students, a common 
subject source of many studies. This adds validity to the scale because in part it controls 
for the fact that students may generally be more radical and open to change than non-
students. Volunteers were approximately equal in terms of gender division, and ages 
ranged from 18 – 67 years. This controls for resistance being a function of personality 
traits as opposed to the demographic factors of gender and age. No significant differences 
were found between the different groups in terms of age, gender or student status. 
Factorial analysis of the items yielded four sub-scales: 
1) Routine-Seeking 
2) Emotional Reaction 
3) Short-term Thinking 
4) Cognitive Rigidity 
Routine seeking measures a person’s desire for novelty and unexpected events. Emotional 
reaction is an indication of how a person reacts to changes that do occur. Short-term 
thinking involves assessment of ideas of temporary inconvenience caused by change. 
Cognitive rigidity is a measure of the degree to which a person changes his/her mind and 
how consistent his/her views and opinions are. 
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To establish construct validity, the scale was administered to a sample of students. 
Independent scales to measure risk aversion, locus of control, dogmatism, tolerance for 
ambiguity, generalised self-efficacy, self-esteem, sensation-seeking and the “Big Five” 
(openness to experience, neuroticism, agreeableness, extraversion and conscientiousness) 
were also completed. The highest correlates of resistance to change scores were sensation 
seeking, risk aversion and tolerance for ambiguity. Self-esteem, extraversion and 
generalised self-efficacy exhibited a small but negative correlation with some of the 
subscales. 
 
To establish concurrent and predictive validity, the scale was used to assess whether 
scores were able to predict voluntary change and resistance to innovation. It was found 
that student subjects with a high resistance to change as scored on the scale were 
significantly less likely to change their academic schedules than those with lower scores. 
In particular, the cognitive rigidity and the short-term focus scales were more important 
predictors. In another sub-study, “resistance to innovation” was operationalised as the 
degree of use by faculty members of a template for creating course websites. These 
websites were designed to facilitate administration and to offer interactive communication 
features. It was found that the higher the resistance to change scores of professors, the less 
likely they were to use these templates. It was also found that for those who did use the 
template, a high score predicted a longer time between introduction of the template and 
initial use thereof. These results helped establish the concurrent and predictive validity to 
the scale. The predictive validity of the scale is important in the current study because it 
can be used to predict resistance to professional growth prior to any change being 
implemented, i.e. the change involving a movement towards STI management. 
 
8.1.5   Distillation of findings 
If resistance is a human characteristic that enables adaptation, it can be expected that this 
trait would show individual variability. The second of Patrick’s (2001) two layers of 
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resistance involves lack of follow-through even if agreement was reached to proceed with 
the solution. Willingness to participate in training was not followed by action on behalf of 
the pharmacists. Willingness to participate indicated that the TOC concepts of necessity 
and sufficiency logic were congruent for pharmacists: if we are to treat STI’s 
syndromically, then we need to be trained. Other factors thus appear to be linked to lack of 
participation. The lack of participation could not be accounted for by Mauer’s (1996) first 
and second levels of intensity because training was agreed as necessary and was not 
opposed, and underlying factors underlying resistance such as lack of time were addressed 
by the fact that the training format was distance learning. The third, more deeply 
embedded form of resistance could thus be operating. The Resistance to Change Scale 
thus seems a useful measure to determine whether the natural human resistance to change 
was a factor in predicting participation in the STI syndromic management training. 
 
The role of two other factors was also be explored. Since Ward et al. (2003) found that the 
male gender predicted willingness to provide syndromic STI treatment; it is possible that 
gender will also predict participation in the training. For two reasons, the year of 
graduation is also a possible predictor of participation in training. Firstly, pharmacists who 
had been practising in apartheid years might have been exposed to more changes due to 
the advent of democracy than those who only began practising post 1994. Exposure to a 
greater number of changes perceived as negative could result in a greater resistance to 
change. Secondly, there has been a trend in pharmacist training over the last 15 years to 
place increasing focus on clinical skills as opposed to academic knowledge and theory in 
isolation. Pharmacists who thus graduated before this change in focus may be more 
inclined to view STI management and treatment as beyond their scope of practice and 
hence may exhibit greater resistance to such training. 
 
8.2 METHODS 
Ethical approval was obtained from the institutional review boards of the University of 
Western Cape. The primary ethical issue taken into consideration was that of 
confidentiality.   
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8.2.1   Sampling and design 
The design of this study was experimental, in that two independent groups, selected on the 
basis of either having participated in an STI training programme or not, were assessed for 
differences in underlying resistance to change. 
 
The Cape Metropole stratum for the main study was selected as the sampling frame for 
this subsidiary study. Community retail pharmacies were divided into two groups, namely 
those who agreed to participate and those who declined.  A random selection of twenty 
pharmacies from each group based on a t-test10 estimate for sample size was selected for 
this study. During the data collection process, the sample frame for the control group had 
to be increased to thirty-two due to lack of response.  
 
The experimental group consisted of those pharmacists who were participating in the 
syndromic management training provided by Ward. The control group consisted of those 
who had indicated that they wanted to participate, but then failed to do so when training 
began.  
 
8.2.1.1   Preliminary considerations 
A pilot study, conducted on five pharmacies from the initial sampling frame, informed the 
decision favouring telephonic as opposed to face-to-face recruitment and interviewing.  
Pharmacists cited variable time and space constraints as deterrents to spontaneous face-to-
face interviews. The ensuing inconvenience of making multiple return visits to pharmacies 
instead of repeated telephone calls became the deciding factor.   
                                                 
10 The sample size was computed using the t-test and an additional 15% was added to the final number 
(Lehmann & Erich, 2006).  With alpha set at 0.05 and beta at 0.2, a sample size of 13 per group (t-test 
+15%) was estimated to afford 80% power to detect an association between the two unpaired groups. A 
larger sample of  20 per group accounted for possible poor response rates. 
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8.2.2   Recruitment 
Eligible pharmacists were contacted by a member(s) of the research group, informed of 
study aims and procedures, and given the assurance of confidentiality. Informed consent 
was obtained verbally, after which the interviewee was requested to complete a consent 
form, which would be faxed to him/her before the formal evaluation and returned to the 
interviewer before administration of the questionnaire. Participants were assured that their 
responses would be confidential and that questionnaires would not be linked with their 
names or other personally identifying information. 
 
8.2.3   Instrument 
A structured questionnaire was immediately administered telephonically to the participants 
by an interviewer. The overall resistance to change (RTC) score, the dependent variable, 
was a composite of 4 subcategories. Each of the following subcategories, in turn, was a 
composite of 4 or more statements, measured according to a likert scale ranging from 1 
“strongly disagree” to 6 “strongly agree”: 
(1) routine seeking (R/S), for example “I’d rather be bored than surprised.” ; 
(2) emotional reaction (E/R), for example “When things don’t go according to 
plans, it stresses me out” ; 
(3) short-term thinking (STT), for example “Changing plans seems like a real 
hassle to me” and 
(4) cognitive rigidity (C/R), for example “I often change my mind”. 
 
8.2.4   Statistical issues 
8.2.4.1   Measurements 
Age, year of graduation and gender were the independent variables of interest, which were 
hypothesized to influence resistance to change. The two latter variables were collected as 
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continuous data and later categorized for statistical analysis, while the gender variable was 
nominal. Ages were categorised into 10-year intervals: 30-39; 40-49, 50-59; 60-69. 
 
Age data was collected because it was hypothesised that older pharmacists may be more 
rigid and less likely to adopt STI management in the scope of their practice. Additionally, 
increased age may be associated with a more conservative approach to matters of a sexual 
nature, as well as a lack of familiarity with STI’s and HIV/AIDS due to not growing up in 
the culture of HIV awareness. 
 
The year of graduation was categorised into three groups: pre-1990 (primarily drug-
oriented care era), 1990-1995 (transition phase) and post-1995 (pharmacist-initiated, 
patient-centred care era).  The rationale for this categorisation was to discriminate between 
those pharmacists who had obtained their degrees before, during or after pharmacy 
curricula changes (Pearson, 2007). One example of recent curricular changes was the 
implementation of pharmacist-initiated therapy at the University of Western Cape, which 
gave further emphasis on the pharmacist’s role in patient care and counselling. The 
transition phase was included because paradigm changes occur gradually. The new school 
of thought may thus have met with some resistance and it may have taken time for the 
patient-driven concept to become entrenched. The third category of graduates was 
probably more inclined to accept this, since the focus of their degree had been centred 
around this concept.  
 
It was thought that gender may be predictive of willingness to participate in the training 
because in Ward et al. (2003), the male gender was predictive of willingness to provide 
STI treatment. 
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8.2.4.2  Statistical analyses  
The Wilcoxon rank-sum test (Wilcoxon, 1945) was used to establish whether a significant 
difference in RTC and sub-category mean scores existed between participants and non-
participants. Statistical significance was set at a p value of less than 0.05. 
  
An ordinal regression model consisting of the sub-categories (R/S, E/R, STT and C/R), 
group (participation or non-participation) age, gender and year of graduation was also 
applied to the data to ascertain whether these variables were significantly correlated with 
RTC scores. To enable this multivariate analysis, the average Likert scale scores were 
categorised: scores between 1 and less than 2 were termed “group 1”, between 2 and less 
than 3 “group 2”, between 3 and less than 4 “group 3”, between 4 and less than 5 “group 
4”, between 5 and less than 6 “group 5” and scores of 6 “group 6”. 
 
8.3   RESULTS 
Fifty-two pharmacists were approached to participate in the study: twenty comprised the 
experimental and thirty-two the control group. The final experimental group was 
composed of fifteen pharmacists. One pharmacy had closed down and three pharmacists 
indirectly refused to participate. A pharmacist was classified as indirectly refusing to 
participate if s/he persistently did not return telephone calls, asked the interviewer to 
telephone again at a later stage or put the interviewer on hold. In the control group, a total 
of thirteen pharmacists participated. Four pharmacies had closed down. Five pharmacists 
refused to participate, five indirectly refused to participate, three were no longer employed 
at the particular pharmacy and two were on leave. The final sample size was, however 
large enough to confer high statistical power.  
 
 
The response rate for participation in the experimental group was 75%, while that in the 
control group was 40.6%. Of the combined group, ten pharmacists fell into the ages of 30-
39, twelve pharmacists into the ages 40-49, four pharmacists into the ages 50-59 and two 
pharmacists into the ages 60-69 (table 12). Seventeen pharmacists graduated before 1990, 
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nine pharmacists between 1990-1995 and only two pharmacists after 1995. Twenty-five 
pharmacists were males and only three were female pharmacists. 
 
The mean resistance to change score (RTC) of the experimental group was 3.1 and that of 
the control group 3.4. Although the experimental group thus exhibited a lower RTC score, 
group differences proved to be insignificant by use of the Wilcoxon rank-sum test for 
ordinal data (p=0.08).  
 
 
In the experimental group the means for the subscales of Routine Seeking (R/S), 
Emotional Reaction (E/R), Short-term Thinking (STT) and Cognitive Rigidity (C/R), were 
2.7, 3.4, 2.8 and 3.7 respectively. The corresponding mean scores in the control group 
were 2.8; 3.6; 3.1 and 3.9 respectively. For both groups, the C/R subscale yielded the 
highest mean, and the R/S subscale the lowest.  
 
To determine whether, group (experimental/control), age, year of graduation, gender, R/S, 
E/R, STT and C/R were predictive of the total RTC score, ordinal logistical regression was 
used. None of these factors were found to have a significant association with the total 
RTC, and were not included in the results.  
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 Table 23: Subject demographics, overall Resistance to Change scores and subscale scores 
expressed as frequencies and mean scores respectively (N=28) 
 
†p-value=0.08 (Wilcoxon rank-sum test) 
 
Participants 
 
 
N=15 
Non-
participants 
 
N=13 
 n ( %) n ( %) 
Age   
30 – 39 years 7(43.8) 3(23) 
40 - 49 5(31.3) 7(53.8) 
50 - 59 3(18.8) 1(7.7) 
60 - 69 0(0) 2(15.4) 
Year of graduation   
Pre-1990 7(43.8) 10(76.9) 
1990 – 1995 6(46.2) 3(23) 
Post 1995 2(12.5) 0(0) 
Gender   
Female 1(6.3) 2(15.4) 
Male 14(87.5) 11(84.6) 
 Means Means 
Subscales   
Routine seeking 2.7 2.8 
Emotional Reaction 3.4 3.6 
Short-term Thinking 2.8 3.1 
Cognitive Rigidity 3.7 3.9 
Resistance to change score 
(mean aggregate)†  3.1 3.4 
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8.4   DISCUSSION 
It was found that there was a greater success rate amongst the participants 
(experimental group) for the telephonic interviewing in comparison to the 
non-participants, which could be attributed to the fact that these pharmacists 
were already participating in the STI training, thus exhibiting a greater 
willingness to participate.  
 
The insignificant differences with respect to resistance to change between the 
participants and non-participants indicate that lack of participation is not 
attributable to any natural human resistance to change. The apparent 
resistance to proposed training can therefore be interpreted as not being an 
intrinsic human characteristic, but due to external factors. The more 
superficial levels of resistance as outlined by Maurer (1996) could thus have 
been pertinent. Although the pharmacists were not related organisationally in 
terms of place of employment, they could be viewed as being organisationally 
related because of the practice of the same profession. The fundamental 
working conditions, economic stresses relating to both single exit pricing and 
a generally competitive market, and time constraints are common to the 
majority of practicing retail pharmacists. If the various extraneous factors can 
be altered in such a manner as to create a more favourable professional 
environment, there would be less resistance to professional growth - 
operationalised as resistance to change in this study. Participation in 
syndromic STI management could thus potentially be increased.   
 
The high C/R score demonstrated by both groups suggests an inherent rigidity 
in mindset among pharmacists in general. Similarly, the low R/S score 
achieved by both groups possibly indicates that pharmacists in general would 
cope with alterations in daily routine; this may create the opportunity to 
gradually incorporate STI syndromic management. The similar scores 
obtained across both groups could also provide further support for the validity 
of the Oreg RTC scale. 
 
 
 
 
 
 141
Another reason for lack of participation could possibly be the content matter 
of the training. Rosemann and Szecsenyi (2004) approached 76 general 
practitioners, requesting whether they were willing to participate in a study 
requiring thirty minutes of their time. The study was aimed at improving the 
quality of care of osteoarthritis patients, a condition deemed to be relevant in 
the German context, as are STIs in the South African one. Only 36% were 
prepared to participate in the research, the others giving reasons of lack of 
time and administrative workload. For pharmacists, for whom treatment of 
clinical conditions is currently beyond their scope of practice, the nature of the 
treatment required could also be relevant. It may be more threatening to 
interact with patients regarding sexually transmitted infections than with 
arthritis. If a lack of participation was exhibited by general practitioners 
whose scope of practice by definition incorporates examination and treatment, 
how much more so in the case of a health care profession traditionally 
primarily involved in the dispensing of drugs? 
 
Over the last twenty years, many changes have occurred in the practice of 
retail pharmacy such as, lay ownership, chain store pharmacies (MediRite, 
Click’s, Dischem pharmacies to name a few) and the introduction of clinics or 
consultation rooms into pharmacies.  
 
The latter could be viewed in a positive light and an implementation thereof 
may suggest a pharmacist’s desire to have a more hands-on approach in the 
medical arena. 
 
On the other hand, and perhaps the most controversial change has been the 
introduction of the recent pricing regulations and associated dispensing fees. 
When this was first proposed and introduced, it was met with outrage by the 
majority of retail pharmacists, primarily non-chain storeowners. The state-set 
prices permitted to be charged for prescription items drastically reduced 
profits. Smaller pharmacies are particularly affected because size, location or 
operating costs are not taken into account.  Of the pharmacists interviewed, 
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the majority indicated that they felt disheartened by the situation and felt that 
the pricing structure was not conducive to the survival of a independently-
owned  community retail pharmacies, resulting in some pharmacies closing 
their doors. Some consequently did not see a future for their business and thus 
did not see the value in participating in research related to professional 
growth, particularly when experiencing stress related to ensuring the day-to-
day survival of the operation. 
 
Non-participation in training could thus rather reflect a negativity created in 
pharmacists by the pricing system rather than a lack of interest in professional 
growth. Refusal to participate in this study could also have reflected this 
generalized negativity rather than resistance towards STI training itself.   
 
In the time period since the proposed introduction of an alternative pricing 
system however, many pharmacists have managed to be creative by 
generating alternative means of income or altering business hours. They have 
all thus adopted mechanisms to cope with the impending changes. This 
supports the above suggestion that professional growth in the form of STI 
management is achievable if favourable environmental and profession-related 
factors are created.   
 
If retail pharmacies could charge for STI treatment and management, monthly 
turnover would be increased. In a situation of decreased profit margins, this 
may make pharmacists more inclined to participate in such treatment. The 
patient would also benefit because although s/he would need to pay for the 
service, the cost would be less than with a private medical practitioner, and 
less work time would be missed compared to receiving treatment at a public 
primary health care setting. Although the motive for providing treatment 
should ideally not be economically driven, it must also be understood that 
some pharmacists are operating under a great deal of economic stress and that 
any additional service provided would need to be economically viable and 
provide what the pharmacist would view as worthwhile remuneration. 
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It was thought that gender may be predictive of willingness to participate in 
the training because in Ward et al. (2003), the male gender was predictive of 
willingness to provide STI treatment. In this study, gender was not predictive 
of resistance to change, and hence of possible willingness to be trained. The 
sample, however, consisted of only three women. This small number may 
have therefore not provided sufficient power to detect gender differences. Had 
more women been included in this study, it may have been found that the 
male gender did predict participation. In the context of unequal power 
relations between the sexes, women may be more reluctant to manage STIs by 
means of physical examination of male patients. This may then be generalised 
to any patient, both male and female. Anecdotal evidence from the data 
collection process provides some support for this assertion. One of the male 
pharmacists said that all of the pharmacists who worked for him were women. 
These employees had expressed their unwillingness to become involved in 
this type of treatment as their pharmacy served a predominantly male, 
working-class clientele. 
 
It was expected that participants who had graduated before 1990 would be 
more likely to resist this form of expanded scope of practice. The discipline of 
pharmacy practice was introduced into curricula in the earlier 1990s (Pearson, 
2007). The objective was to develop in undergraduates a greater patient-
centred as opposed to drug-focused orientation. Graduates having been 
exposed to this philosophy may have been considerably more amenable to the 
clinical interaction and history taking required by the syndromic management 
approach. Year of graduation, however did not significantly predict the RTC. 
This could indicate that pharmacists with primarily drug-oriented training can 
adapt to changes in their scope of practice. 
 
It was also hypothesised that pharmacists practising in apartheid years might 
have been exposed to more changes in many realms of their daily living - due 
to the advent of democracy - than those who only began practising post-1994. 
The age of pharmacists could thus possibly be associated with change 
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behaviour. Two opposing outcomes could be possible. In the first instance, 
such pharmacists may have become more familiar with change and would 
therefore be less resistant to further changes. Alternatively, however, if all of 
these changes were perceived as negative, then an additional change would 
not be embraced. Naturally the latter outcome could be influenced by race 
group to a large degree. Year of graduation, however, was not significantly 
associated with RTC scores. This suggested that even the experience of many 
societal and economic changes experienced over the years did not create 
negativity towards an increased scope of, and hence change in, pharmacy 
practice. 
 
8.5 SUMMARY OF MAIN FINDINGS 
 
The most salient findings are summarised in bullet-point form below: 
 
• No statistically significant difference was found between levels of 
RTC between participants and non-participants 
• Year of graduation, gender, age and the various subcategories of 
resistance to change did not significantly predict the RTC scores  
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CHAPTER 9 
CONCLUSION AND RECOMMENDATIONS 
 
____________________________________________________________________ 
 
The object of this final chapter is to reconcile the findings of this thesis with the 
primary research questions. In addition, a list of recommendations for follow-up 
studies and a proposed plan of action for the implementation of STI partner 
management in community retail pharmacies in South Africa are presented. 
 
___________________________________________________________________ 
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9.1   DISTILLATION OF FINDINGS 
The evidence presented in this thesis demonstrates that community retail pharmacists 
are able to improve their overall knowledge of STI, although their difficulty in 
memorizing correct treatment regimens points to the drawbacks of a potentially 
overloaded correspondence course.  The poor translation of knowledge to general 
partner management among the majority of pharmacists, potentially demonstrates the 
importance of including a practical component in future training interventions. 
Furthermore, the limited demonstrable impact of STI information packets on partner 
management in fast-paced community retail pharmacies underscores the need to 
explore less cumbersome interventions.  Finally, despite the inconsistencies 
demonstrated by community retail pharmacists in the management of STI simulated 
partners, the continuing demand for these services in the informal sector warrants 
their future involvement in presumptive STI partner management.   
 
The literature has demonstrated that professional change is most successful when it is 
instigated and driven by the profession itself, therefore, the unfounded concern that 
underlying resistance to change may have predicted poor participation in this study 
bodes well for future initiatives geared towards professional role expansion.   
 
9.2   RECOMMENDATIONS FOR FUTURE TRAINING INITIATIVES 
With a view to improve the impact of training interventions on future STI 
management in community retail pharmacies, the following recommendations are 
proposed: 
 
a) Course material should be more succinct; presumptive management of 
partners should be the main emphasis, while all other STI topics should be 
provided as background information only. 
b) Given the reality of pharmacist time constraints and the clear benefit of 
learner support, future training interventions targeting qualified pharmacists 
 
 
 
 
 147
should utilize communication technology that fosters greater intra- and 
interdisciplinary interaction, possibly through chat room forums. 
c) With a view to close the gaps in knowledge and management of STI partners 
between urban and rural pharmacists, a further investigation into the 
explanatory factors behind the relative successes achieved in rural areas is 
warranted. 
 
9.3   PROPOSED FOLLOW-UP PLAN 
The proposed plan (and it’s rationale) for effecting policy change and implementing 
the presumptive management of STIs in community pharmacies in South Africa is 
outlined below. 
 
Presented in this thesis is a substantial body of evidence that supports the role of 
community retail pharmacists in the presumptive management of STI partners.  The 
immediate way forward will be to disseminate the arguments and evidences presented 
in this thesis at a national and international level through: a) publication in a reputable 
journal known to have a wide audience ranging from practising private and public 
healthcare workers (particularly general practitioners and pharmacists) to health 
policy-influencers and makers, and b) presentations at selected public health, 
pharmaceutical and STI/HIV national conferences and at least one highly reputable 
and traditionally well-publicized international conference such as an HIV/AIDS 
conference. Further attempts will be made to engage directly with the STI/HIV 
directorate of the Western Cape, with a view to presenting elements of the study and 
a plan for implementing presumptive management services for STI partners in WC 
community retail pharmacies.  Furthermore, a business case for the feasibility of 
offering STI partner management services will be developed for community retail 
pharmacies.  This evaluation will take into account, inter alia, time taken to counsel, 
cost of treatment, willingness to pay by medical schemes and government, and cost of 
training. 
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The proposed plan for implementing partner management services will include 
strategies for: a) pharmacist training, b) PPI establishment, c) promoting 
interdisciplinary consultation, d) ensuring the regulatory oversight of services in 
community retail pharmacies.   
 
 a) Training at undergraduate level 
In theory, pharmacists already possess generic skills in prescribing, dispensing and 
counselling.  However, the poor application of these skills in the area of syndromic 
partner management may stem from the limited attention conferred to the subject at 
an undergraduate training level – undergraduate courses offered in syndromic STI 
management are traditionally brief and purely theoretical.  Thus, interventions should  
ideally be targeted at an undergraduate level of training. Future incorporation of 
partner management course material into a problem-based learning format coupled by 
opportunities for role-play and objective structured clinical examinations  
(customarily used to good effect in the training and assessment of pharmacy students 
in the management of selected acute and chronic health conditions) could potentially 
maximize the use of skills inherent to the profession. 
 
b) Establishing PPIs 
A mutually beneficial relationship between community retail pharmacies and the 
public health sector could be established: community retail pharmacists, in providing 
a vital public health service to the partners of index STI clients could potentially 
contribute to reducing the transmission of STI and therewith become a key role-
player in lowering the incidence of HIV in the WC, while government funded 
treatments and professional remuneration for professional services rendered by 
community retail pharmacists could potentially increase the revenue-making capacity 
of community pharmacies. 
 
c) Establishing local health professional networks 
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A professional network could be established between community retail pharmacists 
and the more traditional providers of STI management in public primary healthcare 
facilities, thereby fostering opportunities for consultation during the early 
implementation stages. Furthermore, this network could facilitate the implementation 
of a central record-keeping system whereby private sector partner management 
records (including partner notification slips received from partners) are fed into a 
centrally located PHC facility. 
  
d) Regulation and supervision of services 
The authenticity of partner management records (as determined through reconciling 
partner notification slips issued to index clients from public PHC facilities with slips 
“filled” by community retail pharmacists) could be verified and later archived by 
administrators employed in designated, centrally located public PHC facilities and 
subsequent quarterly stock checks in community retail pharmacies against the 
archived partner management records could be conducted by administrators of the 
local Department of Health. Furthermore, regular evaluation of the quality of STI 
partner management in community retail pharmacies could be evaluated through 
regular reviewal of partner management records.  
 
 
9.4 CONCLUDING REMARKS 
The future of pharmacy hinges on the human constituents embodying the profession 
and while this thesis has proposed one potential avenue of change, it will remain a 
mere suggestion unless the profession is mobilised behind this ideology. To this end, 
external barriers toward change such as legislative restrictions, opposition by the 
medical fraternity and poor remunerative incentives should be minimised, while the 
evidence qualifying proposed advances within the profession should be maximised. 
 
 
 
 
 
 
 150
 REFERENCES 
 
Actuarial Society of South Africa. (2003). ASSA 2003 Model: ProvOutput. AIDS 
Committee of Actuarial Society of South Africa. Retrieved October 13, 2007, 
from http://www.assa.org.za/scripts/file_build.asp?id=100000546&pageid=1000 
000050 
 
Adams, J.D. (2003). Successful change: Paying attention to the intangibles. 
Organisational Development Practitioner, 35(4): 3-7. 
 
Adu-Sarkodie, Y., Steiner, M.J., Attafuah, J., & Tweedy, K. (2000). Syndromic 
management of urethral discharge in Ghanaian pharmacies. Sexually Transmitted 
Infections, 76: 439-442. 
 
Alary, M., Baganizi, E., Guèdèmè, A., Padonou, F., Davo, N., Adjovi, C., van 
Dyck, E., Germain, M., Joly, J., & Mahony, J.B. (1998). Evaluation of clinical 
algorithms for the diagnosis of gonococcal and chlamydial infections among men 
with urethral discharge or dysuria and women with vaginal discharge in Benin. 
Sexually Transmitted Infections, 74(Suppl 1): S44-49. 
 
Aljunid, S. (1995). The role of private medical practitioners and their interactions 
with public health services in Asian countries. Health Policy and Planning, 10: 
333-49. 
 
Ballard, R., Htun, Y., Fehler, G., & Neilson, G. (2000). The diagnosis & 
management of sexually transmitted infections in Southern Africa. Johannesburg: 
South African Institute for Medical Research. 
 
 
 
 
 
 151
Baron, P., Day, C., Monticelli, F., Vermaak, K., Okorafor, O., Moodley, K., & 
Doherty, T. (2006). District health barometer – Year 2005/06. Durban: Health 
Systems Trust. 
 
Bender, R., & Grouven, U. (1998). Using binary logistic regression models for 
ordinal data with non-proportional odds. Journal of Clinical Epidemiology, 
51(10): 809-816. 
 
Bista, K.P., Chaudhary, P., Slanger, T.E., Khan, M.H. (2002). The practice of STI 
treatment among chemists and druggists in Pokhara, Nepal. Sexually Transmitted 
Infections 78 (3): 223. 
 
Blythe, M.J., Katz, B.P., Batteiger, B.E., Ganser, J.A., & Jones, R.B. (1992). 
Recurrent genitourinary chlamydial infections in sexually active female 
adolescents.  Journal of Pediatrics, 121(3): 487-93. 
 
Boily, M.C., Lowndes, C.M., & Alary, M. (2000). Complementary hypothesis 
concerning the community sexually transmitted disease mass treatment puzzle in 
Rakai, Uganda.  AIDS, 14: 2583-92. 
 
Buchanan, J., & Dal Poz, M. (2002). Skill-mix in the health-care workforce: 
reviewing the evidence. Bulletin of the World Health Organization, 80 (7): 575-
80. 
Carne, C.A.  (1997). Epidemiological treatment and tests of cure in gonococcal 
infection: evidence for value.  Genitourinary Medicine, 73(1): 112-15 
 
Carrara, V., Terris-Prestholt, F., Kumaranayake, L., & Mayaud, P. (2005). 
Operational and economic evaluation of an NGO-led sexually transmitted 
 
 
 
 
 152
infections intervention: north-western Cambodia. Bulleting of the World Health 
Organization, 83(6): 434-42. 
 
Chabikuli, N., Schneider, H., Blaauw, D., Zwi, A.B., & Brugha, R.  (2002). 
Quality and equity of private sector care for sexually transmitted diseases in 
South Africa.  Health Policy and Planning, 17(Suppl 1): 40-6. 
 
Chalamilla, G., Mbawana, J., Mhalu, F., Mmari, E., Majigo, M., Swai, A., Urassa, 
W., & Sandstrom, E. (2006). Patterns of sexually transmitted infections in 
adolescents and youth in Dar es Salaam, Tanzania. BMC Infectious diseases, 6: 
22. 
 
Cho, H.S.M., & Kashka, M.S. (2004). The evolution of the community health 
nurse practitioner in Korea. Public Health Nursing, 21(3): 287-94. 
 
Chuc, N.T.K., Larsson, M., Do, N.T., Diwan, V.K., Tomson, G.B., & Falkenberg, 
T. (2002). Improving private pharmacy practice: A multi-intervention experiment 
in Hanoi, Vietnam. Journal of Clinical Epidemiology, 55: 1148-1155. 
 
Cohen, M.S. (1998). Sexually transmitted disease enhances HIV transmission: no 
longer a hypothesis. Lancet, 351(Suppl 3): S5-7. 
 
Cohen, M.S., Hoffman, I.F., Royce, R.A., Kazembe, P., Dyer, J.R., Daly, C.C., 
Zimba, D., Vernazza, P.L., Maida, M., Fiscus, S.A., & Eron, J.J. Jr. (1997). 
Reduction of concentration of HIV-1 in semen after treatment of urethritis: 
implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi 
Research Group. Lancet, 349(9069): 1868-73. 
 
 
 
 
 
 153
Crabbé, H., Carsauw, H., Buvé, A., Laga, M., Tchupo, J.P. & Trebucq.  (1996). 
Why do men with urethritis in Cameroon prefer to seek care in the informal 
sector?  Genitourinary Medicine, 72: 220-22. 
 
Cu-Uvin, S., Caliendo, A.M. & Reinert, S. (2000). Effect of highly active 
antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS, 14: 415-21. 
 
Dallabetta, G.A., & Neilson, G. (2004). Efforts to control sexually transmitted 
infections as a means to limit HIV transmission: What is the evidence?  Current 
HIV/AIDS reports, 1(4): 166-71  
 
Dallabetta, G.A., Gerbase, A.C., & Holmes, K.K. (1998a). Problems, solutions, 
and challenges in syndromic management of sexually transmitted disease. 
Sexually Transmitted  Infections, 74 (Suppl 1): S1-11. 
 
Dallabetta, G.A, Behets, F., Lule, G., Hoffman, I., Hamilton, H., Wangel, A.M., 
Moeng, S., Cohen, M., & Liomba, G. (1998b). Specificity of dysuria and 
discharge complaints and presence of urethritis in male patients attending an STI 
clinic in Malawi. Sexually  Transmitted  Infections, 74 (Suppl 1): S34-7. 
 
Dartnall, E., Schneider, H., Hlatshwayo, Z., & Clews, F. (1997). STI management 
in private sector: A national evaluation. Johannesberg: Centre for Health Policy.   
 
Dayi, C., & Gray, A. (2006). Health indicators. In: Ijumba, P., Paradath, A. 
Editors. South African Health Review 2006.  Durban: Health Systems Trust. 
 
Dent, E.B., & Goldberg, S.G. (1999a). Challenging resistance to change. The 
Journal of Applied Behavioural Science, 35(1): 25-41. 
 
 
 
 
 
 154
Dent, E.B. & Goldberg, S.G. (1999b). Resistance to change: A limiting 
perspective. The Journal of Applied Behavioural Science, 35(1): 45-7. 
 
Department of Health. (2007a). HIV and AIDS and STI Strategic Plan for South 
Africa, 2007-2011. South Africa: Department of Health. 
 
Department of Health. (2007b). Report: National HIV and Syphilis Antenatal 
sero-prevalence survey in South Africa 2006. South Africa: Department of 
Health. 
 
Department of health.   (2004). The Charter of the Public and Private Health 
Sectors.  South Africa: Department of Health.  Retrieved February 5, 2008 from 
http://www.doh.gov.za/docs/index.html 
 
Department of Health. (2003). Operational plan for comprehensive HIV and 
AIDS care, management and treatment for South Africa. South Africa: 
Department of Health. 
 
Department of Health, Western Cape.  (2001). Health status report and health 
services evaluation 1999/2000.  Cape Town: Provincial Administration, Western 
Cape: Health Services. 
 
Department of Health, California.  (2001).  Patient-delivered therapy for 
chlamydia trachomatis guidance for medical providers in California. California: 
California Deparment of Health Services STD Control Branch. 
 
Department of Health. (2000a). Policy document: Health Sector Strategic 
Framework 1999 - 2004. Pretoria: Government Printer. Retrieved October 13, 
2007, from http://www.doh.gov.za/docs/policy/framewrk/index.html 
 
 
 
 
 155
 
Department of Health. (2000b). Policy document:  District Health System policy 
document. The District Health System in South Africa: Progress made and next 
steps. Government Printer: Pretoria. Retrieved October 13, 2007, from 
http://www.doh.gov.za/docs/ 
 
Department of Health. (2000c). HIV and AIDS and STI Strategic Plan for South 
Africa, 2000-2005. South Africa: Department of Health. 
 
Department of Health. (1997). White Paper for the Transformation of the Health 
System in South Africa: Policy objectives and principles upon which the Unified 
National Health System of South Africa will be based. Pretoria: Government 
Gazette No 17910. 
 
Department of Health. (1996). National Drug Policy for South Africa. Pretoria: 
Government Printer. 
 
Desai, V.K., Kosambiya, J.K., Thakor, H.G., Umrigar, D.D., Khandwala, B.R., 
Bhuyan, K.K. (2003). Prevalence of sexually transmitted infections and 
performance of STI syndromes against aetiological diagnosis, in female sex 
workers of red light area in Surat, India. Sexually Transmitted Infections, 79(2): 
111-15. 
 
Dik, J., Habbema, J.D.H., & de Vlas, S.J.  (1995). Impact of improved treatment 
of sexually transmitted disease on HIV infection [letter]. Lancet, 346: 1157-8 
(discussion 1159-60). 
 
Djajakusumah, S., Sudigdoadi, S., Keersmaekers, K., & Meheus, A. (1998).  
Evaluation of syndromic patient management algorithm for urethral discharge.  
Sexually  Transmitted Infections, 74 (Suppl 1): S29-33. 
 
 
 
 
 156
 
Dorrington, R.E., Bourne, D., Bradshaw, D., Laubscher, R., & Timæus, I.M.  
(2001). The impact of HIV/AIDS on adult mortality in South Africa. Cape Town: 
Medical Research Council. 
 
Fleming, D.T., & Wasserheit, J.N. (1999). From epidemiological synergy to 
public health policy and practice: the contribution of other sexually transmitted 
diseases to sexual transmission of HIV infection. Sexually Transmitted Infections, 
75(1): 3-17. 
 
Galvin, S.R., & Cohen, M.S. (2004). The role of sexually transmitted disease in 
HIV transmission. Nature Reviews Microbiology, 2: 33–42. 
 
Garcia, P.J., & Holmes, K.K. (2003). STD trends and patterns of treatment for 
STD by physicians in private practice in Peru. Sexually Transmitted Infections, 
79: 403-407. 
 
Garcia, P., Hughes, J., Carcamo, C., & Holmes, K.K. (2003). Training pharmacy 
workers in recognition, management and prevention of STDs: district randomized 
control trial. Bulletin of the world health organization, 81(11): 806-814. 
 
Garcia, P.J., Gotuzzo, E., Hughes, J.P., & Holmes, K.K. (1998). Syndromic 
management of STDs in pharmacies: evaluation and randomized intervention 
trial.  Sexually Transmitted Infections, 74(Suppl 1): S153-58. 
 
Ghys, P.D., Fransen, K., Diallo, M.O., Ettiègne-Traoré, V., Coulibaly, I.M., 
Yeboué, K.M., Kalish, M.L, Maurice, C., Whitaker, J.P., Greenberg, A.E., & 
Laga, M. (1997). The associations between cervicovaginal HIV shedding, 
sexually transmitted diseases and immunosuppression in female sex workers in 
Abidjan, Cote d'Ivoire. AIDS, 11(12): F85-93. 
 
 
 
 
 157
 
Gilbert., L. (1998).  Pharmacy’s attempts to extend its roles: a case study in South 
Africa. Social Science in Medicine, 47(2): 153–164. 
 
Golden, M.R., Whittington, W.L.H., Handsfield, H., Malinski, C., Clark, A., 
Hughes, J., Gorbach, P., & Holmes, K. (2001). Partner management for 
gonococcal and chlamydial infection: expansion of public health services to the 
private sector and expedited sex partner treatment through a partnership with 
commercial pharmacies. Sexually Transmitted Diseases, 25: 658-65. 
 
Green, M., Hoffman, I.F., Brathwaite, A., Wedderburn, M., Figueroa, P., Behets, 
F., Dallabetta, G., Hoyo, C., & Cohen, M.S. (1998). Improving sexually 
transmitted diseases management in private sector: The Jamaica experience.  
AIDS, 12(Suppl 2): S67- 72. 
 
Grosskurth, H., Gray, R., Hayes, R., Mabey, D., & Wawer, M. (2000a). Control 
of sexually transmitted diseases for HIV-1 prevention: understanding the 
implications of the Mwanza and Rakai trials. Lancet, 355(9219): 1981-7. 
 
Grosskurth, H., Mwijarubi, E., Todd, J., Rwakatare, M., Orroth, K., Mayaud, P., 
Cleophas, B., Buve, A., Mkanje, R., Ndeki, L., Gavyole, A., Hayes, R., & Mabey, 
D. (2000b). Operational performance of an STD control programme in Mwanza 
Region, Tanzania. Sexually Transmitted Infections, 76: 426-436. 
 
Grosskurth, H., Mosha, F., Todd, J., Mwajarubi, E., Klokke, A., Senkoro, K., 
Mayaud, P., Changalucha, J., Nicoll, A., Ka-Gina, G., Newell, J., Mugeye, K., 
Mabey, D., & Hayes, R. (1995). Impact of improved treatment of sexually 
transmitted diseases on HIV infection in rural Tanzania: randomised controlled 
trial. Lancet, 346(8974): 530-536. 
 
 
 
 
 
 158
Hargie, D.D.W., & Morrow, N.V. (1987). Introducing interpersonal skill training 
into the pharmaceutical curriculum. International Pharmacy Journal, 1: 175-8. 
 
Harrison, A., Karim, S.A., Floyd, K., Lombard, C., Lurie, M., Ntuli, N. & 
Wilkinson, D. (2000). Syndrome packets and health worker training improve 
sexually transmitted disease case management in rural South Africa: randomized 
controlled trial. AIDS, 14(17): 2769-79. 
 
Hawkes, S., Morison, L., Foster, S., Gausia, K., Chakraborty,  J., Peeling,  R.W., 
& Mabey, D. (1999). Reproductive-tract infections in women in low-income, 
low-prevalence situations: assessment of syndromic management in Matlab, 
Bangladesh. Lancet, 354: 1776-81. 
 
Health Systems Trust (n.d.). Health statistics. Durban: Health Systems Trust. 
Retrieved 25 October, 2007, from http://www.hst.org.za/healthstats/index.php. 
 
Helper, D.D., & Strand, L.M. (1989). Opportunities and responsibilities in 
pharmaceutical care. American Journal of pharmaceutical education. 53 (Winter 
Suppl): S7-15. 
 
Hicks, C. (1999). Research methods for clinical therapists. London: Churchill 
Livingstone. 
 
 Hicks, C., & Hennessy, D. (1997). The use of a customized training needs 
analysis tool for nurse practitioner development. Journal of Advanced Nursing, 
26(2): 389-98. 
 
Hitchcock, P., & Fransen, L. (1999). Preventing HIV infection: lessons from 
Mwanza and Rakai. Lancet, 353: 513-5. 
 
 
 
 
 
 159
Huang, H. (2002). Toward constructivism for adult learners in online learning 
environments. British Journal of Educational Technology, 33(1): 27–37. 
 
Houweling, T.A.J., Kunst, A.E.., & Mackenbach, J.P.  (2001).  World Health 
Report: inequality index and socioeconomic inequalities in mortality.  Lancet, 
357: 1671-72. 
 
Hudson, C.P. (2001). Community-based trials of sexually transmitted disease 
treatment: repercussions for epidemiology and HIV prevention.  Bulletin of the 
World Health Organization, 79: 48-58. 
 
Hugo, J. (2005). Mid-level health workers in South Africa: not an easy option. 
Health Systems Trust: Durban. 
 
Hulley, B., Cummings, S.R., Browner, W.S., Grady, D., Hearst, N., & Newman, 
T.B. (2001). Designing clinical research (2nd ed.). USA: Lippincott Wiliams & 
Wilkins. 
 
Hyde, P., McBride, A., Young, R., & Walshe, K. (2005). Role redesign: new 
ways of working in the NHS.  Personnel Review, 34(6): 697-712. 
 
International Council of Nurses. (2001). Nurse practitioner: definition and 
characteristics of the role. Geneva, Switzerland: International Council of Nurses.  
  
Jha, N., Premarajan, K.C., Nagesh, S., Khanal, S., Thapa, L.B. (2005). Five-star 
doctors for the 21st century. Journal of Health Management, 7(2): 237-47. 
 
Judge, T.A., Thoreson, C.J., Pucik, V. & Welborne, T.M. (1999). Managerial 
coping with organisational change: a dispositional perspective. Applied 
Psychology, 84(1): 107-22. 
 
 
 
 
 160
 
Kamali, A., Quigley, M., Nakiyingi, J., Kinsman, J., Kengeya-Kayondo, J., 
Gopal, R., Ojwiya, A., Hughes, P., Carpenter, L.M., & Whitworth, J. (2003).  
Syndromic management of sexually-transmitted infections and behaviour  
change interventions on transmission of HIV-1 in rural Uganda: a community  
randomised trial. Lancet, 361: 645-52. 
 
Keyzer, D. (1997). The advanced nurse practitioner and the rural doctor. 
Australian Journal of Rural Health, 5(4): 184-9. 
 
Khamboonruang, C., Beyrer, C., Natpratan, C., Keawvichit, R., Wongworapat, 
K., Eiumtrakul, S., Celentano, D., & Nelson, K.E.  (1996). Human 
immunodeficiency virus infection and self treatment for sexually transmitted 
diseases among Northern Thai men. Sexually Transmitted Diseases, 23(4): 264-
69. 
 
Khandwalla, H.E., Luby, S., & Rahman, S.  (2000). Knowledge, attitudes and 
practices regarding sexually transmitted infections among general practioners and 
medical specialists in Karachi, Pakistan. Sexually Transmitted Infections, 76: 383-
85. 
 
Korenromp, E. L., White, R. G., Orroth, K. K., Bakker, R., Kamali, A., Serwadda, 
D., Gray, R. H., Grosskurth, H., Habbema, J. D. F., & Hayes, R. J. (2004). 
Determinants of the Impact of Sexually Transmitted Infection Treatment on 
Prevention of HIV Infection: A Synthesis of Evidence from the Mwanza, Rakai, 
and Masaka Intervention Trials. Identifiers. The Journal of Infectious Diseases, 
191 (Suppl. 1): S168-78. 
 
Korenromp, E.L., Bakker, R., & De Vlas, S.J., Eline, L., Gray, R.,  Wawer, M.J., 
Serwadda, D., Sewankambo, N.K. & Habbema, J.D. (2002). HIV dynamics and 
 
 
 
 
 161
behaviour change as determinants of the impact of STD treatment on HIV 
transmission in the context of the Rakai trial. AIDS, 16: 2209-18. 
 
Korenromp, E.L. (2001). Treatment of usually transmitted disease as an HIB 
prevention strategy? Cofactor magmitudes, syndromic management and 
reappraisal of the Mwanza and Rakai trials. [PhD thesis]. Rotterdam, The 
Netherlands: Erasmus University Rotterdam, 264. 
 
Lehmann, E. L. & Erich, L. (2006). Statistical methods based on ranks (Revised 
ed.).  San Fransisco: Prentice-Hall. 
 
Lenz, T.L., Monaghan, M.S., Wilson, A.F., Tilleman, J.A., Jones, R.M. & Hayes, 
M.M. (2006).  Using Performance-based Assessments to Evaluate Parity Between 
a Campus and Distance Education Pathway, American Journal of Pharmaceutical 
Education, 70(4): 90. 
 
Leon, N., & Mabope, R. (2005). The private sector. In: Ijumba P and Barron P, 
editors. South African Health Review 2005. Durban: Health Systems Trust. 
 
Mak, D.B., Plant, A.J., & Bulsara, M.K. (2004). Quality of sexually transmitted 
infection clinical management and contact tracing outcomes in a remote area of 
high sexually transmitted infection endemnicity. Sexually Transmitted Diseases, 
31(8): 449-54. 
 
Marris, P. (1984). Loss and Change. London: Routledge & Kegan Paul. 
 
Maurer, R. (1996). Beyond the Wall of Resistance: Unconventional Strategies 
that Build Support for Change. Austin, Texas: Bard Books Inc. 
 
 
 
 
 
 162
McCelland, S.R., Wang, C.C., Mandaliya, K., Overbaugh, J., Reiner, M.T., 
Panteleeff, L.L., Ndinya-Achola, J., Bwayo, J.J., & Kreiss, J.K.  (2001).  
Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.  
AIDS, 15:105-110 
 
Mayaud, P., & Mabey, D. (2004). Approaches to the control of sexually 
transmitted infections in developing countries: old problems and modern 
challenges. Sexually Transmitted Infections, 80: 174-182. 
 
Motulsky, H.  (1996). Intuitive Biostatistics.  New York: Oxford University Press. 
 
National Treasury.  (2007). PPP introduction guide: Introducing public private 
partnerships in South Africa. Retrieved February 5, 2008, from 
http://www.ppp.gov.za/Documents/News/Final%20PPP%20Introdution%20Guid
e%2024.01.08.pdf 
 
O’Connell, A.A. (2006). Logistic regression models for ordinal response 
variables: Quantitative applications in the social sciences. Thousand Oaks, CA: 
SAGE publications. 
 
O’Farrel, N. (2001). Interpretation of the Mwanza and Rakai trials [letter].  
Bulletin of the World Health Organisation, 79: 482. 
 
Oreg, S. (2003). Resistance to Change: Developing an Individual Differences 
Measure.  Journal of Applied Psychology, 88 (4): 680-693. 
 
Paradath, A., Chamberlain, C., McCoy, D., Ntuli, A., Rowson, M., & Loewenson, 
R. (2003). Health Personnel in Southern Africa: Confronting maldistribution and 
brain drain.  In: Loewenson R, Thompson C, editors.  Durban: Health Systems 
Trust. 
 
 
 
 
 163
 
Patrick, F.S.F (2001). Taking advantages of resistance to change (and the TOC 
Thinking Processes) to improve improvements (Part 1). Presented and included in 
proceedings of the Institute of Industrial Engineers (IIE) Solutions Conference 
(Dallas, May 2001). 
 
Pearson, G. (2007). Evolution in the practice of pharmacy: not a revolution.  
Canadian Medical Association Journal, 176(9): 1295-6. 
 
Republic of South Africa, Department of Health. (2007). Board notice: Rules 
relating to the services for which a pharmacist may levy a fee and guidelines for 
levying such a fee or fees. Government gazette number 29643, volume 500 of 23 
February 2007.  Pretoria: Government printer.  
 
Republic of South Africa, Department of Health. (2003). National Health Act (Act 
No 61 of 2003). Pretoria: Government Printer. Retrieved October 13, 2007, from 
http://www.info.gov.za/ gazette/acts/2003/a61-03.pdf 
 
Republic of South Africa, Department of Health.  (1998). Medical Schemes Act 
(Act No 131 of 1998). Pretoria: Government Printer. 
  
Republic of South Africa, Department of Health. (1997a). Medicines and Related 
Substances Control Amendment Act (Act No 101 of 1965). Pretoria: Government 
Printer. 
  
Republic of South Africa, Department of Health.  (1997b). Pharmacy Amendment 
Act, No. 53 of 1974.  Pretoria: Government Printer. 
 
Republic of South Africa, Department of Education. (1997c). Higher Education 
Act (Act 101 of 1997).  Pretoria: Government Printer. 
 
 
 
 
 164
 
Republic of South Africa. (1978). Nursing Act (Act 50 of 1978). Pretoria: 
Government Printer. 
 
Robinson, J. (1991). Project 2000: The role of resistance in the process of 
professional growth. Journal of Advanced Nursing, 16: 820-824. 
 
Rosemann, T. & Szecsenyi, J. (2004). General Pracitioners’ Attitudes Towards 
Research in Primary Care: Qualitative Results of a Cross Sectional Study. BMC 
Family Practice, 5: 31-35. 
 
Rottingen, J.E., William, C.D., & Garnett, G.P. (2001). A systematic review of 
the epidemiologic interactions between classic sexually transmitted diseases and 
HIV: How much really is known. Sexually Transmitted Diseases, 28(10): 579-
597. 
 
Royal College of General Practitioners. (2007). The primary care practice and its 
team. London: RCGP. Retrieved May 20, 2007, from http://www.rcgp.org.uk/ 
PDF/ISS_INFO _21_FEB07.pdf. 
 
Russel, B., Turnbull, D., Leibach, E.K., Pretlow, L., Arnette, A., Ranne, A., Kraj, 
B., Mobley, R. & Stone, B. (2007). Evaluating distance learning in clinical 
laboratory science. Clinical Laboratory Science, 20(2): 106-11. 
 
Sangani, P., Rutherford, G., & Wilkinson, D. (2004). Population-based 
interventions for reducing sexually transmitted infections, including HIV 
infection. Cochrane Database of Systemic Reviews, 2004 (3). Retrieved April 10, 
2007, from The Cochrane Library Database. 
 
 
 
 
 
 165
Schillinger, J.A., Kissinger. P., Cavalet, H., et al. (2003). Patient-delivered partner 
treatment with azithromycin to prevent repeated Chlamydia trachomatis infection 
among women: a randomized, controlled trial. Sexually Transmited Diseases, 30: 
49-56. 
 
Schneider, H., Chabikuli, N., Blaauw, D., Funani, I., & Brugha, R. (2005). 
Improving the quality of STI care by private general practitioners: a South 
African case study. Sexually Transmitted  Infections, 81: 419-420. 
 
Schneider, H., Blaauw, D., Dartnall, E., Coetzee, D.J., & Ballard, R.C. (2001). 
STD care in the South African private health sector. South African Medical 
Journal, 91(2): 151-6. 
 
Sihavong, A., Lundbhorg, C.S., Syhakhang, L., Akkhavong, K., Tomson, G., & 
Wahlström, R. (2006). Antimicrobial self medication for reproductive tract 
infections in two provinces in Lao’s People’s Democratic Republic. Sexually 
Transmitted Infections, 82: 182-186. 
 
Silverman, L.L (2001). Key considerations in organisational change. The 
Business Improvement Journal, 15(3): 13. 
 
Sloan, N.L. Winikoff, B., Haberland, N., Coggins, C., Elias, C. (2000). Screening 
and syndromic approaches to identify gonorrhea and chlamydial infection among 
women. Studies in Family Planning, 31(1): 55-68. 
 
Sonko, R., McCoy, D., Gosa, E., Hamelmann, C., Chabikuli, N., Moys, A., 
Ramkissoon, A., & Hlazo, J. (2003). Sexually transmitted infections: An overview 
of issues on STI management and control in South Africa. Durban: Health 
Systems Trust. 
 
 
 
 
 
 166
South African Pharmacy Council (n.d.). Stats on pharmacies.  Pretoria: South 
African Pharmacy Council. Retrieved 12 November, 2007, from 
http://www.pharmcouncil.co.za/content.asp?ContentId=60 
 
SPSS Inc., Statistics Software Version 14.0 for Windows, Release Date 05 
September 2005. Chicago, IL: SPSS Inc: 2005. 
 
Steen, R., Soliman, C., Mujyambwani, A., Twagirakristu, J.B., Bucyana, S., 
Grundmann, C., Ngabonziza, M., & Moran, J. (1998). Notes from the field: 
Practical issues in upgrading STD services based on experience from primary 
healthcare facilities in two Rwandan towns. Sexually Transmitted  Infections, 74 
(Suppl 1):S159-65. 
 
Stekler, J., Bachmann, L., Brotman, R.M., Erbelding, E.J., Lloyd, L.V., 
Rietmeijer, C.A., Handsfield, H.H., Holmes, K.K., & Golden, M.R. (2004). 
Concurrent sexually transmitted infections (STIs) in sex partners of patients with 
selected STIs: implications for patient-delivered partner therapy. Clinical 
Infectious Diseases, 40(6): 787-93. 
 
Summers, R., Haavik, C., Summers, B., Moolaa, F., Lowes, M., & Enslin, G. 
(2001). Pharmaceutical Education in the South African Multicultural Society. 
American Journal of Pharmaceutical Education, 65: 150-154. 
 
Swan, M. & Zwi, A. (1997). Private providers and public health: close the gap or 
increase the distance? PHP Publication no 24, Department of Public Health and 
Policy.  London: London School of Hygiene and Tropical Medicine. 
 
Trader-Leigh, K.E. (2002). Case Study: Identifying Resistance in Managing 
Change. Journal of Organisational Change Management, 15(2): 138-155. 
 
 
 
 
 
 167
Tuladhar, S.M., Mills, S., Acharya, S., Pradhan, M., Pollock, J., & Dallabetta G. 
(1998). The role of pharmacists in HIV/STD prevention: evaluation of an STD 
syndromic management intervention in Nepal. AIDS, 12(Suppl 2): S81-87. 
 
Turner, A., Ellerston, C., Thomas, S., & Garcia, S. (2003). Diagnosis and 
treatment of presumed STIs at Mexican pharmacies: survey results from a random 
sample of pharmacy attendants. Sexually Transmitted Infections, 79(3): 224-8. 
 
UNAIDS. (2006). Report on the global AIDS epidemic 2006. Geneva: World 
Health Organisation. Retrieved September 18, 2006, from 
http://www.unaids.org/en/ 
 
Voeten, H.A., Otido, J.M., O’Hara, H.B., Kuperus, A.G., Borsboom, G.J., 
Ndinya-Achola, J.O., Bwayo, J.J., & Habbema, J.d. (2001). Quality of sexually 
transmitted diseases case management in Nairobi, Kenya: a comparison among 
different types of healthcare facilities. Sexually Transmitted Diseases, 28(11): 
633-42. 
 
Vollman, A.R., & Martin-Misener, R. (2005). A conceptual model for nurse 
prationer practice. Canada: Canadian Nurse Practitioner Initiative 
 
Vuylsteke, B., Gjys, P.D., Mah-bi, G., Konan, Y., Traore, M., Wiktor, S.Z., & 
Laga, M. (2001). Where do sex workers go for health care? A community based 
study in Abidjan, Cote d’Ivoire. Sexually Transmitted  Infections, 77: 351-352. 
 
Wanberg, C.R., & Banas, J.T. (2000). Predictors and outcomes of openness to 
changes in a reorganising workplace. Journal of Applied Psychology, 85(1): 132-
142. 
 
 
 
 
 
 168
Ward, K., Butler, N., Mugabo, P., Klausner, J., McFarland, W., Chen, S., & 
Schwarcz, S. (2003). Provision of syndromic treatment of sexually transmitted 
infections by community pharmacists: a potentially underutilized HIV prevention 
strategy. Sexually Transmitted Diseases, 30(8): 609-613. 
 
Watson, M.C., Norris, P., & Granas, A.G. (2006). A systematic review of the use 
of simulated patients and pharmacy practice research. International Journal of 
Pharmacy Practice, 14: 83-89.  
 
Wawer, M.J., Sewankambo, N.K., Serwadda, D., Quinn, T.C., Paxton, L.A., 
Kiwanuka, N., Wabwire-Mangen, F., Li, C., Lutalo, T., Nalugoda, F., Gaydos, 
C.A., Moulton, L.H., Meehan, M.O., Ahmed, A., The Rakai Project Study Group, 
& Gray, R.H. (1999). Control of sexually transmitted diseases for AIDS 
prevention in Uganda: a randomised community trial. Lancet, 353: 525-35. 
 
Whittington, W.L.H., Kent, C., Kissinger, P., Kim-Oh, K., Fortenberry, J.D., 
Ellis, S.E., Litchfield, B., Bolan, G.A., St. Louis, M.E., Farley, T.A., & Hansfield, 
H. (2001). Determinants of persistent and recurrent Chlamydia trachomatis 
infection in young women –results of a multicentre cohort study. Sexually 
Transmitted Diseases, 28(2): 117-23. 
 
Wiedenmayer, K., Summers, R.S., Mackie, C.A., Gous, A.G.S., & Everard, M. 
(2006). Developing pharmacy practice: a focus on patient care. Geneva: World 
Health Organisation, 87. 
 
Wilcoxon, F. (1945).  Individual comparisons by ranking methods.  Biometrics, 1: 
80-83. 
 
 
 
 
 
 169
Wilkinson, D., Connolly, A., Harrison, A., Lurie, M., & Abdool, K.S. (1998).  
Sexually transmitted disease syndromes in rural South Africa: Results from health 
facility surveillance. Sexually Transmitted Diseases, 25: 20-25. 
 
Wolday, D., Gebremariam, Z., Mohammed, Z., Dorigo-Zetsma, W., Meles, H., 
Messele, T., Geyid, A., Sanders, E., & Maayan, S. (2004). The impact of 
syndromic treatment of sexually transmitted diseases on genital shedding of HIV-
1. AIDS, 18(5): 781-785. 
 
World Health Organisation. (2003). Guidelines for the management of sexually 
transmitted infections. Geneva: World Health Organisation. WHO document 
WHO/HIV-AIDS/2003.01. 
 
World Health Organisation. (2001). Guidelines for the management of sexually 
transmitted infections.  Geneva:  World Health Organisation. WHO document 
WHO/HIV-AIDS/2001.01. 
 
World Health Organisation. (2000). The world health report 2000 - Health 
systems: improving performance. Geneva:  World Health Organisation. Retrieved 
October 11, 2007, from http://www.who.int/whr/2000/en/ 
World Health Organisation.  (1997). STD Case Management: The syndromic 
approach for primary health care settings. A training manual. Geneva: World 
Health Organisation.  Retrieved February 18, 2006, from 
http://www.wpro.who.int/NR/rdonlyres/73F8E5F9-BFEA-4895-AAF8-
3079AD4F104F/0/ParticipantsVersion.pdf 
World Health Organisation. (1978). Primary Health Care. Report of the 
International Conference on Primary Health Care. Alma Ata, 6–12 September 
1978.  Geneva: World Health Organisation.  
 
 
 
 
 170
APPENDIX I
 
 
  
 
 
Source: South African Health Review (Dayi & Gray, 2006) 
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APPENDIX II 
 
 
 
 
 
 
FACULTY of NATURAL SCIENCES 
SCHOOL OF PHARMACY 
 
CONSENT TO PARTICIPATE IN RESEARCH 
 
Expanding Presumptive Partner Management Of Sexually Transmitted Infections 
(STIs) To Western Cape, South African Community Retail Pharmacies: An 
Intervention Study. 
  
Purpose and Background 
Kim Ward (M. Pharm.), Professor Nadine Butler, and Prof. Peirre Mugabo from the 
University of Western Cape, School of Pharmacy are conducting a research study to 
measure the impact of providing training on the syndromic management of sexually 
transmitted infections to community pharmacists will have on their treatment 
practices. 
 
A previous study of community pharmacists in the Western Cape confirmed 
anecdotal reports that patients often seek care for symptomatic sexually transmitted 
infections from community pharmacists. This study also identified knowledge gaps in 
syndromic management of sexually transmitted infections and demonstrated 
willingness on the part of community pharmacists to be trained in order to provide 
syndromic treatment for sexually transmitted infections.  
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You are being asked to participate in this study because you are a registered 
community pharmacist in the Western Cape. 
 
Procedures 
If you agree to participate in this study the following will occur: 
1. You will participate in an STI distance-learning course on the theoretical 
aspects of syndromic management of sexually transmitted infections. 
2. You will complete a written test that will assess knowledge of the 
theoretical aspects of syndromic management of sexually transmitted 
infections before the course begins. 
3. You will complete a written test that will assess knowledge of the 
theoretical aspects of syndromic management of sexually transmitted 
infections after completing the course. 
4. After the post-test you will be selected to either receive patient treatment 
packets to be distributed to simulated (mock) male partners who seek care 
for asymptomatic genital ulcer disease or urethral discharge or not to 
receive these packets.  
5. You will receive a copy of manuals that describe treatment protocols for 
syndromic management of sexually transmitted infections. 
6. You will receive visits by six male research staff who will pose as sexual 
contacts of patients with urethral discharge or genital ulcer disease. 
7. You will treat these simulated partners as per study directive  (referring 
elsewhere or counselling and providing a prescription for filling at public 
health dispensary). 
8. These research staff will identify themselves as simulated patients after 
you have completed the management of their complaints. 
9. The research staff will complete a form that indicates how you managed 
their cases. 
10. You will be provided with written feedback from the investigators 
regarding how well you managed the simulated patients. 
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Risks/discomforts 
1. The pre- and post-tests and materials presented in the training course may be 
unfamiliar. You may feel some discomfort learning about sexually transmitted 
diseases or your performance in the course. 
2. You are free to discontinue the course and end your participation in the study 
at any time. 
3. You may discuss your discomfort with the training staff. 
4. Participation in research may involve a loss of privacy; however, your records 
will be handled as confidentially as possible. Your names will not be used on 
the pre- or post- tests or other printed materials associated with the study. You 
name will be linked to your study number and only research staff will have 
access to this linking file. Any publications or presentations of the findings 
from this study will not include personally identifying information. 
 
Benefits 
You may increase your knowledge of the theoretical aspects of syndromic 
management of sexually transmitted infections. This may assist you in the service 
you provide to patients who request information and or treatment from you at your 
pharmacy. There may be a societal benefit if presumptive partner management by 
community pharmacists reduces the incidence and prevalence of sexually transmitted 
infections and thereby, possibly reduce transmission and acquisition of HIV infection. 
 
Costs 
You will be required to fax this consent form  back to the research assistant. 
 
Questions 
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You have talked to Mrs. L. Maritz about this study and have had your current 
questions answered. If you have additional questions you may call her or Ms Ward at 
the University of Western Cape, School of Pharmacy (telephone:021-9593440). 
 
If you have any comments or concerns about participation in this study, you should 
first talk with the researchers. If for some reason you do not wish to do this, you may 
contact the Committee on Human Research, which is concerned with the protection 
of volunteers in research projects. You may reach the University of California 
committee office between 8:00 and 16:00 Monday through Friday by calling 091 415 
476 1814 or by writing: Committee on Human Research, Box 0962, University of 
California, San Francisco, CA, USA 94143 
 
Consent 
You will be given a copy of this consent form to keep. 
 
Participation in research is voluntary. You are free to decline to be in this study, or to 
withdraw from it at any point without penalty of loss of benefits to which you are 
otherwise entitled.  If you agree to participate, you should sign below. 
 
 
 
______________    _____________________________ 
Date      Signature of study participant 
 
_____________             _____________________________ 
Date              Signature of person obtaining consent 
 
PLEASE RETURN BY FAX TO MRS MARITZ AT 021-9593407 
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APPENDIX III 
 
STD CASE MANAGEMENT 
THE SYNDROMIC APPROACH   
FOR PRIMARY HEALTH CARE SETTINGS 
 
THE TRAINING MODULES 
MODULE 1:  
THE PUBLIC HEALTH SIGNIFICANCE OF STDS 
• The epidemiology of STDs. 
• Why STDs are a major burden for individuals, families, health services and 
national economies. 
• The impact of STDs in the Western Pacific Region. 
• The reasons for using the syndromic approach. 
 
LEARNING OBJECTIVES 
• Identify how STDs are transmitted and the factors that influence transmission. 
• Appreciate the complications that can result from untreated STDs. 
• Explore the extent of STDs, the true level of infection in a population, and 
why these are sometimes difficult to see from statistics. 
• Understand how STDs are linked with the spread of HIV. 
 
• Explain why the control of STD is so difficult, and what must be done to achieve 
control. 
• Talk about STD rates in your country or area and explain why these rates may or 
may not reflect the true STD burden    
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• Explain some of the serious consequences and complications that can arise if 
STDs are left undiagnosed and untreated.  
• Describe the two-way link between STDs and the spread of HIV and 
explain why STD control is important for HIV prevention.   
    
    
MODULE 2:  
USING FLOW-CHARTS  
FOR SYNDROMIC MANAGEMENT 
• Traditional approaches to STD case management and their limitations. 
• The syndromic approach. 
• The benefits of the syndromic approach for treating and preventing STDs. 
• Flow-charts. 
• How flow-charts are used to diagnose and treat STDs. 
 
LEARNING OBJECTIVES 
• Describe the problems with syndromic approach to treating patients with ST 
• Describe the advantages that syndromic case management offers. 
• Identify the main features and benefits of syndromic case management. 
• Explain that there are different steps specified by flow-charts  to diagnose an 
STD syndrome and treat patients. 
• Identify your further learning needs, which will depend on your responsibilities as 
a member of a health care team. 
• Be able to defend the using traditional approaches to those who criticize it. 
 
MODULE 3:  
HISTORY-TAKING AND EXAMINATION 
• Verbal and non-verbal communication skills. 
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• How to interview and examine patients comfortably to get the greatest benefit 
from the flow charts when diagnosing an STD syndrome. 
 
LEARNING OBJECTIVES 
• Identify the four areas of information to cover during the interview. 
• Recall the steps in conducting a clinical examination for men and women. 
• List both non-verbal and verbal communication skills. 
• Explain the value of using communication skills to gather information effectively, 
conduct a clinical examination and ensure patient compliance. 
• Describe the challenges of interviewing a patient with a suspected STD and the 
need to offer privacy and confidentiality. 
• Explain the importance of demonstrating your respect for each patient. 
• Use the techniques, including several non-verbal skills, to establish rapport with 
a patient and begin a productive encounter. 
• Ask questions effectively, keeping them free of moral judgement, preserving  
 confidentiality, and using clear words that patient’s understand. 
• Use verbal skills to respond to a patient's emotions appropriately. 
• Use open and closed questions appropriately and employ techniques to improve 
two-way communication with patients. 
• Conduct an efficient examination of both male and female patients. 
• Anticipate patients' anxiety and embarrassment, and acknowledge your own 
feelings. 
 
MODULE 4:  
DIAGNOSIS AND TREATMENT 
• The flow-charts for four syndromes, including specific signs and symptoms and a 
list of recommended drugs for each condition. 
• The options for treating a patient with an STD syndrome. 
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LEARNING OBJECTIVES 
• Remember and name the decisions and actions that consitute the four flow-
charts to diagnose STD accurately. 
• List the drug therapies and dosages for each diagnosis. 
• Identify which drugs are recommended compared with those you have available 
in your health centre. 
• Explain that patient education on a number of important issues and partner  
referral are a part of all the flow-charts. 
• Use the four flow-charts to make a clinical diagnosis for a variety of case studies. 
• Give the correct drug therapies and dosages for each diagnosis. 
 
MODULE 5:  
EDUCATING THE PATIENT 
• Practical ways to inform and motivate patients about what they can do to help 
cure their infection(s) and prevent another one in the future. 
• Skills to make education more effective. 
 
LEARNING OBJECTIVES 
• Explain the differences between information-giving and education to encourage 
behaviour change. 
• Explain why educating and motivating patients is vital in STD case management. 
• Identify the main topics on which to educate STD patients. 
• Identify six skills that will help you to educate and motivate patients. 
• List the benefits of using condoms. 
• Recall the basic steps for putting on condoms. 
• Recognize and use a range of communications skills and a range of education 
skills for encouraging behaviour change in patients. 
• Explain the benefits of using condoms to the patients. 
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• Demonstrate correct use of condom. 
 
MODULE 6:  
PARTNER MANAGEMENT 
•  Why partner management is important. 
• Two methods of partner management. 
• A practical approach to treating the partners of patients whom you have 
diagnosed with a STD syndrome. 
 
LEARNING OBJECTIVES 
• Discuss the importance of partner management. 
• Explain its possible impact on individuals. 
• List the differences between patient referral and provider referral. 
• List the four issues to discuss with the patient. 
• Name the skills to use when educating STD patients  on the need to treat 
partners. 
• Describe the value of referral cards at the health centre. 
• Describe how to manage a referred partner based on the patient’s diagnosis. 
• Demonstrate the ability to manage a patient's partners, while maintaining each  
person's confidentiality. 
• Demonstrate the ability to identify proper treatment action for a referred partner  
based on the patient’s diagnosis. 
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APPENDIX IV 
 
PRE- AND POST-TRAINING TEST  
 
 
Study number:  _________________________________________ 
 
Region:    Rural    Urban  
 
Pharmacist’s gender    Male    Female  
 
 
Pharmacist’s age in years:   < 30    30-39 
              40-49    50-59 
              60-69  
 
Pharmacist’s year of graduation:        <1990                ≥1990 
 
Total test score (out of 15marks):  ____             
 
Total test score percentage:  ____%   
 
 
Question 1 (7 marks)        
Indicate which STIs are curable or incurable by ticking the appropriate box (?). 
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    Curable  Incurable 
a) HIV/AIDS 
  
b) Syphilis 
 
c) Chlamydia 
 
d) Gonorrhoea 
 
e) Herpes 
 
f) Trichomoniasis 
 
g) Candidiasis 
 
h) Chancroid    
 
 
Question 2 (1 mark) 
The STI most likely to facilitate HIV transmission is: 
a) Genital ulcer syndrome 
b) Any STI that causes genital inflammation 
c) An STI that causes urethral discharge or cervicitis 
d) An STI that causes vaginitis 
 
Question 3 (1 mark) 
Which of the following is the most high risk behaviour for STI? 
a) A man having unprotected oral sex with another man  
b) A man and a sex worker/prostitute having vaginal sex without a condom 
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c) Receiving manual stimulation (hand job) from a prostitute 
 
Question 4 (1 mark) 
A 21-year old man is complaining of frequent urination.  After taking a history and 
examining him, you now know that he has some discharge from his penis.  You also 
learn that he is recently married to a very young woman and has had unprotected 
intercourse with three different prostitutes since his wedding day.  The BEST 
RESPONSE of the health worker is: 
a) We will treat you today but it is important to treat your wife as soon as 
possible.  Let’s talk about how to do that. 
b) We will treat you today and if your wife has similar symptoms to yours, she 
must go to her doctor right away. 
c) It is critical for your wife to be treated immediately.  If she is pregnant, this 
could cause big problems for her or the baby. 
 
Question 5 (1 mark) 
A 30-year old male has a three-day history of a thick, greenish discharge from his 
penis.  He has received a stat dose of medication at a health facility.  He returns in 
one week still complaining of a discharge.  Which of the following is likely to be an 
explanation of the persistent discharge? 
a) He had gonorrhoea, but has been reinfected. 
b) The cause of his discharge was chlamydia infection 
c) He had gonorrhoea which was resistant to the treatment given. 
d)  He was infected initially with both gonorrhoea and chlamydia 
 
Question 6 (1 mark) 
The practice of treating for two different types of genital ulcer disease (chancroid 
and syphilis) at the same time is: 
a) Bad because an individual is rarely infected with two different pathogens 
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b) Wasteful because a good clinical examination will almost always lead to a 
specific diagnosis 
c) Necessary because it is difficult to predict clinically the cause of many genital 
ulcers 
d) Dangerous because of drug interactions 
 
Question 7 (1 mark) 
The protection against HIV provided by using condoms properly for each act of 
sexual intercourse is best expressed as: 
a) 25% 
b) 65% 
c) 95% 
 
Question 8 (1 mark) 
Which drugs are used in the syndromic management of STI to treat urethral 
discharge? 
 
Question 9 (1 mark) 
Which drugs are used in the syndromic management of STI to treat genital ulcers? 
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APPENDIX V 
 
 
 
 
 
 
FACULTY of NATURAL SCIENCES 
SCHOOL OF PHARMACY    
 
 
Date:   
Dear pharmacist, 
 
We would like to thank you for your participation in the training phase of the project 
entitled: “The impact of an STI intervention on the syndromic management of STI in 
community pharmacies”.  Your participation has assisted us in evaluating the impact 
of a short STI correspondence course on the knowledge of STI management. 
Dissemination of the results at this point would be premature, given the incomplete 
statistical computation; however a reference to the final published work will be made 
available in the future.   
  
We are now embarking on the second phase of this study: the provision of STI 
services in community pharmacies. We have enlisted the co-operation of local health 
authorities for the implementation of this phase; the sexual partners of individuals 
diagnosed and treated for an STI at neighbouring public STI clinics, will, for the 
purposes of the study be diverted to selected pharmacies for management by way of a 
partner notification slip bearing the encoded diagnosis of the index patient and the 
private community retail pharmacy as an alternative option to a public health clinic 
for seeking management. Interspersed with these real patients, we will send mock 
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patients to your pharmacy over the next 6 months to gather data pertaining to your 
proficiency in STI management.  Mock patients will not be disparate from actual 
patients and you are therefore encouraged to manage every case equally. Partner 
treatment is based on the diagnosis of the index patient in the event of the partner 
being asymptomatic; conversely, if the partner presents with specific symptoms, the 
treatment is based on his/her clinical presentation (see manual for clarification). 
 
STI management offered in pharmacies will not encompass any legally prohibitive 
actions such as conducting a physical examination or prescribing and dispensing of 
antimicrobials.  It may however, at your discretion entail some or all of the following: 
 
• Diagnosing the syndrome (using flowcharts) to be treated based on the 
diagnosis of the partner and/or the presentation of symptoms 
 
• Reaching a treatment decision based on rational pharmacotherapy and in line 
with the flowcharts 
 
• Writing out a prescription for the antimicrobials – valid for the purposes of 
this study for filling at a nearby public health dispensary free of charge.  
 
• Counselling and educating patient about disease. 
 
We implore you, as the pharmacist enrolled in this study, to attend to patients for this 
study.  The data collected from any other pharmacist will render results invalid. 
 
We have enclosed STI information packets intended to facilitate your provision of 
STI management. You may incorporate them into your counselling session with 
clients and dispense them to study patients at no cost.  
 
 
 
 
 
 186
Also included in the package received, is a sample partner notification slip which 
patients will produce to you.  These slips will be encoded with the diagnosis of the 
index patient which can be decoded by making quick reference to the manual 
provided as part of the course material (pg. 9 of “Guidelines for the syndromic 
management of STI in the Western Cape”).  Any patient presenting with an STI, yet 
failing to produce a contact slip, are not enrolled in the study, and you may handle 
these cases as you ordinarily would. 
  
A researcher should contact you shortly to confirm your receipt of this package and to 
answer any questions you may have. 
 
Kind regards 
 
 
Kim Ward (M.Pharm) 
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APPENDIX VI 
 
 
 
 
 
 
 
This person’s partner was treated for: 
 
                           
 
 
 
 
 
 
   
Please provide the appropriate syndromic management.  
 For any questions, please call telephone number below. 
 
 
Name: _____________________________  Signature: _______________________ 
 
 
 
Date: ___________         Clinic Stamp: 
 
Tel:_________________Fax:__________________ 
MUS 
VDS 
LAP 
GUS 
SSW 
BAL 
GW 
PL 
MC 
RPR+ 
PARTNER NOTIFICATION SLIP               DEPARTMENT OF HEALTH 
 
CLINIC NAME: 
 
 
 
Dear Madam/Sir, 
 
Please go to a clinic as soon as possible. Although you might feel well, you need to 
be treated.  
Take this slip with you to the clinic.  
                
Besoek asseblief u naaste kliniek. Al voel u gesond, het u steeds behandeling nodig. 
Neem hierdie briefie saam na die kliniek.        
 
Nceda uye ekliniki msinyane. Noxa usiva ngathi uphilile kufuneka ufumene unyango. 
Yiza neliphetshana e kliniki 
 
 
THANKYOU                                           DANKIE                                             ENKOSI
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APPENDIX VII 
 
CLINICAL MANAGEMENT ASSESSMENT FORM 
A.  In the management of the simulated client, did the pharmacist broach the 
following 13 elements of counselling? 
 Yes No 
1. Inform about STIs transmission      
2. Inform about STI signs and symptoms   
3. Explain importance of prompt treatment   
4. Mention possible complications   
5. Risk of HIV transmission   
6. Promote VCT   
7. Counsel about risk reduction   
8. Promote condom use   
9. Provide/sell/attempt to sell a condom   
10. Explain how to use a condom   
11. Promote abstinence for the duration of 
treatment 
  
12. Explain the importance of completing treatment   
13. Promote treatment of other partners   
 
B.  Did the pharmacist prescribe the correct treatment regimen (according to 
WC treatment guidelines)?    
 
Yes    No  
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APPENDIX VIII 
 
 
 
 
 
 
 
FACULTY of NATURAL SCIENCES 
SCHOOL OF PHARMACY 
 
 
CONSENT TO PARTICIPATE IN RESEARCH 
 
Resistance To Change: Predictor Of Poor Participation In STI Training Course By 
Community Retail Pharmacists? 
 
Purpose and Background 
Kim Ward (M. Pharm.) from the University of Western Cape, School of Pharmacy is 
conducting an exit interview with a sample of participants and non-participants from 
the study entitled, “Extending presumptive partner management of sexually 
transmitted infections to Western Cape, South African community retail pharmacies: 
An intervention study.”  The poor enrollment into the aforementioned study will be 
investigated to determine  underlying contributory factors. 
  
You are being asked to participate in this study because you were approached to 
participate in the above-mentioned study. 
 
Procedures 
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If you agree to participate in this study, you will participate in a telephonic interview 
that will last 7-8 minutes. 
 
Risks/discomforts 
Participation in research may involve a loss of privacy; however your records will be 
handled as confidentially as possible.  Your name and location of your pharmacy will 
not appear on the questionnaire and will only be linkable by code. 
 
Costs 
You will be required to fax this consent form back to the research assistant. 
 
Questions 
You have talked to James Stocken about this study and have had your current 
questions answered. If you have additional questions you may call him or Ms Ward at 
the University of Western Cape, School of Pharmacy (telephone:021-9593440). 
 
Consent 
You will be given a copy of this consent form to keep. 
 
Participation in research is voluntary. You are free to decline to be in this study, or to 
withdraw from it at any point without penalty of loss of benefits to which you are 
otherwise entitled.  If you agree to participate, you should sign below. 
 
______________    _____________________________ 
Date      Signature of study participant 
 
_____________             _____________________________ 
Date                 Signature of person obtaining consent 
 
PLEASE RETURN BY FAX TO JAMES STOCKEN AT 021-9593407 
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APPENDIX IX 
 
RESISTANCE TO CHANGE QUESTIONNAIRE 
 
 
Study number:  _________________________________________ 
 
Region:    Rural    Urban  
 
Pharmacist’s gender   Male    Female  
 
 
Pharmacist’s age in years:  < 30    30-39 
              40-49    50-59 
             60-69  
 
Pharmacist’s year of graduation:  <1990    ≥1990 
 
 
Please provide the most appropriate answer, where 1 indicates 
strongly disagree and 6 indicates strongly agree 
 
 
1. I generally consider changes to be a positive thing.  
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
 
 
2. Once I’ve come to a conclusion, I’m not likely to change my mind. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
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3. I like to do the same old things rather than try new and different ones. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
 
 
4. Often, I feel a bit uncomfortable even a about changes that may 
potentially improve my life. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
 
 
5. I’d rather be bored than surprised. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
 
 
6. If I were to be informed that there’s going to be a significant change 
regarding the way things are done at work, I would probably feel 
stressed. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
 
 
 
 
 
7. Once I’ve made plans, I am not likely to change them 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
                       
 
8. When things don’t go according to plans, it stresses me out. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
 
 
9. I often change my mind 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
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10.  My views are very consistent over time. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
                       
 
11.  Whenever my life forms a stable routine, I look for ways to change it. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
                       
 
12.  When someone pressures me to change something, I tend to resist 
even if I think the change might benefit me. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
                       
 
13.  When I am informed of a change of plans, I tense up a bit. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
                       
 
14.  I sometimes find myself avoiding changes that I know will be good 
for me. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
                       
 
15.  If my boss changed the criteria for evaluating employees, it would 
make me feel uncomfortable even though I would do just as well without 
having to do any extra work. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
                       
 
16.  I’ll take a routine day over a day full of unexpected events any time 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
 
 
17.  I change my mind easily. 
1 2 3 4 5 6 
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   Strongly disagree                                                             Strongly agree 
                       
 
18.  Changing plans seems like a real hassle to me. 
1 2 3 4 5 6 
   Strongly disagree                                                             Strongly agree 
                       
 
 
 
 
Thank you for your time and cooperation. 
 
 
 
 
 
